id	sid	tid	token	lemma	pos
ffhd-35	1	1	effect	effect	NOUN
ffhd-35	1	2	of	of	ADP
ffhd-35	1	3	an	an	DET
ffhd-35	1	4	aqueous	aqueous	ADJ
ffhd-35	1	5	extract	extract	NOUN
ffhd-35	1	6	of	of	ADP
ffhd-35	1	7	dichrostachys	dichrostachy	NOUN
ffhd-35	1	8	glomerata	glomerata	NOUN
ffhd-35	1	9	on	on	ADP
ffhd-35	1	10	anthropometric	anthropometric	ADJ
ffhd-35	1	11	,	,	PUNCT
ffhd-35	1	12	lipid	lipid	NOUN
ffhd-35	1	13	and	and	CCONJ
ffhd-35	1	14	inflammatory	inflammatory	ADJ
ffhd-35	1	15	parameters	parameter	NOUN
ffhd-35	1	16	of	of	ADP
ffhd-35	1	17	obese	obese	ADJ
ffhd-35	1	18	patients	patient	NOUN
ffhd-35	1	19	with	with	ADP
ffhd-35	1	20	metabolic	metabolic	NOUN
ffhd-35	1	21	syndrome	syndrome	NOUN
ffhd-35	1	22	functional	functional	ADJ
ffhd-35	1	23	foods	food	NOUN
ffhd-35	1	24	in	in	ADP
ffhd-35	1	25	health	health	NOUN
ffhd-35	1	26	and	and	CCONJ
ffhd-35	1	27	disease	disease	NOUN
ffhd-35	1	28	2013	2013	NUM
ffhd-35	1	29	;	;	PUNCT
ffhd-35	1	30	3(11):416	3(11):416	NUM
ffhd-35	1	31	-	-	SYM
ffhd-35	1	32	427	427	NUM
ffhd-35	1	33	page	page	NOUN
ffhd-35	1	34	416	416	NUM
ffhd-35	1	35	of	of	ADP
ffhd-35	1	36	427	427	NUM
ffhd-35	1	37	research	research	NOUN
ffhd-35	1	38	article	article	NOUN
ffhd-35	1	39	open	open	VERB
ffhd-35	1	40	access	access	NOUN
ffhd-35	1	41	anti	anti	ADJ
ffhd-35	1	42	-	-	ADJ
ffhd-35	1	43	inflammatory	inflammatory	ADJ
ffhd-35	1	44	,	,	PUNCT
ffhd-35	1	45	anthropometric	anthropometric	ADJ
ffhd-35	1	46	and	and	CCONJ
ffhd-35	1	47	lipomodulatory	lipomodulatory	ADJ
ffhd-35	1	48	effects	effect	NOUN
ffhd-35	1	49	dyglomera	dyglomera	NOUN
ffhd-35	1	50	®	®	NOUN
ffhd-35	1	51	(	(	PUNCT
ffhd-35	1	52	aqueous	aqueous	ADJ
ffhd-35	1	53	extract	extract	NOUN
ffhd-35	1	54	of	of	ADP
ffhd-35	1	55	dichrostachys	dichrostachy	NOUN
ffhd-35	1	56	glomerata	glomerata	NOUN
ffhd-35	1	57	)	)	PUNCT
ffhd-35	1	58	in	in	ADP
ffhd-35	1	59	obese	obese	ADJ
ffhd-35	1	60	patients	patient	NOUN
ffhd-35	1	61	with	with	ADP
ffhd-35	1	62	metabolic	metabolic	NOUN
ffhd-35	1	63	syndrome	syndrome	NOUN
ffhd-35	1	64	dieudonne	dieudonne	PROPN
ffhd-35	1	65	kuate	kuate	PROPN
ffhd-35	1	66	abd	abd	PROPN
ffhd-35	1	67	,	,	PUNCT
ffhd-35	1	68	blanche	blanche	PROPN
ffhd-35	1	69	c.	c.	PROPN
ffhd-35	1	70	etoundi	etoundi	PROPN
ffhd-35	1	71	ac	ac	PROPN
ffhd-35	1	72	,	,	PUNCT
ffhd-35	1	73	judith	judith	PROPN
ffhd-35	1	74	l.	l.	PROPN
ffhd-35	1	75	ngondi	ngondi	PROPN
ffhd-35	1	76	,	,	PUNCT
ffhd-35	1	77	a	a	DET
ffhd-35	1	78	wan	wan	PROPN
ffhd-35	1	79	abdul	abdul	PROPN
ffhd-35	1	80	manan	manan	PROPN
ffhd-35	1	81	bin	bin	PROPN
ffhd-35	1	82	wan	wan	PROPN
ffhd-35	1	83	muda	muda	PROPN
ffhd-35	1	84	d	d	PROPN
ffhd-35	1	85	and	and	CCONJ
ffhd-35	1	86	julius	julius	PROPN
ffhd-35	1	87	e.	e.	PROPN
ffhd-35	1	88	oben	oben	PROPN
ffhd-35	2	1	a	a	PRON
ffhd-35	2	2	*	*	PUNCT
ffhd-35	2	3	a	a	DET
ffhd-35	2	4	laboratory	laboratory	NOUN
ffhd-35	2	5	of	of	ADP
ffhd-35	2	6	nutrition	nutrition	NOUN
ffhd-35	2	7	and	and	CCONJ
ffhd-35	2	8	nutritional	nutritional	ADJ
ffhd-35	2	9	biochemistry	biochemistry	NOUN
ffhd-35	2	10	,	,	PUNCT
ffhd-35	2	11	department	department	NOUN
ffhd-35	2	12	of	of	ADP
ffhd-35	2	13	biochemistry	biochemistry	NOUN
ffhd-35	2	14	,	,	PUNCT
ffhd-35	2	15	faculty	faculty	NOUN
ffhd-35	2	16	of	of	ADP
ffhd-35	2	17	science	science	NOUN
ffhd-35	2	18	,	,	PUNCT
ffhd-35	2	19	university	university	NOUN
ffhd-35	2	20	of	of	ADP
ffhd-35	2	21	yaounde	yaounde	PROPN
ffhd-35	2	22	1	1	NUM
ffhd-35	2	23	,	,	PUNCT
ffhd-35	2	24	yaounde	yaounde	PROPN
ffhd-35	2	25	,	,	PUNCT
ffhd-35	2	26	cameroon	cameroon	PROPN
ffhd-35	2	27	;	;	PUNCT
ffhd-35	2	28	b	b	X
ffhd-35	2	29	department	department	NOUN
ffhd-35	2	30	of	of	ADP
ffhd-35	2	31	biochemistry	biochemistry	NOUN
ffhd-35	2	32	,	,	PUNCT
ffhd-35	2	33	faculty	faculty	NOUN
ffhd-35	2	34	of	of	ADP
ffhd-35	2	35	science	science	NOUN
ffhd-35	2	36	,	,	PUNCT
ffhd-35	2	37	university	university	PROPN
ffhd-35	2	38	of	of	ADP
ffhd-35	2	39	dschang	dschang	PROPN
ffhd-35	2	40	;	;	PUNCT
ffhd-35	2	41	c	c	PROPN
ffhd-35	2	42	department	department	PROPN
ffhd-35	2	43	of	of	ADP
ffhd-35	2	44	biochemistry	biochemistry	NOUN
ffhd-35	2	45	,	,	PUNCT
ffhd-35	2	46	faculty	faculty	NOUN
ffhd-35	2	47	of	of	ADP
ffhd-35	2	48	science	science	NOUN
ffhd-35	2	49	,	,	PUNCT
ffhd-35	2	50	university	university	NOUN
ffhd-35	2	51	of	of	ADP
ffhd-35	2	52	douala	douala	PROPN
ffhd-35	2	53	;	;	PUNCT
ffhd-35	2	54	d	d	X
ffhd-35	2	55	program	program	NOUN
ffhd-35	2	56	in	in	ADP
ffhd-35	2	57	nutrition	nutrition	NOUN
ffhd-35	2	58	,	,	PUNCT
ffhd-35	2	59	school	school	NOUN
ffhd-35	2	60	of	of	ADP
ffhd-35	2	61	health	health	PROPN
ffhd-35	2	62	sciences	sciences	PROPN
ffhd-35	2	63	universiti	universiti	PROPN
ffhd-35	2	64	sains	sain	VERB
ffhd-35	2	65	malaysia	malaysia	PROPN
ffhd-35	2	66	,	,	PUNCT
ffhd-35	2	67	16150	16150	NUM
ffhd-35	2	68	kubang	kubang	PROPN
ffhd-35	2	69	kerian	kerian	PROPN
ffhd-35	2	70	kelantan	kelantan	PROPN
ffhd-35	2	71	,	,	PUNCT
ffhd-35	2	72	malaysia	malaysia	PROPN
ffhd-35	2	73	*	*	PUNCT
ffhd-35	2	74	corresponding	correspond	VERB
ffhd-35	2	75	author	author	NOUN
ffhd-35	2	76	:	:	PUNCT
ffhd-35	2	77	julius	julius	PROPN
ffhd-35	2	78	e.	e.	PROPN
ffhd-35	2	79	oben	oben	PROPN
ffhd-35	2	80	:	:	PUNCT
ffhd-35	2	81	laboratory	laboratory	NOUN
ffhd-35	2	82	of	of	ADP
ffhd-35	2	83	nutrition	nutrition	NOUN
ffhd-35	2	84	and	and	CCONJ
ffhd-35	2	85	nutritional	nutritional	ADJ
ffhd-35	2	86	biochemistry	biochemistry	NOUN
ffhd-35	2	87	,	,	PUNCT
ffhd-35	2	88	department	department	NOUN
ffhd-35	2	89	of	of	ADP
ffhd-35	2	90	biochemistry	biochemistry	NOUN
ffhd-35	2	91	,	,	PUNCT
ffhd-35	2	92	faculty	faculty	NOUN
ffhd-35	2	93	of	of	ADP
ffhd-35	2	94	science	science	NOUN
ffhd-35	2	95	,	,	PUNCT
ffhd-35	2	96	university	university	NOUN
ffhd-35	2	97	of	of	ADP
ffhd-35	2	98	yaounde	yaounde	PROPN
ffhd-35	2	99	1	1	NUM
ffhd-35	2	100	,	,	PUNCT
ffhd-35	2	101	po	po	PROPN
ffhd-35	2	102	box	box	PROPN
ffhd-35	2	103	812	812	PROPN
ffhd-35	2	104	yaounde	yaounde	PROPN
ffhd-35	2	105	,	,	PUNCT
ffhd-35	2	106	cameroon	cameroon	PROPN
ffhd-35	2	107	.	.	PUNCT
ffhd-35	3	1	submission	submission	NOUN
ffhd-35	3	2	date	date	NOUN
ffhd-35	3	3	:	:	PUNCT
ffhd-35	3	4	october	october	PROPN
ffhd-35	3	5	8	8	NUM
ffhd-35	3	6	,	,	PUNCT
ffhd-35	3	7	2013	2013	NUM
ffhd-35	3	8	;	;	PUNCT
ffhd-35	3	9	acceptance	acceptance	NOUN
ffhd-35	3	10	date	date	NOUN
ffhd-35	3	11	:	:	PUNCT
ffhd-35	3	12	november	november	PROPN
ffhd-35	3	13	11	11	NUM
ffhd-35	3	14	,	,	PUNCT
ffhd-35	3	15	2013	2013	NUM
ffhd-35	3	16	;	;	PUNCT
ffhd-35	3	17	publication	publication	NOUN
ffhd-35	3	18	date	date	NOUN
ffhd-35	3	19	:	:	PUNCT
ffhd-35	3	20	november	november	PROPN
ffhd-35	3	21	18	18	NUM
ffhd-35	3	22	,	,	PUNCT
ffhd-35	3	23	2013	2013	NUM
ffhd-35	3	24	running	running	NOUN
ffhd-35	3	25	title	title	NOUN
ffhd-35	3	26	:	:	PUNCT
ffhd-35	3	27	anti	anti	X
ffhd-35	3	28	metabolic	metabolic	ADJ
ffhd-35	3	29	syndrome	syndrome	NOUN
ffhd-35	3	30	effects	effect	NOUN
ffhd-35	3	31	of	of	ADP
ffhd-35	3	32	dyglomera	dyglomera	NOUN
ffhd-35	3	33	®	®	NOUN
ffhd-35	3	34	abstract	abstract	ADJ
ffhd-35	3	35	background	background	NOUN
ffhd-35	3	36	:	:	PUNCT
ffhd-35	3	37	increased	increase	VERB
ffhd-35	3	38	visceral	visceral	ADJ
ffhd-35	3	39	fat	fat	NOUN
ffhd-35	3	40	,	,	PUNCT
ffhd-35	3	41	dyslipidemia	dyslipidemia	NOUN
ffhd-35	3	42	and	and	CCONJ
ffhd-35	3	43	increased	increase	VERB
ffhd-35	3	44	markers	marker	NOUN
ffhd-35	3	45	of	of	ADP
ffhd-35	3	46	inflammation	inflammation	NOUN
ffhd-35	3	47	and	and	CCONJ
ffhd-35	3	48	coagulation	coagulation	NOUN
ffhd-35	3	49	are	be	AUX
ffhd-35	3	50	cardiovascular	cardiovascular	ADJ
ffhd-35	3	51	risk	risk	NOUN
ffhd-35	3	52	factors	factor	NOUN
ffhd-35	3	53	commonly	commonly	ADV
ffhd-35	3	54	encountered	encounter	VERB
ffhd-35	3	55	in	in	ADP
ffhd-35	3	56	obese	obese	ADJ
ffhd-35	3	57	people	people	NOUN
ffhd-35	3	58	with	with	ADP
ffhd-35	3	59	metabolic	metabolic	NOUN
ffhd-35	3	60	syndrome	syndrome	NOUN
ffhd-35	3	61	.	.	PUNCT
ffhd-35	4	1	previous	previous	ADJ
ffhd-35	4	2	studies	study	NOUN
ffhd-35	4	3	have	have	AUX
ffhd-35	4	4	shown	show	VERB
ffhd-35	4	5	that	that	SCONJ
ffhd-35	4	6	ground	ground	NOUN
ffhd-35	4	7	dichrostachys	dichrostachys	PROPN
ffhd-35	4	8	glomerata	glomerata	NOUN
ffhd-35	4	9	(	(	PUNCT
ffhd-35	4	10	dg	dg	PROPN
ffhd-35	4	11	)	)	PUNCT
ffhd-35	4	12	,	,	PUNCT
ffhd-35	4	13	a	a	DET
ffhd-35	4	14	spice	spice	NOUN
ffhd-35	4	15	used	use	VERB
ffhd-35	4	16	in	in	ADP
ffhd-35	4	17	western	western	ADJ
ffhd-35	4	18	cameroon	cameroon	NOUN
ffhd-35	4	19	,	,	PUNCT
ffhd-35	4	20	can	can	AUX
ffhd-35	4	21	have	have	VERB
ffhd-35	4	22	beneficial	beneficial	ADJ
ffhd-35	4	23	effects	effect	NOUN
ffhd-35	4	24	on	on	ADP
ffhd-35	4	25	inflammation	inflammation	NOUN
ffhd-35	4	26	and	and	CCONJ
ffhd-35	4	27	various	various	ADJ
ffhd-35	4	28	other	other	ADJ
ffhd-35	4	29	cardiovascular	cardiovascular	ADJ
ffhd-35	4	30	disease	disease	NOUN
ffhd-35	4	31	risk	risk	NOUN
ffhd-35	4	32	factors	factor	NOUN
ffhd-35	4	33	.	.	PUNCT
ffhd-35	5	1	the	the	DET
ffhd-35	5	2	purpose	purpose	NOUN
ffhd-35	5	3	of	of	ADP
ffhd-35	5	4	the	the	DET
ffhd-35	5	5	present	present	ADJ
ffhd-35	5	6	study	study	NOUN
ffhd-35	5	7	was	be	AUX
ffhd-35	5	8	to	to	PART
ffhd-35	5	9	evaluate	evaluate	VERB
ffhd-35	5	10	the	the	DET
ffhd-35	5	11	effects	effect	NOUN
ffhd-35	5	12	of	of	ADP
ffhd-35	5	13	dyglomera	dyglomera	NOUN
ffhd-35	5	14	®	®	NOUN
ffhd-35	5	15	,	,	PUNCT
ffhd-35	5	16	an	an	DET
ffhd-35	5	17	aqueous	aqueous	ADJ
ffhd-35	5	18	extract	extract	NOUN
ffhd-35	5	19	of	of	ADP
ffhd-35	5	20	dg	dg	NOUN
ffhd-35	5	21	(	(	PUNCT
ffhd-35	5	22	standardized	standardize	VERB
ffhd-35	5	23	to	to	ADP
ffhd-35	5	24	nlt	nlt	PROPN
ffhd-35	5	25	10	10	NUM
ffhd-35	5	26	%	%	NOUN
ffhd-35	5	27	polyphenols	polyphenol	NOUN
ffhd-35	5	28	)	)	PUNCT
ffhd-35	5	29	on	on	ADP
ffhd-35	5	30	certain	certain	ADJ
ffhd-35	5	31	anthropometric	anthropometric	ADJ
ffhd-35	5	32	,	,	PUNCT
ffhd-35	5	33	biochemical	biochemical	ADJ
ffhd-35	5	34	(	(	PUNCT
ffhd-35	5	35	including	include	VERB
ffhd-35	5	36	pro	pro	ADJ
ffhd-35	5	37	-	-	ADJ
ffhd-35	5	38	inflammatory	inflammatory	ADJ
ffhd-35	5	39	and	and	CCONJ
ffhd-35	5	40	pro	pro	ADJ
ffhd-35	5	41	-	-	ADJ
ffhd-35	5	42	thrombotic	thrombotic	ADJ
ffhd-35	5	43	states	state	NOUN
ffhd-35	5	44	)	)	PUNCT
ffhd-35	5	45	and	and	CCONJ
ffhd-35	5	46	hemodynamic	hemodynamic	ADJ
ffhd-35	5	47	parameters	parameter	NOUN
ffhd-35	5	48	in	in	ADP
ffhd-35	5	49	obese	obese	ADJ
ffhd-35	5	50	patients	patient	NOUN
ffhd-35	5	51	with	with	ADP
ffhd-35	5	52	metabolic	metabolic	NOUN
ffhd-35	5	53	syndrome	syndrome	NOUN
ffhd-35	5	54	.	.	PUNCT
ffhd-35	6	1	methods	method	NOUN
ffhd-35	6	2	:	:	PUNCT
ffhd-35	6	3	the	the	DET
ffhd-35	6	4	study	study	NOUN
ffhd-35	6	5	was	be	AUX
ffhd-35	6	6	an	an	DET
ffhd-35	6	7	8	8	NUM
ffhd-35	6	8	-	-	PUNCT
ffhd-35	6	9	week	week	NOUN
ffhd-35	6	10	randomized	randomize	VERB
ffhd-35	6	11	,	,	PUNCT
ffhd-35	6	12	double	double	ADJ
ffhd-35	6	13	-	-	PUNCT
ffhd-35	6	14	blind	blind	ADJ
ffhd-35	6	15	,	,	PUNCT
ffhd-35	6	16	placebo	placebo	NOUN
ffhd-35	6	17	-	-	PUNCT
ffhd-35	6	18	controlled	control	VERB
ffhd-35	6	19	trial	trial	NOUN
ffhd-35	6	20	involving	involve	VERB
ffhd-35	6	21	116	116	NUM
ffhd-35	6	22	males	male	NOUN
ffhd-35	6	23	and	and	CCONJ
ffhd-35	6	24	202	202	NUM
ffhd-35	6	25	females	female	NOUN
ffhd-35	6	26	aged	age	VERB
ffhd-35	6	27	between	between	ADP
ffhd-35	6	28	24	24	NUM
ffhd-35	6	29	and	and	CCONJ
ffhd-35	6	30	58	58	NUM
ffhd-35	6	31	years	year	NOUN
ffhd-35	6	32	.	.	PUNCT
ffhd-35	7	1	participants	participant	NOUN
ffhd-35	7	2	were	be	AUX
ffhd-35	7	3	randomly	randomly	ADV
ffhd-35	7	4	divided	divide	VERB
ffhd-35	7	5	into	into	ADP
ffhd-35	7	6	two	two	NUM
ffhd-35	7	7	groups	group	NOUN
ffhd-35	7	8	:	:	PUNCT
ffhd-35	7	9	treatment	treatment	NOUN
ffhd-35	7	10	and	and	CCONJ
ffhd-35	7	11	placebo	placebo	NOUN
ffhd-35	7	12	.	.	PUNCT
ffhd-35	8	1	capsules	capsule	NOUN
ffhd-35	8	2	containing	contain	VERB
ffhd-35	8	3	the	the	DET
ffhd-35	8	4	active	active	ADJ
ffhd-35	8	5	treatment	treatment	NOUN
ffhd-35	8	6	(	(	PUNCT
ffhd-35	8	7	200	200	NUM
ffhd-35	8	8	mg	mg	PROPN
ffhd-35	8	9	dyglomera	dyglomera	PROPN
ffhd-35	8	10	®	®	NOUN
ffhd-35	8	11	)	)	PUNCT
ffhd-35	8	12	or	or	CCONJ
ffhd-35	8	13	placebo	placebo	NOUN
ffhd-35	8	14	(	(	PUNCT
ffhd-35	8	15	200	200	NUM
ffhd-35	8	16	mg	mg	NOUN
ffhd-35	8	17	maize	maize	NOUN
ffhd-35	8	18	powder	powder	NOUN
ffhd-35	8	19	)	)	PUNCT
ffhd-35	8	20	were	be	AUX
ffhd-35	8	21	administered	administer	VERB
ffhd-35	8	22	30–60	30–60	NUM
ffhd-35	8	23	minutes	minute	NOUN
ffhd-35	8	24	before	before	ADP
ffhd-35	8	25	lunch	lunch	NOUN
ffhd-35	8	26	and	and	CCONJ
ffhd-35	8	27	dinner	dinner	NOUN
ffhd-35	8	28	throughout	throughout	ADP
ffhd-35	8	29	the	the	DET
ffhd-35	8	30	study	study	NOUN
ffhd-35	8	31	period	period	NOUN
ffhd-35	8	32	.	.	PUNCT
ffhd-35	9	1	various	various	ADJ
ffhd-35	9	2	biochemical	biochemical	ADJ
ffhd-35	9	3	(	(	PUNCT
ffhd-35	9	4	namely	namely	ADV
ffhd-35	9	5	,	,	PUNCT
ffhd-35	9	6	blood	blood	NOUN
ffhd-35	9	7	glucose	glucose	NOUN
ffhd-35	9	8	,	,	PUNCT
ffhd-35	9	9	lipid	lipid	NOUN
ffhd-35	9	10	profile	profile	NOUN
ffhd-35	9	11	,	,	PUNCT
ffhd-35	9	12	pro	pro	ADJ
ffhd-35	9	13	-	-	ADJ
ffhd-35	9	14	inflammatory	inflammatory	ADJ
ffhd-35	9	15	and	and	CCONJ
ffhd-35	9	16	pro	pro	ADJ
ffhd-35	9	17	-	-	ADJ
ffhd-35	9	18	thrombotic	thrombotic	ADJ
ffhd-35	9	19	markers	marker	NOUN
ffhd-35	9	20	)	)	PUNCT
ffhd-35	9	21	,	,	PUNCT
ffhd-35	9	22	anthropometric	anthropometric	ADJ
ffhd-35	9	23	and	and	CCONJ
ffhd-35	9	24	hemodynamic	hemodynamic	ADJ
ffhd-35	9	25	parameters	parameter	NOUN
ffhd-35	9	26	were	be	AUX
ffhd-35	9	27	measured	measure	VERB
ffhd-35	9	28	at	at	ADP
ffhd-35	9	29	baseline	baseline	NOUN
ffhd-35	9	30	and	and	CCONJ
ffhd-35	9	31	after	after	ADP
ffhd-35	9	32	4	4	NUM
ffhd-35	9	33	and	and	CCONJ
ffhd-35	9	34	8	8	NUM
ffhd-35	9	35	weeks	week	NOUN
ffhd-35	9	36	of	of	ADP
ffhd-35	9	37	treatment	treatment	NOUN
ffhd-35	9	38	.	.	PUNCT
ffhd-35	10	1	functional	functional	ADJ
ffhd-35	10	2	foods	food	NOUN
ffhd-35	10	3	in	in	ADP
ffhd-35	10	4	health	health	NOUN
ffhd-35	10	5	and	and	CCONJ
ffhd-35	10	6	disease	disease	NOUN
ffhd-35	10	7	2013	2013	NUM
ffhd-35	10	8	;	;	PUNCT
ffhd-35	10	9	3(11):416	3(11):416	NUM
ffhd-35	10	10	-	-	SYM
ffhd-35	10	11	427	427	NUM
ffhd-35	10	12	page	page	NOUN
ffhd-35	10	13	417	417	NUM
ffhd-35	10	14	of	of	ADP
ffhd-35	10	15	427	427	NUM
ffhd-35	10	16	results	result	NOUN
ffhd-35	10	17	:	:	PUNCT
ffhd-35	10	18	at	at	ADP
ffhd-35	10	19	the	the	DET
ffhd-35	10	20	end	end	NOUN
ffhd-35	10	21	of	of	ADP
ffhd-35	10	22	the	the	DET
ffhd-35	10	23	study	study	NOUN
ffhd-35	10	24	,	,	PUNCT
ffhd-35	10	25	the	the	DET
ffhd-35	10	26	dyglomera	dyglomera	NOUN
ffhd-35	10	27	®	®	NOUN
ffhd-35	10	28	group	group	NOUN
ffhd-35	10	29	showed	show	VERB
ffhd-35	10	30	statistically	statistically	ADV
ffhd-35	10	31	significant	significant	ADJ
ffhd-35	10	32	differences	difference	NOUN
ffhd-35	10	33	in	in	ADP
ffhd-35	10	34	all	all	DET
ffhd-35	10	35	16	16	NUM
ffhd-35	10	36	parameters	parameter	NOUN
ffhd-35	10	37	compared	compare	VERB
ffhd-35	10	38	to	to	PART
ffhd-35	10	39	baseline	baseline	VERB
ffhd-35	10	40	values	value	NOUN
ffhd-35	10	41	.	.	PUNCT
ffhd-35	11	1	changes	change	NOUN
ffhd-35	11	2	in	in	ADP
ffhd-35	11	3	bmi	bmi	NOUN
ffhd-35	11	4	and	and	CCONJ
ffhd-35	11	5	waist	waist	NOUN
ffhd-35	11	6	circumference	circumference	NOUN
ffhd-35	11	7	were	be	AUX
ffhd-35	11	8	accompanied	accompany	VERB
ffhd-35	11	9	by	by	ADP
ffhd-35	11	10	changes	change	NOUN
ffhd-35	11	11	in	in	ADP
ffhd-35	11	12	biochemical	biochemical	ADJ
ffhd-35	11	13	parameters	parameter	NOUN
ffhd-35	11	14	,	,	PUNCT
ffhd-35	11	15	with	with	ADP
ffhd-35	11	16	the	the	DET
ffhd-35	11	17	exception	exception	NOUN
ffhd-35	11	18	of	of	ADP
ffhd-35	11	19	adiponectin	adiponectin	NOUN
ffhd-35	11	20	levels	level	NOUN
ffhd-35	11	21	which	which	PRON
ffhd-35	11	22	were	be	AUX
ffhd-35	11	23	not	not	PART
ffhd-35	11	24	correlated	correlate	VERB
ffhd-35	11	25	to	to	ADP
ffhd-35	11	26	waist	waist	NOUN
ffhd-35	11	27	circumference	circumference	NOUN
ffhd-35	11	28	and	and	CCONJ
ffhd-35	11	29	pai-1	pai-1	ADJ
ffhd-35	11	30	values	value	NOUN
ffhd-35	11	31	.	.	PUNCT
ffhd-35	12	1	the	the	DET
ffhd-35	12	2	results	result	NOUN
ffhd-35	12	3	confirm	confirm	VERB
ffhd-35	12	4	the	the	DET
ffhd-35	12	5	hypothesis	hypothesis	NOUN
ffhd-35	12	6	that	that	DET
ffhd-35	12	7	dyglomera	dyglomera	PROPN
ffhd-35	12	8	®	®	PROPN
ffhd-35	12	9	,	,	PUNCT
ffhd-35	12	10	the	the	DET
ffhd-35	12	11	aqueous	aqueous	ADJ
ffhd-35	12	12	extract	extract	NOUN
ffhd-35	12	13	of	of	ADP
ffhd-35	12	14	dg	dg	PROPN
ffhd-35	12	15	,	,	PUNCT
ffhd-35	12	16	has	have	VERB
ffhd-35	12	17	antiinflammatory	antiinflammatory	NOUN
ffhd-35	12	18	properties	property	NOUN
ffhd-35	12	19	,	,	PUNCT
ffhd-35	12	20	and	and	CCONJ
ffhd-35	12	21	is	be	AUX
ffhd-35	12	22	effective	effective	ADJ
ffhd-35	12	23	in	in	ADP
ffhd-35	12	24	reducing	reduce	VERB
ffhd-35	12	25	cardiovascular	cardiovascular	ADJ
ffhd-35	12	26	disease	disease	NOUN
ffhd-35	12	27	risk	risk	NOUN
ffhd-35	12	28	factors	factor	NOUN
ffhd-35	12	29	associated	associate	VERB
ffhd-35	12	30	with	with	ADP
ffhd-35	12	31	metabolic	metabolic	NOUN
ffhd-35	12	32	syndrome	syndrome	NOUN
ffhd-35	12	33	in	in	ADP
ffhd-35	12	34	obese	obese	ADJ
ffhd-35	12	35	human	human	ADJ
ffhd-35	12	36	subjects	subject	NOUN
ffhd-35	12	37	.	.	PUNCT
ffhd-35	13	1	key	key	ADJ
ffhd-35	13	2	words	word	NOUN
ffhd-35	13	3	:	:	PUNCT
ffhd-35	13	4	dichrostachys	dichrostachy	VERB
ffhd-35	13	5	glomerata	glomerata	NOUN
ffhd-35	13	6	extract	extract	NOUN
ffhd-35	13	7	,	,	PUNCT
ffhd-35	13	8	inflammation	inflammation	NOUN
ffhd-35	13	9	,	,	PUNCT
ffhd-35	13	10	obesity	obesity	NOUN
ffhd-35	13	11	,	,	PUNCT
ffhd-35	13	12	metabolic	metabolic	NOUN
ffhd-35	13	13	syndrome	syndrome	NOUN
ffhd-35	13	14	1	1	NUM
ffhd-35	13	15	.	.	PUNCT
ffhd-35	13	16	introduction	introduction	NOUN
ffhd-35	13	17	obesity	obesity	NOUN
ffhd-35	13	18	and	and	CCONJ
ffhd-35	13	19	its	its	PRON
ffhd-35	13	20	related	related	ADJ
ffhd-35	13	21	complications	complication	NOUN
ffhd-35	13	22	are	be	AUX
ffhd-35	13	23	generally	generally	ADV
ffhd-35	13	24	referred	refer	VERB
ffhd-35	13	25	to	to	ADP
ffhd-35	13	26	as	as	ADP
ffhd-35	13	27	metabolic	metabolic	NOUN
ffhd-35	13	28	syndrome	syndrome	NOUN
ffhd-35	13	29	(	(	PUNCT
ffhd-35	13	30	mets	met	NOUN
ffhd-35	13	31	)	)	PUNCT
ffhd-35	13	32	and	and	CCONJ
ffhd-35	13	33	its	its	PRON
ffhd-35	13	34	prevalence	prevalence	NOUN
ffhd-35	13	35	is	be	AUX
ffhd-35	13	36	increasing	increase	VERB
ffhd-35	13	37	worldwide	worldwide	ADV
ffhd-35	13	38	,	,	PUNCT
ffhd-35	13	39	with	with	ADP
ffhd-35	13	40	some	some	DET
ffhd-35	13	41	countries	country	NOUN
ffhd-35	13	42	experiencing	experience	VERB
ffhd-35	13	43	as	as	ADV
ffhd-35	13	44	much	much	ADV
ffhd-35	13	45	as	as	ADP
ffhd-35	13	46	a	a	DET
ffhd-35	13	47	three	three	NUM
ffhd-35	13	48	-	-	ADJ
ffhd-35	13	49	fold	fold	ADJ
ffhd-35	13	50	increase	increase	NOUN
ffhd-35	13	51	in	in	ADP
ffhd-35	13	52	the	the	DET
ffhd-35	13	53	last	last	ADJ
ffhd-35	13	54	three	three	NUM
ffhd-35	13	55	decades	decade	NOUN
ffhd-35	13	56	[	[	X
ffhd-35	13	57	1	1	NUM
ffhd-35	13	58	]	]	PUNCT
ffhd-35	13	59	.	.	PUNCT
ffhd-35	14	1	due	due	ADP
ffhd-35	14	2	to	to	ADP
ffhd-35	14	3	the	the	DET
ffhd-35	14	4	fact	fact	NOUN
ffhd-35	14	5	that	that	SCONJ
ffhd-35	14	6	mets	met	NOUN
ffhd-35	14	7	is	be	AUX
ffhd-35	14	8	a	a	DET
ffhd-35	14	9	multifactorial	multifactorial	ADJ
ffhd-35	14	10	disorder	disorder	NOUN
ffhd-35	14	11	involving	involve	VERB
ffhd-35	14	12	genetic	genetic	ADJ
ffhd-35	14	13	and	and	CCONJ
ffhd-35	14	14	environmental	environmental	ADJ
ffhd-35	14	15	factors	factor	NOUN
ffhd-35	14	16	,	,	PUNCT
ffhd-35	14	17	its	its	PRON
ffhd-35	14	18	management	management	NOUN
ffhd-35	14	19	remains	remain	VERB
ffhd-35	14	20	a	a	DET
ffhd-35	14	21	challenge	challenge	NOUN
ffhd-35	14	22	to	to	ADP
ffhd-35	14	23	scientists	scientist	NOUN
ffhd-35	14	24	worldwide	worldwide	ADV
ffhd-35	14	25	.	.	PUNCT
ffhd-35	15	1	even	even	ADV
ffhd-35	15	2	though	though	SCONJ
ffhd-35	15	3	obesity	obesity	NOUN
ffhd-35	15	4	-	-	PUNCT
ffhd-35	15	5	related	relate	VERB
ffhd-35	15	6	complications	complication	NOUN
ffhd-35	15	7	appear	appear	VERB
ffhd-35	15	8	to	to	PART
ffhd-35	15	9	be	be	AUX
ffhd-35	15	10	secondary	secondary	ADJ
ffhd-35	15	11	to	to	ADP
ffhd-35	15	12	the	the	DET
ffhd-35	15	13	condition	condition	NOUN
ffhd-35	15	14	itself	itself	PRON
ffhd-35	15	15	,	,	PUNCT
ffhd-35	15	16	some	some	PRON
ffhd-35	15	17	of	of	ADP
ffhd-35	15	18	the	the	DET
ffhd-35	15	19	accompanying	accompanying	ADJ
ffhd-35	15	20	changes	change	NOUN
ffhd-35	15	21	are	be	AUX
ffhd-35	15	22	life	life	NOUN
ffhd-35	15	23	-	-	PUNCT
ffhd-35	15	24	threatening	threatening	ADJ
ffhd-35	15	25	,	,	PUNCT
ffhd-35	15	26	requiring	require	VERB
ffhd-35	15	27	a	a	DET
ffhd-35	15	28	combination	combination	NOUN
ffhd-35	15	29	of	of	ADP
ffhd-35	15	30	management	management	NOUN
ffhd-35	15	31	strategies	strategy	NOUN
ffhd-35	15	32	for	for	ADP
ffhd-35	15	33	appropriate	appropriate	ADJ
ffhd-35	15	34	control	control	NOUN
ffhd-35	15	35	.	.	PUNCT
ffhd-35	16	1	this	this	PRON
ffhd-35	16	2	is	be	AUX
ffhd-35	16	3	the	the	DET
ffhd-35	16	4	case	case	NOUN
ffhd-35	16	5	in	in	ADP
ffhd-35	16	6	type	type	NOUN
ffhd-35	16	7	2	2	NUM
ffhd-35	16	8	diabetes	diabetes	NOUN
ffhd-35	16	9	mellitus	mellitus	NOUN
ffhd-35	16	10	,	,	PUNCT
ffhd-35	16	11	dyslipidemia	dyslipidemia	NOUN
ffhd-35	16	12	,	,	PUNCT
ffhd-35	16	13	atherosclerosis	atherosclerosis	NOUN
ffhd-35	16	14	,	,	PUNCT
ffhd-35	16	15	hypertension	hypertension	NOUN
ffhd-35	16	16	,	,	PUNCT
ffhd-35	16	17	oxidative	oxidative	ADJ
ffhd-35	16	18	stress	stress	NOUN
ffhd-35	16	19	,	,	PUNCT
ffhd-35	16	20	and	and	CCONJ
ffhd-35	16	21	inflammation	inflammation	NOUN
ffhd-35	16	22	.	.	PUNCT
ffhd-35	17	1	mets	met	NOUN
ffhd-35	17	2	comprises	comprise	VERB
ffhd-35	17	3	a	a	DET
ffhd-35	17	4	clustering	clustering	NOUN
ffhd-35	17	5	of	of	ADP
ffhd-35	17	6	atherosclerotic	atherosclerotic	ADJ
ffhd-35	17	7	factors	factor	NOUN
ffhd-35	17	8	,	,	PUNCT
ffhd-35	17	9	including	include	VERB
ffhd-35	17	10	visceral	visceral	ADJ
ffhd-35	17	11	obesity	obesity	NOUN
ffhd-35	17	12	,	,	PUNCT
ffhd-35	17	13	dyslipidemia	dyslipidemia	NOUN
ffhd-35	17	14	,	,	PUNCT
ffhd-35	17	15	and	and	CCONJ
ffhd-35	17	16	disturbed	disturb	VERB
ffhd-35	17	17	carbohydrate	carbohydrate	ADJ
ffhd-35	17	18	metabolism	metabolism	NOUN
ffhd-35	17	19	[	[	X
ffhd-35	17	20	2	2	NUM
ffhd-35	17	21	]	]	PUNCT
ffhd-35	17	22	.	.	PUNCT
ffhd-35	18	1	it	it	PRON
ffhd-35	18	2	is	be	AUX
ffhd-35	18	3	associated	associate	VERB
ffhd-35	18	4	with	with	ADP
ffhd-35	18	5	pro	pro	ADJ
ffhd-35	18	6	-	-	ADJ
ffhd-35	18	7	inflammatory	inflammatory	ADJ
ffhd-35	18	8	and	and	CCONJ
ffhd-35	18	9	pro	pro	ADJ
ffhd-35	18	10	-	-	ADJ
ffhd-35	18	11	thrombotic	thrombotic	ADJ
ffhd-35	18	12	states	state	NOUN
ffhd-35	18	13	,	,	PUNCT
ffhd-35	18	14	in	in	ADP
ffhd-35	18	15	which	which	PRON
ffhd-35	18	16	the	the	DET
ffhd-35	18	17	role	role	NOUN
ffhd-35	18	18	of	of	ADP
ffhd-35	18	19	increased	increase	VERB
ffhd-35	18	20	visceral	visceral	ADJ
ffhd-35	18	21	fat	fat	ADJ
ffhd-35	18	22	deposits	deposit	NOUN
ffhd-35	18	23	is	be	AUX
ffhd-35	18	24	thought	think	VERB
ffhd-35	18	25	to	to	PART
ffhd-35	18	26	be	be	AUX
ffhd-35	18	27	central	central	ADJ
ffhd-35	18	28	.	.	PUNCT
ffhd-35	19	1	abdominal	abdominal	ADJ
ffhd-35	19	2	obesity	obesity	NOUN
ffhd-35	19	3	leads	lead	VERB
ffhd-35	19	4	to	to	ADP
ffhd-35	19	5	alteration	alteration	NOUN
ffhd-35	19	6	of	of	ADP
ffhd-35	19	7	the	the	DET
ffhd-35	19	8	normal	normal	ADJ
ffhd-35	19	9	physiological	physiological	ADJ
ffhd-35	19	10	balance	balance	NOUN
ffhd-35	19	11	of	of	ADP
ffhd-35	19	12	adipokines	adipokine	NOUN
ffhd-35	19	13	,	,	PUNCT
ffhd-35	19	14	insulin	insulin	NOUN
ffhd-35	19	15	resistance	resistance	NOUN
ffhd-35	19	16	,	,	PUNCT
ffhd-35	19	17	endothelial	endothelial	ADJ
ffhd-35	19	18	dysfunction	dysfunction	NOUN
ffhd-35	19	19	and	and	CCONJ
ffhd-35	19	20	a	a	DET
ffhd-35	19	21	pro	pro	ADJ
ffhd-35	19	22	-	-	ADJ
ffhd-35	19	23	atherogenic	atherogenic	ADJ
ffhd-35	19	24	state	state	NOUN
ffhd-35	19	25	[	[	X
ffhd-35	19	26	3,4	3,4	NUM
ffhd-35	19	27	]	]	PUNCT
ffhd-35	19	28	.	.	PUNCT
ffhd-35	20	1	in	in	ADP
ffhd-35	20	2	association	association	NOUN
ffhd-35	20	3	with	with	ADP
ffhd-35	20	4	this	this	PRON
ffhd-35	20	5	,	,	PUNCT
ffhd-35	20	6	the	the	DET
ffhd-35	20	7	presence	presence	NOUN
ffhd-35	20	8	of	of	ADP
ffhd-35	20	9	conventional	conventional	ADJ
ffhd-35	20	10	cardiovascular	cardiovascular	ADJ
ffhd-35	20	11	risk	risk	NOUN
ffhd-35	20	12	factors	factor	NOUN
ffhd-35	20	13	such	such	ADJ
ffhd-35	20	14	as	as	ADP
ffhd-35	20	15	hypertension	hypertension	NOUN
ffhd-35	20	16	results	result	NOUN
ffhd-35	20	17	in	in	ADP
ffhd-35	20	18	a	a	DET
ffhd-35	20	19	significantly	significantly	ADV
ffhd-35	20	20	elevated	elevated	ADJ
ffhd-35	20	21	cardiometabolic	cardiometabolic	NOUN
ffhd-35	20	22	risk	risk	NOUN
ffhd-35	20	23	.	.	PUNCT
ffhd-35	21	1	the	the	DET
ffhd-35	21	2	pathway	pathway	NOUN
ffhd-35	21	3	leading	lead	VERB
ffhd-35	21	4	to	to	ADP
ffhd-35	21	5	mets	met	NOUN
ffhd-35	21	6	involves	involve	VERB
ffhd-35	21	7	the	the	DET
ffhd-35	21	8	abnormal	abnormal	ADJ
ffhd-35	21	9	production	production	NOUN
ffhd-35	21	10	of	of	ADP
ffhd-35	21	11	hormones	hormone	NOUN
ffhd-35	21	12	and	and	CCONJ
ffhd-35	21	13	cytokines	cytokine	NOUN
ffhd-35	21	14	from	from	ADP
ffhd-35	21	15	the	the	DET
ffhd-35	21	16	adipose	adipose	ADJ
ffhd-35	21	17	tissue	tissue	NOUN
ffhd-35	21	18	[	[	X
ffhd-35	21	19	3	3	NUM
ffhd-35	21	20	]	]	PUNCT
ffhd-35	21	21	,	,	PUNCT
ffhd-35	21	22	namely	namely	ADV
ffhd-35	21	23	,	,	PUNCT
ffhd-35	21	24	excessive	excessive	ADJ
ffhd-35	21	25	production	production	NOUN
ffhd-35	21	26	of	of	ADP
ffhd-35	21	27	il-6	il-6	NUM
ffhd-35	21	28	,	,	PUNCT
ffhd-35	21	29	tnfα	tnfα	NOUN
ffhd-35	21	30	and	and	CCONJ
ffhd-35	21	31	the	the	DET
ffhd-35	21	32	prothrombotic	prothrombotic	ADJ
ffhd-35	21	33	agent	agent	NOUN
ffhd-35	21	34	plasminogen	plasminogen	NOUN
ffhd-35	21	35	activator	activator	NOUN
ffhd-35	21	36	inhibitor	inhibitor	NOUN
ffhd-35	21	37	type	type	NOUN
ffhd-35	21	38	1	1	NUM
ffhd-35	21	39	(	(	PUNCT
ffhd-35	21	40	pai-1	pai-1	NUM
ffhd-35	21	41	)	)	PUNCT
ffhd-35	21	42	.	.	PUNCT
ffhd-35	22	1	this	this	PRON
ffhd-35	22	2	is	be	AUX
ffhd-35	22	3	accompanied	accompany	VERB
ffhd-35	22	4	by	by	ADP
ffhd-35	22	5	low	low	ADJ
ffhd-35	22	6	secretion	secretion	NOUN
ffhd-35	22	7	of	of	ADP
ffhd-35	22	8	the	the	DET
ffhd-35	22	9	protective	protective	ADJ
ffhd-35	22	10	adipocytokine	adipocytokine	NOUN
ffhd-35	22	11	adiponectin	adiponectin	NOUN
ffhd-35	22	12	,	,	PUNCT
ffhd-35	22	13	a	a	DET
ffhd-35	22	14	molecule	molecule	NOUN
ffhd-35	22	15	that	that	PRON
ffhd-35	22	16	exerts	exert	VERB
ffhd-35	22	17	anti	anti	ADJ
ffhd-35	22	18	-	-	ADJ
ffhd-35	22	19	inflammatory	inflammatory	ADJ
ffhd-35	22	20	,	,	PUNCT
ffhd-35	22	21	anti	anti	ADJ
ffhd-35	22	22	-	-	ADJ
ffhd-35	22	23	atherogenic	atherogenic	ADJ
ffhd-35	22	24	,	,	PUNCT
ffhd-35	22	25	and	and	CCONJ
ffhd-35	22	26	anti	anti	ADJ
ffhd-35	22	27	-	-	ADJ
ffhd-35	22	28	diabetic	diabetic	ADJ
ffhd-35	22	29	effects	effect	NOUN
ffhd-35	22	30	,	,	PUNCT
ffhd-35	22	31	and	and	CCONJ
ffhd-35	22	32	whose	whose	DET
ffhd-35	22	33	production	production	NOUN
ffhd-35	22	34	is	be	AUX
ffhd-35	22	35	down	down	ADV
ffhd-35	22	36	-	-	PUNCT
ffhd-35	22	37	regulated	regulate	VERB
ffhd-35	22	38	in	in	ADP
ffhd-35	22	39	obese	obese	ADJ
ffhd-35	22	40	individuals	individual	NOUN
ffhd-35	22	41	with	with	ADP
ffhd-35	22	42	metabolic	metabolic	NOUN
ffhd-35	22	43	syndrome	syndrome	NOUN
ffhd-35	22	44	[	[	X
ffhd-35	22	45	3,5	3,5	NUM
ffhd-35	22	46	]	]	PUNCT
ffhd-35	22	47	.	.	PUNCT
ffhd-35	23	1	on	on	ADP
ffhd-35	23	2	the	the	DET
ffhd-35	23	3	other	other	ADJ
ffhd-35	23	4	hand	hand	NOUN
ffhd-35	23	5	,	,	PUNCT
ffhd-35	23	6	overproduction	overproduction	NOUN
ffhd-35	23	7	of	of	ADP
ffhd-35	23	8	il-6	il-6	NOUN
ffhd-35	23	9	by	by	ADP
ffhd-35	23	10	the	the	DET
ffhd-35	23	11	adipose	adipose	ADJ
ffhd-35	23	12	tissue	tissue	NOUN
ffhd-35	23	13	in	in	ADP
ffhd-35	23	14	obesity	obesity	NOUN
ffhd-35	23	15	induces	induce	VERB
ffhd-35	23	16	hepatic	hepatic	NOUN
ffhd-35	23	17	(	(	PUNCT
ffhd-35	23	18	c	c	NOUN
ffhd-35	23	19	-	-	PUNCT
ffhd-35	23	20	reactive	reactive	ADJ
ffhd-35	23	21	protein	protein	NOUN
ffhd-35	23	22	)	)	PUNCT
ffhd-35	23	23	crp	crp	PROPN
ffhd-35	23	24	synthesis	synthesis	NOUN
ffhd-35	23	25	,	,	PUNCT
ffhd-35	23	26	which	which	PRON
ffhd-35	23	27	promotes	promote	VERB
ffhd-35	23	28	the	the	DET
ffhd-35	23	29	onset	onset	NOUN
ffhd-35	23	30	of	of	ADP
ffhd-35	23	31	cardiovascular	cardiovascular	ADJ
ffhd-35	23	32	complications	complication	NOUN
ffhd-35	23	33	[	[	X
ffhd-35	23	34	6	6	NUM
ffhd-35	23	35	]	]	PUNCT
ffhd-35	23	36	.	.	PUNCT
ffhd-35	24	1	the	the	DET
ffhd-35	24	2	management	management	NOUN
ffhd-35	24	3	of	of	ADP
ffhd-35	24	4	disorders	disorder	NOUN
ffhd-35	24	5	clustered	cluster	VERB
ffhd-35	24	6	in	in	ADP
ffhd-35	24	7	this	this	DET
ffhd-35	24	8	syndrome	syndrome	NOUN
ffhd-35	24	9	and	and	CCONJ
ffhd-35	24	10	the	the	DET
ffhd-35	24	11	elucidation	elucidation	NOUN
ffhd-35	24	12	of	of	ADP
ffhd-35	24	13	the	the	DET
ffhd-35	24	14	mechanisms	mechanism	NOUN
ffhd-35	24	15	involved	involve	VERB
ffhd-35	24	16	in	in	ADP
ffhd-35	24	17	its	its	PRON
ffhd-35	24	18	development	development	NOUN
ffhd-35	24	19	are	be	AUX
ffhd-35	24	20	of	of	ADP
ffhd-35	24	21	great	great	ADJ
ffhd-35	24	22	interest	interest	NOUN
ffhd-35	24	23	for	for	ADP
ffhd-35	24	24	the	the	DET
ffhd-35	24	25	benefit	benefit	NOUN
ffhd-35	24	26	of	of	ADP
ffhd-35	24	27	health	health	NOUN
ffhd-35	24	28	.	.	PUNCT
ffhd-35	25	1	while	while	SCONJ
ffhd-35	25	2	lifestyle	lifestyle	NOUN
ffhd-35	25	3	modification	modification	NOUN
ffhd-35	25	4	through	through	ADP
ffhd-35	25	5	dietary	dietary	ADJ
ffhd-35	25	6	intervention	intervention	NOUN
ffhd-35	25	7	and	and	CCONJ
ffhd-35	25	8	exercise	exercise	NOUN
ffhd-35	25	9	have	have	AUX
ffhd-35	25	10	had	have	VERB
ffhd-35	25	11	limited	limit	VERB
ffhd-35	25	12	success	success	NOUN
ffhd-35	25	13	in	in	ADP
ffhd-35	25	14	treating	treat	VERB
ffhd-35	25	15	these	these	DET
ffhd-35	25	16	disorders	disorder	NOUN
ffhd-35	25	17	,	,	PUNCT
ffhd-35	25	18	they	they	PRON
ffhd-35	25	19	have	have	AUX
ffhd-35	25	20	not	not	PART
ffhd-35	25	21	stopped	stop	VERB
ffhd-35	25	22	the	the	DET
ffhd-35	25	23	increasing	increase	VERB
ffhd-35	25	24	prevalence	prevalence	NOUN
ffhd-35	25	25	of	of	ADP
ffhd-35	25	26	mets	met	NOUN
ffhd-35	25	27	and	and	CCONJ
ffhd-35	25	28	may	may	AUX
ffhd-35	25	29	have	have	VERB
ffhd-35	25	30	low	low	ADJ
ffhd-35	25	31	long	long	ADJ
ffhd-35	25	32	-	-	PUNCT
ffhd-35	25	33	term	term	NOUN
ffhd-35	25	34	sustainability	sustainability	NOUN
ffhd-35	25	35	.	.	PUNCT
ffhd-35	26	1	pharmacological	pharmacological	NOUN
ffhd-35	26	2	therapy	therapy	NOUN
ffhd-35	26	3	has	have	AUX
ffhd-35	26	4	therefore	therefore	ADV
ffhd-35	26	5	been	be	AUX
ffhd-35	26	6	proposed	propose	VERB
ffhd-35	26	7	as	as	ADP
ffhd-35	26	8	an	an	DET
ffhd-35	26	9	adjunct	adjunct	ADJ
ffhd-35	26	10	to	to	ADP
ffhd-35	26	11	diet	diet	NOUN
ffhd-35	26	12	and	and	CCONJ
ffhd-35	26	13	lifestyle	lifestyle	NOUN
ffhd-35	26	14	changes	change	NOUN
ffhd-35	26	15	to	to	PART
ffhd-35	26	16	improve	improve	VERB
ffhd-35	26	17	long	long	ADJ
ffhd-35	26	18	-	-	PUNCT
ffhd-35	26	19	term	term	NOUN
ffhd-35	26	20	weight	weight	NOUN
ffhd-35	26	21	loss	loss	NOUN
ffhd-35	26	22	[	[	X
ffhd-35	26	23	7	7	NUM
ffhd-35	26	24	]	]	PUNCT
ffhd-35	26	25	.	.	PUNCT
ffhd-35	27	1	the	the	DET
ffhd-35	27	2	numerous	numerous	ADJ
ffhd-35	27	3	synthetic	synthetic	ADJ
ffhd-35	27	4	drugs	drug	NOUN
ffhd-35	27	5	developed	develop	VERB
ffhd-35	27	6	to	to	PART
ffhd-35	27	7	combat	combat	VERB
ffhd-35	27	8	obesity	obesity	NOUN
ffhd-35	27	9	and	and	CCONJ
ffhd-35	27	10	metabolic	metabolic	NOUN
ffhd-35	27	11	syndrome	syndrome	NOUN
ffhd-35	27	12	have	have	AUX
ffhd-35	27	13	had	have	VERB
ffhd-35	27	14	only	only	ADJ
ffhd-35	27	15	marginal	marginal	ADJ
ffhd-35	27	16	success	success	NOUN
ffhd-35	27	17	,	,	PUNCT
ffhd-35	27	18	due	due	ADJ
ffhd-35	27	19	in	in	ADP
ffhd-35	27	20	functional	functional	ADJ
ffhd-35	27	21	foods	food	NOUN
ffhd-35	27	22	in	in	ADP
ffhd-35	27	23	health	health	NOUN
ffhd-35	27	24	and	and	CCONJ
ffhd-35	27	25	disease	disease	NOUN
ffhd-35	27	26	2013	2013	NUM
ffhd-35	27	27	;	;	PUNCT
ffhd-35	27	28	3(11):416	3(11):416	NUM
ffhd-35	27	29	-	-	SYM
ffhd-35	27	30	427	427	NUM
ffhd-35	27	31	page	page	NOUN
ffhd-35	27	32	418	418	NUM
ffhd-35	27	33	of	of	ADP
ffhd-35	27	34	427	427	NUM
ffhd-35	27	35	part	part	NOUN
ffhd-35	27	36	to	to	ADP
ffhd-35	27	37	their	their	PRON
ffhd-35	27	38	accompanying	accompanying	ADJ
ffhd-35	27	39	adverse	adverse	ADJ
ffhd-35	27	40	effects	effect	NOUN
ffhd-35	27	41	[	[	X
ffhd-35	27	42	8,9	8,9	NUM
ffhd-35	27	43	]	]	PUNCT
ffhd-35	27	44	.	.	PUNCT
ffhd-35	28	1	this	this	PRON
ffhd-35	28	2	has	have	AUX
ffhd-35	28	3	turned	turn	VERB
ffhd-35	28	4	the	the	DET
ffhd-35	28	5	focus	focus	NOUN
ffhd-35	28	6	of	of	ADP
ffhd-35	28	7	some	some	DET
ffhd-35	28	8	researchers	researcher	NOUN
ffhd-35	28	9	towards	towards	ADP
ffhd-35	28	10	nutraceuticals	nutraceutical	NOUN
ffhd-35	28	11	,	,	PUNCT
ffhd-35	28	12	compounds	compound	NOUN
ffhd-35	28	13	derived	derive	VERB
ffhd-35	28	14	from	from	ADP
ffhd-35	28	15	foods	food	NOUN
ffhd-35	28	16	or	or	CCONJ
ffhd-35	28	17	other	other	ADJ
ffhd-35	28	18	natural	natural	ADJ
ffhd-35	28	19	products	product	NOUN
ffhd-35	28	20	that	that	PRON
ffhd-35	28	21	are	be	AUX
ffhd-35	28	22	considered	consider	VERB
ffhd-35	28	23	to	to	PART
ffhd-35	28	24	be	be	AUX
ffhd-35	28	25	safer	safe	ADJ
ffhd-35	28	26	.	.	PUNCT
ffhd-35	29	1	medicinal	medicinal	ADJ
ffhd-35	29	2	foods	food	NOUN
ffhd-35	29	3	and	and	CCONJ
ffhd-35	29	4	herbal	herbal	ADJ
ffhd-35	29	5	drugs	drug	NOUN
ffhd-35	29	6	are	be	AUX
ffhd-35	29	7	therefore	therefore	ADV
ffhd-35	29	8	widely	widely	ADV
ffhd-35	29	9	prescribed	prescribe	VERB
ffhd-35	29	10	,	,	PUNCT
ffhd-35	29	11	even	even	ADV
ffhd-35	29	12	when	when	SCONJ
ffhd-35	29	13	their	their	PRON
ffhd-35	29	14	biologically	biologically	ADV
ffhd-35	29	15	active	active	ADJ
ffhd-35	29	16	compounds	compound	NOUN
ffhd-35	29	17	are	be	AUX
ffhd-35	29	18	unknown	unknown	ADJ
ffhd-35	30	1	[	[	X
ffhd-35	30	2	10,11	10,11	NOUN
ffhd-35	30	3	]	]	PUNCT
ffhd-35	30	4	.	.	PUNCT
ffhd-35	31	1	dichrostachys	dichrostachys	PROPN
ffhd-35	31	2	glomerata	glomerata	NOUN
ffhd-35	31	3	(	(	PUNCT
ffhd-35	31	4	dg	dg	X
ffhd-35	31	5	)	)	PUNCT
ffhd-35	31	6	(	(	PUNCT
ffhd-35	31	7	forssk	forssk	NOUN
ffhd-35	31	8	.	.	PUNCT
ffhd-35	31	9	)	)	PUNCT
ffhd-35	31	10	.	.	PUNCT
ffhd-35	32	1	chiov	chiov	PROPN
ffhd-35	32	2	.	.	PUNCT
ffhd-35	33	1	is	be	AUX
ffhd-35	33	2	a	a	DET
ffhd-35	33	3	deciduous	deciduous	ADJ
ffhd-35	33	4	tree	tree	NOUN
ffhd-35	33	5	found	find	VERB
ffhd-35	33	6	in	in	ADP
ffhd-35	33	7	cameroon	cameroon	PROPN
ffhd-35	33	8	and	and	CCONJ
ffhd-35	33	9	other	other	ADJ
ffhd-35	33	10	tropical	tropical	ADJ
ffhd-35	33	11	countries	country	NOUN
ffhd-35	33	12	.	.	PUNCT
ffhd-35	34	1	dg	dg	PROPN
ffhd-35	34	2	produces	produce	VERB
ffhd-35	34	3	edible	edible	ADJ
ffhd-35	34	4	fruits	fruit	NOUN
ffhd-35	34	5	and	and	CCONJ
ffhd-35	34	6	seeds	seed	NOUN
ffhd-35	34	7	,	,	PUNCT
ffhd-35	34	8	and	and	CCONJ
ffhd-35	34	9	the	the	DET
ffhd-35	34	10	dried	dry	VERB
ffhd-35	34	11	fruits	fruit	NOUN
ffhd-35	34	12	are	be	AUX
ffhd-35	34	13	commonly	commonly	ADV
ffhd-35	34	14	used	use	VERB
ffhd-35	34	15	as	as	ADP
ffhd-35	34	16	a	a	DET
ffhd-35	34	17	spice	spice	NOUN
ffhd-35	34	18	in	in	ADP
ffhd-35	34	19	a	a	DET
ffhd-35	34	20	traditional	traditional	ADJ
ffhd-35	34	21	soup	soup	NOUN
ffhd-35	34	22	of	of	ADP
ffhd-35	34	23	the	the	DET
ffhd-35	34	24	western	western	ADJ
ffhd-35	34	25	provinces	province	NOUN
ffhd-35	34	26	of	of	ADP
ffhd-35	34	27	cameroon	cameroon	NOUN
ffhd-35	34	28	called	call	VERB
ffhd-35	34	29	“	"	PUNCT
ffhd-35	34	30	nah	nah	INTJ
ffhd-35	34	31	poh”[12	poh”[12	NOUN
ffhd-35	34	32	]	]	PUNCT
ffhd-35	34	33	.	.	PUNCT
ffhd-35	35	1	the	the	DET
ffhd-35	35	2	hypotensive	hypotensive	ADJ
ffhd-35	35	3	property	property	NOUN
ffhd-35	35	4	of	of	ADP
ffhd-35	35	5	the	the	DET
ffhd-35	35	6	plant	plant	NOUN
ffhd-35	35	7	was	be	AUX
ffhd-35	35	8	first	first	ADV
ffhd-35	35	9	reported	report	VERB
ffhd-35	35	10	more	more	ADJ
ffhd-35	35	11	than	than	ADP
ffhd-35	35	12	four	four	NUM
ffhd-35	35	13	decades	decade	NOUN
ffhd-35	35	14	ago	ago	ADV
ffhd-35	35	15	[	[	X
ffhd-35	35	16	13	13	NUM
ffhd-35	35	17	]	]	PUNCT
ffhd-35	35	18	.	.	PUNCT
ffhd-35	36	1	this	this	DET
ffhd-35	36	2	plant	plant	NOUN
ffhd-35	36	3	has	have	AUX
ffhd-35	36	4	been	be	AUX
ffhd-35	36	5	shown	show	VERB
ffhd-35	36	6	to	to	PART
ffhd-35	36	7	have	have	VERB
ffhd-35	36	8	antiviral	antiviral	ADJ
ffhd-35	36	9	,	,	PUNCT
ffhd-35	36	10	anti	anti	ADJ
ffhd-35	36	11	-	-	ADJ
ffhd-35	36	12	infectious	infectious	ADJ
ffhd-35	36	13	,	,	PUNCT
ffhd-35	36	14	[	[	X
ffhd-35	36	15	14	14	NUM
ffhd-35	36	16	]	]	PUNCT
ffhd-35	36	17	anti	anti	ADJ
ffhd-35	36	18	-	-	ADJ
ffhd-35	36	19	inflammatory	inflammatory	ADJ
ffhd-35	36	20	,	,	PUNCT
ffhd-35	36	21	and	and	CCONJ
ffhd-35	36	22	analgesic	analgesic	ADJ
ffhd-35	36	23	effects	effect	NOUN
ffhd-35	36	24	in	in	ADP
ffhd-35	36	25	rats	rat	NOUN
ffhd-35	36	26	[	[	X
ffhd-35	36	27	15	15	NUM
ffhd-35	36	28	]	]	PUNCT
ffhd-35	36	29	and	and	CCONJ
ffhd-35	36	30	cicatrizing	cicatrizing	NOUN
ffhd-35	36	31	effects	effect	NOUN
ffhd-35	36	32	[	[	X
ffhd-35	36	33	16	16	NUM
ffhd-35	36	34	]	]	PUNCT
ffhd-35	36	35	.	.	PUNCT
ffhd-35	37	1	a	a	DET
ffhd-35	37	2	study	study	NOUN
ffhd-35	37	3	from	from	ADP
ffhd-35	37	4	our	our	PRON
ffhd-35	37	5	laboratory	laboratory	NOUN
ffhd-35	37	6	showed	show	VERB
ffhd-35	37	7	that	that	SCONJ
ffhd-35	37	8	dg	dg	NOUN
ffhd-35	37	9	fruits	fruit	NOUN
ffhd-35	37	10	also	also	ADV
ffhd-35	37	11	exhibit	exhibit	VERB
ffhd-35	37	12	in	in	ADP
ffhd-35	37	13	vitro	vitro	X
ffhd-35	37	14	and	and	CCONJ
ffhd-35	37	15	in	in	ADP
ffhd-35	37	16	vivo	vivo	ADJ
ffhd-35	37	17	antioxidant	antioxidant	ADJ
ffhd-35	37	18	activity	activity	NOUN
ffhd-35	37	19	and	and	CCONJ
ffhd-35	37	20	can	can	AUX
ffhd-35	37	21	inhibit	inhibit	VERB
ffhd-35	37	22	oxidation	oxidation	NOUN
ffhd-35	37	23	of	of	ADP
ffhd-35	37	24	low	low	ADJ
ffhd-35	37	25	-	-	PUNCT
ffhd-35	37	26	density	density	NOUN
ffhd-35	37	27	lipoproteins	lipoprotein	NOUN
ffhd-35	37	28	(	(	PUNCT
ffhd-35	37	29	ldl	ldl	NOUN
ffhd-35	37	30	)	)	PUNCT
ffhd-35	38	1	[	[	X
ffhd-35	38	2	17	17	NUM
ffhd-35	38	3	]	]	PUNCT
ffhd-35	38	4	.	.	PUNCT
ffhd-35	39	1	a	a	DET
ffhd-35	39	2	study	study	NOUN
ffhd-35	39	3	of	of	ADP
ffhd-35	39	4	diabetic	diabetic	ADJ
ffhd-35	39	5	rats	rat	NOUN
ffhd-35	39	6	showed	show	VERB
ffhd-35	39	7	the	the	DET
ffhd-35	39	8	ability	ability	NOUN
ffhd-35	39	9	of	of	ADP
ffhd-35	39	10	dg	dg	PRON
ffhd-35	39	11	to	to	PART
ffhd-35	39	12	reduce	reduce	VERB
ffhd-35	39	13	fasting	fast	VERB
ffhd-35	39	14	blood	blood	NOUN
ffhd-35	39	15	glucose	glucose	NOUN
ffhd-35	39	16	and	and	CCONJ
ffhd-35	39	17	glycosylated	glycosylated	ADJ
ffhd-35	39	18	hemoglobin	hemoglobin	NOUN
ffhd-35	39	19	levels	level	NOUN
ffhd-35	39	20	[	[	X
ffhd-35	39	21	18	18	NUM
ffhd-35	39	22	]	]	PUNCT
ffhd-35	39	23	.	.	PUNCT
ffhd-35	40	1	a	a	DET
ffhd-35	40	2	recent	recent	ADJ
ffhd-35	40	3	study	study	NOUN
ffhd-35	40	4	indicated	indicate	VERB
ffhd-35	40	5	that	that	SCONJ
ffhd-35	40	6	whole	whole	NOUN
ffhd-35	40	7	,	,	PUNCT
ffhd-35	40	8	ground	ground	NOUN
ffhd-35	40	9	dg	dg	NOUN
ffhd-35	40	10	had	have	VERB
ffhd-35	40	11	a	a	DET
ffhd-35	40	12	positive	positive	ADJ
ffhd-35	40	13	effect	effect	NOUN
ffhd-35	40	14	on	on	ADP
ffhd-35	40	15	cardiovascular	cardiovascular	ADJ
ffhd-35	40	16	risk	risk	NOUN
ffhd-35	40	17	factors	factor	NOUN
ffhd-35	40	18	associated	associate	VERB
ffhd-35	40	19	with	with	ADP
ffhd-35	40	20	obesity	obesity	NOUN
ffhd-35	40	21	and	and	CCONJ
ffhd-35	40	22	type	type	NOUN
ffhd-35	40	23	2	2	NUM
ffhd-35	40	24	diabetes	diabetes	NOUN
ffhd-35	40	25	[	[	X
ffhd-35	40	26	19	19	NUM
ffhd-35	40	27	]	]	PUNCT
ffhd-35	40	28	.	.	PUNCT
ffhd-35	41	1	while	while	SCONJ
ffhd-35	41	2	these	these	DET
ffhd-35	41	3	reports	report	NOUN
ffhd-35	41	4	suggest	suggest	VERB
ffhd-35	41	5	that	that	SCONJ
ffhd-35	41	6	dg	dg	PROPN
ffhd-35	41	7	can	can	AUX
ffhd-35	41	8	have	have	VERB
ffhd-35	41	9	beneficial	beneficial	ADJ
ffhd-35	41	10	effects	effect	NOUN
ffhd-35	41	11	on	on	ADP
ffhd-35	41	12	health	health	NOUN
ffhd-35	41	13	,	,	PUNCT
ffhd-35	41	14	the	the	DET
ffhd-35	41	15	bioactive	bioactive	ADJ
ffhd-35	41	16	components	component	NOUN
ffhd-35	41	17	of	of	ADP
ffhd-35	41	18	dg	dg	NOUN
ffhd-35	41	19	have	have	AUX
ffhd-35	41	20	not	not	PART
ffhd-35	41	21	been	be	AUX
ffhd-35	41	22	well	well	ADV
ffhd-35	41	23	characterized	characterize	VERB
ffhd-35	41	24	.	.	PUNCT
ffhd-35	42	1	toward	toward	ADP
ffhd-35	42	2	this	this	DET
ffhd-35	42	3	end	end	NOUN
ffhd-35	42	4	the	the	DET
ffhd-35	42	5	current	current	ADJ
ffhd-35	42	6	study	study	NOUN
ffhd-35	42	7	was	be	AUX
ffhd-35	42	8	undertaken	undertake	VERB
ffhd-35	42	9	to	to	PART
ffhd-35	42	10	evaluate	evaluate	VERB
ffhd-35	42	11	the	the	DET
ffhd-35	42	12	effects	effect	NOUN
ffhd-35	42	13	of	of	ADP
ffhd-35	42	14	an	an	DET
ffhd-35	42	15	aqueous	aqueous	ADJ
ffhd-35	42	16	extract	extract	NOUN
ffhd-35	42	17	of	of	ADP
ffhd-35	42	18	standardized	standardized	ADJ
ffhd-35	42	19	dg	dg	NOUN
ffhd-35	42	20	on	on	ADP
ffhd-35	42	21	mets	met	NOUN
ffhd-35	42	22	markers	marker	NOUN
ffhd-35	42	23	in	in	ADP
ffhd-35	42	24	obese	obese	ADJ
ffhd-35	42	25	humans	human	NOUN
ffhd-35	42	26	.	.	PUNCT
ffhd-35	43	1	2	2	X
ffhd-35	43	2	.	.	X
ffhd-35	43	3	methods	method	NOUN
ffhd-35	43	4	and	and	CCONJ
ffhd-35	43	5	materials	material	NOUN
ffhd-35	43	6	2.1	2.1	NUM
ffhd-35	43	7	.	.	PUNCT
ffhd-35	43	8	test	test	NOUN
ffhd-35	43	9	material	material	NOUN
ffhd-35	43	10	:	:	PUNCT
ffhd-35	43	11	dyglomera	dyglomera	NOUN
ffhd-35	43	12	®	®	NOUN
ffhd-35	43	13	,	,	PUNCT
ffhd-35	43	14	an	an	DET
ffhd-35	43	15	aqueous	aqueous	ADJ
ffhd-35	43	16	extract	extract	NOUN
ffhd-35	43	17	of	of	ADP
ffhd-35	43	18	dg	dg	NOUN
ffhd-35	43	19	(	(	PUNCT
ffhd-35	43	20	standardized	standardize	VERB
ffhd-35	43	21	to	to	ADP
ffhd-35	43	22	nlt	nlt	PROPN
ffhd-35	43	23	10	10	NUM
ffhd-35	43	24	%	%	NOUN
ffhd-35	43	25	polyphenols	polyphenol	NOUN
ffhd-35	43	26	)	)	PUNCT
ffhd-35	43	27	,	,	PUNCT
ffhd-35	43	28	was	be	AUX
ffhd-35	43	29	supplied	supply	VERB
ffhd-35	43	30	by	by	ADP
ffhd-35	43	31	gateway	gateway	NOUN
ffhd-35	43	32	health	health	NOUN
ffhd-35	43	33	alliances	alliance	NOUN
ffhd-35	43	34	,	,	PUNCT
ffhd-35	43	35	fairfield	fairfield	PROPN
ffhd-35	43	36	,	,	PUNCT
ffhd-35	43	37	california	california	PROPN
ffhd-35	43	38	,	,	PUNCT
ffhd-35	43	39	usa	usa	PROPN
ffhd-35	43	40	.	.	PUNCT
ffhd-35	44	1	they	they	PRON
ffhd-35	44	2	were	be	AUX
ffhd-35	44	3	supplied	supply	VERB
ffhd-35	44	4	as	as	ADP
ffhd-35	44	5	200	200	NUM
ffhd-35	44	6	mg	mg	ADJ
ffhd-35	44	7	capsules	capsule	NOUN
ffhd-35	44	8	.	.	PUNCT
ffhd-35	45	1	identical	identical	ADJ
ffhd-35	45	2	-	-	PUNCT
ffhd-35	45	3	looking	look	VERB
ffhd-35	45	4	placebo	placebo	NOUN
ffhd-35	45	5	capsules	capsule	NOUN
ffhd-35	45	6	were	be	AUX
ffhd-35	45	7	also	also	ADV
ffhd-35	45	8	manufactured	manufacture	VERB
ffhd-35	45	9	containing	contain	VERB
ffhd-35	45	10	200	200	NUM
ffhd-35	45	11	mg	mg	NOUN
ffhd-35	45	12	of	of	ADP
ffhd-35	45	13	maize	maize	NOUN
ffhd-35	45	14	-	-	PUNCT
ffhd-35	45	15	based	base	VERB
ffhd-35	45	16	powder	powder	NOUN
ffhd-35	45	17	.	.	PUNCT
ffhd-35	46	1	2.2	2.2	NUM
ffhd-35	46	2	.	.	PUNCT
ffhd-35	47	1	study	study	NOUN
ffhd-35	47	2	population	population	NOUN
ffhd-35	47	3	and	and	CCONJ
ffhd-35	47	4	intervention	intervention	NOUN
ffhd-35	47	5	the	the	DET
ffhd-35	47	6	study	study	NOUN
ffhd-35	47	7	was	be	AUX
ffhd-35	47	8	a	a	DET
ffhd-35	47	9	double	double	ADJ
ffhd-35	47	10	-	-	PUNCT
ffhd-35	47	11	blind	blind	ADJ
ffhd-35	47	12	,	,	PUNCT
ffhd-35	47	13	placebo	placebo	NOUN
ffhd-35	47	14	-	-	PUNCT
ffhd-35	47	15	controlled	control	VERB
ffhd-35	47	16	trial	trial	NOUN
ffhd-35	47	17	lasting	last	VERB
ffhd-35	47	18	8	8	NUM
ffhd-35	47	19	weeks	week	NOUN
ffhd-35	47	20	.	.	PUNCT
ffhd-35	48	1	a	a	DET
ffhd-35	48	2	total	total	NOUN
ffhd-35	48	3	of	of	ADP
ffhd-35	48	4	318	318	NUM
ffhd-35	48	5	participants	participant	NOUN
ffhd-35	48	6	(	(	PUNCT
ffhd-35	48	7	202	202	NUM
ffhd-35	48	8	females	female	NOUN
ffhd-35	48	9	and	and	CCONJ
ffhd-35	48	10	116	116	NUM
ffhd-35	48	11	males	male	NOUN
ffhd-35	48	12	)	)	PUNCT
ffhd-35	48	13	were	be	AUX
ffhd-35	48	14	randomly	randomly	ADV
ffhd-35	48	15	selected	select	VERB
ffhd-35	48	16	from	from	ADP
ffhd-35	48	17	a	a	DET
ffhd-35	48	18	pool	pool	NOUN
ffhd-35	48	19	of	of	ADP
ffhd-35	48	20	1,360	1,360	NUM
ffhd-35	48	21	obese	obese	ADJ
ffhd-35	48	22	subjects	subject	NOUN
ffhd-35	48	23	previously	previously	ADV
ffhd-35	48	24	recruited	recruit	VERB
ffhd-35	48	25	from	from	ADP
ffhd-35	48	26	the	the	DET
ffhd-35	48	27	city	city	NOUN
ffhd-35	48	28	of	of	ADP
ffhd-35	48	29	yaounde	yaounde	PROPN
ffhd-35	48	30	and	and	CCONJ
ffhd-35	48	31	its	its	PRON
ffhd-35	48	32	environs	environ	NOUN
ffhd-35	48	33	.	.	PUNCT
ffhd-35	49	1	the	the	DET
ffhd-35	49	2	participants	participant	NOUN
ffhd-35	49	3	included	include	VERB
ffhd-35	49	4	males	male	NOUN
ffhd-35	49	5	and	and	CCONJ
ffhd-35	49	6	non	non	ADJ
ffhd-35	49	7	-	-	ADJ
ffhd-35	49	8	pregnant	pregnant	ADJ
ffhd-35	49	9	/	/	SYM
ffhd-35	49	10	non	non	ADJ
ffhd-35	49	11	-	-	ADJ
ffhd-35	49	12	lactating	lactating	ADJ
ffhd-35	49	13	females	female	NOUN
ffhd-35	49	14	aged	age	VERB
ffhd-35	49	15	24–58	24–58	NUM
ffhd-35	49	16	years	year	NOUN
ffhd-35	49	17	,	,	PUNCT
ffhd-35	49	18	with	with	ADP
ffhd-35	49	19	a	a	DET
ffhd-35	49	20	bmi	bmi	NOUN
ffhd-35	49	21	between	between	ADP
ffhd-35	49	22	30	30	NUM
ffhd-35	49	23	-	-	SYM
ffhd-35	49	24	40	40	NUM
ffhd-35	49	25	kg	kg	NOUN
ffhd-35	49	26	/	/	SYM
ffhd-35	49	27	m	m	PROPN
ffhd-35	49	28	2	2	NUM
ffhd-35	49	29	.	.	PUNCT
ffhd-35	50	1	the	the	DET
ffhd-35	50	2	ncep	ncep	PROPN
ffhd-35	50	3	atp	atp	PROPN
ffhd-35	50	4	iii	iii	PROPN
ffhd-35	50	5	criteria	criterion	NOUN
ffhd-35	50	6	were	be	AUX
ffhd-35	50	7	used	use	VERB
ffhd-35	50	8	for	for	ADP
ffhd-35	50	9	the	the	DET
ffhd-35	50	10	diagnosis	diagnosis	NOUN
ffhd-35	50	11	of	of	ADP
ffhd-35	50	12	mets	met	NOUN
ffhd-35	50	13	,	,	PUNCT
ffhd-35	50	14	such	such	ADJ
ffhd-35	50	15	that	that	SCONJ
ffhd-35	50	16	if	if	SCONJ
ffhd-35	50	17	any	any	DET
ffhd-35	50	18	three	three	NUM
ffhd-35	50	19	of	of	ADP
ffhd-35	50	20	the	the	DET
ffhd-35	50	21	following	follow	VERB
ffhd-35	50	22	conditions	condition	NOUN
ffhd-35	50	23	were	be	AUX
ffhd-35	50	24	present	present	ADJ
ffhd-35	50	25	in	in	ADP
ffhd-35	50	26	the	the	DET
ffhd-35	50	27	same	same	ADJ
ffhd-35	50	28	patient	patient	NOUN
ffhd-35	50	29	they	they	PRON
ffhd-35	50	30	were	be	AUX
ffhd-35	50	31	considered	consider	VERB
ffhd-35	50	32	to	to	PART
ffhd-35	50	33	have	have	VERB
ffhd-35	50	34	mets	met	NOUN
ffhd-35	50	35	:	:	PUNCT
ffhd-35	50	36	waist	waist	NOUN
ffhd-35	50	37	circumference	circumference	NOUN
ffhd-35	50	38	>	>	X
ffhd-35	50	39	102	102	NUM
ffhd-35	50	40	cm	cm	NOUN
ffhd-35	50	41	in	in	ADP
ffhd-35	50	42	men	man	NOUN
ffhd-35	50	43	and	and	CCONJ
ffhd-35	50	44	>	>	X
ffhd-35	50	45	88	88	NUM
ffhd-35	50	46	cm	cm	NOUN
ffhd-35	50	47	in	in	ADP
ffhd-35	50	48	women	woman	NOUN
ffhd-35	50	49	;	;	PUNCT
ffhd-35	50	50	triglycerides	triglyceride	NOUN
ffhd-35	50	51	(	(	PUNCT
ffhd-35	50	52	tag	tag	NOUN
ffhd-35	50	53	)	)	PUNCT
ffhd-35	50	54	≥	≥	NOUN
ffhd-35	50	55	150	150	NUM
ffhd-35	50	56	mg	mg	PROPN
ffhd-35	50	57	/	/	SYM
ffhd-35	50	58	dl	dl	PROPN
ffhd-35	50	59	;	;	PUNCT
ffhd-35	50	60	high	high	ADJ
ffhd-35	50	61	-	-	PUNCT
ffhd-35	50	62	density	density	NOUN
ffhd-35	50	63	lipoprotein	lipoprotein	ADJ
ffhd-35	50	64	(	(	PUNCT
ffhd-35	50	65	hdl	hdl	NOUN
ffhd-35	50	66	)	)	PUNCT
ffhd-35	50	67	<	<	X
ffhd-35	50	68	40	40	NUM
ffhd-35	50	69	mg	mg	PROPN
ffhd-35	50	70	/	/	SYM
ffhd-35	50	71	dl	dl	PROPN
ffhd-35	50	72	in	in	ADP
ffhd-35	50	73	men	man	NOUN
ffhd-35	50	74	and	and	CCONJ
ffhd-35	50	75	<	<	X
ffhd-35	50	76	50	50	NUM
ffhd-35	50	77	mg	mg	PROPN
ffhd-35	50	78	/	/	SYM
ffhd-35	50	79	dl	dl	PROPN
ffhd-35	50	80	in	in	ADP
ffhd-35	50	81	women	woman	NOUN
ffhd-35	50	82	;	;	PUNCT
ffhd-35	50	83	fasting	fast	VERB
ffhd-35	50	84	glucose	glucose	NOUN
ffhd-35	50	85	≥	≥	NUM
ffhd-35	50	86	110	110	NUM
ffhd-35	50	87	mg	mg	PROPN
ffhd-35	50	88	/	/	SYM
ffhd-35	50	89	dl	dl	PROPN
ffhd-35	50	90	and	and	CCONJ
ffhd-35	50	91	blood	blood	NOUN
ffhd-35	50	92	pressure	pressure	NOUN
ffhd-35	50	93	≥	≥	NOUN
ffhd-35	50	94	130/85	130/85	NUM
ffhd-35	50	95	mm	mm	NUM
ffhd-35	50	96	hg	hg	NOUN
ffhd-35	50	97	(	(	PUNCT
ffhd-35	50	98	or	or	CCONJ
ffhd-35	50	99	use	use	NOUN
ffhd-35	50	100	of	of	ADP
ffhd-35	50	101	antihypertensive	antihypertensive	ADJ
ffhd-35	50	102	agents	agent	NOUN
ffhd-35	50	103	)	)	PUNCT
ffhd-35	51	1	[	[	X
ffhd-35	51	2	20	20	NUM
ffhd-35	51	3	]	]	PUNCT
ffhd-35	51	4	.	.	PUNCT
ffhd-35	52	1	a	a	DET
ffhd-35	52	2	physician	physician	NOUN
ffhd-35	52	3	examined	examine	VERB
ffhd-35	52	4	participants	participant	NOUN
ffhd-35	52	5	to	to	PART
ffhd-35	52	6	ascertain	ascertain	VERB
ffhd-35	52	7	their	their	PRON
ffhd-35	52	8	eligibility	eligibility	NOUN
ffhd-35	52	9	for	for	ADP
ffhd-35	52	10	inclusion	inclusion	NOUN
ffhd-35	52	11	in	in	ADP
ffhd-35	52	12	the	the	DET
ffhd-35	52	13	study	study	NOUN
ffhd-35	52	14	.	.	PUNCT
ffhd-35	53	1	participants	participant	NOUN
ffhd-35	53	2	were	be	AUX
ffhd-35	53	3	randomly	randomly	ADV
ffhd-35	53	4	divided	divide	VERB
ffhd-35	53	5	into	into	ADP
ffhd-35	53	6	two	two	NUM
ffhd-35	53	7	groups	group	NOUN
ffhd-35	53	8	,	,	PUNCT
ffhd-35	53	9	and	and	CCONJ
ffhd-35	53	10	were	be	AUX
ffhd-35	53	11	instructed	instruct	VERB
ffhd-35	53	12	to	to	PART
ffhd-35	53	13	take	take	VERB
ffhd-35	53	14	200	200	NUM
ffhd-35	53	15	mg	mg	NOUN
ffhd-35	53	16	of	of	ADP
ffhd-35	53	17	either	either	PRON
ffhd-35	53	18	dyglomera	dyglomera	NOUN
ffhd-35	53	19	®	®	NOUN
ffhd-35	53	20	or	or	CCONJ
ffhd-35	53	21	placebo	placebo	NOUN
ffhd-35	53	22	30	30	NUM
ffhd-35	53	23	-	-	SYM
ffhd-35	53	24	60	60	NUM
ffhd-35	53	25	min	min	NOUN
ffhd-35	53	26	before	before	ADP
ffhd-35	53	27	lunch	lunch	NOUN
ffhd-35	53	28	or	or	CCONJ
ffhd-35	53	29	dinner	dinner	NOUN
ffhd-35	53	30	throughout	throughout	ADP
ffhd-35	53	31	the	the	DET
ffhd-35	53	32	study	study	NOUN
ffhd-35	53	33	period	period	NOUN
ffhd-35	53	34	.	.	PUNCT
ffhd-35	54	1	they	they	PRON
ffhd-35	54	2	were	be	AUX
ffhd-35	54	3	asked	ask	VERB
ffhd-35	54	4	to	to	PART
ffhd-35	54	5	report	report	VERB
ffhd-35	54	6	any	any	DET
ffhd-35	54	7	lapses	lapse	NOUN
ffhd-35	54	8	in	in	ADP
ffhd-35	54	9	taking	take	VERB
ffhd-35	54	10	the	the	DET
ffhd-35	54	11	pills	pill	NOUN
ffhd-35	54	12	.	.	PUNCT
ffhd-35	55	1	since	since	SCONJ
ffhd-35	55	2	the	the	DET
ffhd-35	55	3	capsules	capsule	NOUN
ffhd-35	55	4	were	be	AUX
ffhd-35	55	5	identical	identical	ADJ
ffhd-35	55	6	in	in	ADP
ffhd-35	55	7	size	size	NOUN
ffhd-35	55	8	,	,	PUNCT
ffhd-35	55	9	shape	shape	NOUN
ffhd-35	55	10	,	,	PUNCT
ffhd-35	55	11	and	and	CCONJ
ffhd-35	55	12	appearance	appearance	NOUN
ffhd-35	55	13	,	,	PUNCT
ffhd-35	55	14	neither	neither	CCONJ
ffhd-35	55	15	the	the	DET
ffhd-35	55	16	researchers	researcher	NOUN
ffhd-35	55	17	nor	nor	CCONJ
ffhd-35	55	18	participants	participant	NOUN
ffhd-35	55	19	knew	know	VERB
ffhd-35	55	20	which	which	DET
ffhd-35	55	21	treatment	treatment	NOUN
ffhd-35	55	22	was	be	AUX
ffhd-35	55	23	given	give	VERB
ffhd-35	55	24	.	.	PUNCT
ffhd-35	56	1	participants	participant	NOUN
ffhd-35	56	2	were	be	AUX
ffhd-35	56	3	encouraged	encourage	VERB
ffhd-35	56	4	to	to	PART
ffhd-35	56	5	maintain	maintain	VERB
ffhd-35	56	6	their	their	PRON
ffhd-35	56	7	prior	prior	ADJ
ffhd-35	56	8	lifestyle	lifestyle	NOUN
ffhd-35	56	9	and	and	CCONJ
ffhd-35	56	10	dietary	dietary	ADJ
ffhd-35	56	11	habits	habit	NOUN
ffhd-35	56	12	throughout	throughout	ADP
ffhd-35	56	13	the	the	DET
ffhd-35	56	14	study	study	NOUN
ffhd-35	56	15	.	.	PUNCT
ffhd-35	57	1	functional	functional	ADJ
ffhd-35	57	2	foods	food	NOUN
ffhd-35	57	3	in	in	ADP
ffhd-35	57	4	health	health	NOUN
ffhd-35	57	5	and	and	CCONJ
ffhd-35	57	6	disease	disease	NOUN
ffhd-35	57	7	2013	2013	NUM
ffhd-35	57	8	;	;	PUNCT
ffhd-35	57	9	3(11):416	3(11):416	NUM
ffhd-35	57	10	-	-	SYM
ffhd-35	57	11	427	427	NUM
ffhd-35	57	12	page	page	NOUN
ffhd-35	57	13	419	419	NUM
ffhd-35	57	14	of	of	ADP
ffhd-35	57	15	427	427	NUM
ffhd-35	57	16	2.3	2.3	NUM
ffhd-35	57	17	.	.	PUNCT
ffhd-35	58	1	exclusion	exclusion	NOUN
ffhd-35	58	2	criteria	criterion	NOUN
ffhd-35	58	3	exclusion	exclusion	NOUN
ffhd-35	58	4	criteria	criterion	NOUN
ffhd-35	58	5	included	include	VERB
ffhd-35	58	6	impaired	impaired	ADJ
ffhd-35	58	7	kidney	kidney	NOUN
ffhd-35	58	8	function	function	NOUN
ffhd-35	58	9	,	,	PUNCT
ffhd-35	58	10	cardiac	cardiac	ADJ
ffhd-35	58	11	problems	problem	NOUN
ffhd-35	58	12	,	,	PUNCT
ffhd-35	58	13	serious	serious	ADJ
ffhd-35	58	14	hypertension	hypertension	NOUN
ffhd-35	58	15	(	(	PUNCT
ffhd-35	58	16	systolic	systolic	ADJ
ffhd-35	58	17	and	and	CCONJ
ffhd-35	58	18	diastolic	diastolic	ADJ
ffhd-35	58	19	blood	blood	NOUN
ffhd-35	58	20	pressure	pressure	NOUN
ffhd-35	58	21	above	above	ADP
ffhd-35	58	22	180	180	NUM
ffhd-35	58	23	mm	mm	NUM
ffhd-35	58	24	hg	hg	NOUN
ffhd-35	58	25	,	,	PUNCT
ffhd-35	58	26	and	and	CCONJ
ffhd-35	58	27	110	110	NUM
ffhd-35	58	28	mm	mm	NUM
ffhd-35	58	29	hg	hg	NOUN
ffhd-35	58	30	,	,	PUNCT
ffhd-35	58	31	respectively	respectively	ADV
ffhd-35	58	32	)	)	PUNCT
ffhd-35	58	33	,	,	PUNCT
ffhd-35	58	34	need	need	VERB
ffhd-35	58	35	for	for	ADP
ffhd-35	58	36	daily	daily	ADJ
ffhd-35	58	37	insulin	insulin	NOUN
ffhd-35	58	38	management	management	NOUN
ffhd-35	58	39	,	,	PUNCT
ffhd-35	58	40	and	and	CCONJ
ffhd-35	58	41	enrollment	enrollment	NOUN
ffhd-35	58	42	in	in	ADP
ffhd-35	58	43	another	another	DET
ffhd-35	58	44	clinical	clinical	ADJ
ffhd-35	58	45	study	study	NOUN
ffhd-35	58	46	within	within	ADP
ffhd-35	58	47	the	the	DET
ffhd-35	58	48	past	past	ADJ
ffhd-35	58	49	6	6	NUM
ffhd-35	58	50	months	month	NOUN
ffhd-35	58	51	.	.	PUNCT
ffhd-35	59	1	also	also	ADV
ffhd-35	59	2	excluded	exclude	VERB
ffhd-35	59	3	were	be	AUX
ffhd-35	59	4	volunteers	volunteer	NOUN
ffhd-35	59	5	with	with	ADP
ffhd-35	59	6	a	a	DET
ffhd-35	59	7	history	history	NOUN
ffhd-35	59	8	of	of	ADP
ffhd-35	59	9	drug	drug	NOUN
ffhd-35	59	10	or	or	CCONJ
ffhd-35	59	11	alcohol	alcohol	NOUN
ffhd-35	59	12	abuse	abuse	NOUN
ffhd-35	59	13	,	,	PUNCT
ffhd-35	59	14	those	those	PRON
ffhd-35	59	15	on	on	ADP
ffhd-35	59	16	cholesterollowering	cholesterollowering	NOUN
ffhd-35	59	17	,	,	PUNCT
ffhd-35	59	18	inflammation	inflammation	NOUN
ffhd-35	59	19	-	-	PUNCT
ffhd-35	59	20	reducing	reduce	VERB
ffhd-35	59	21	and/or	and/or	CCONJ
ffhd-35	59	22	other	other	ADJ
ffhd-35	59	23	medications	medication	NOUN
ffhd-35	59	24	(	(	PUNCT
ffhd-35	59	25	e.g.	e.g.	ADV
ffhd-35	59	26	,	,	PUNCT
ffhd-35	59	27	steroids	steroid	NOUN
ffhd-35	59	28	)	)	PUNCT
ffhd-35	59	29	that	that	PRON
ffhd-35	59	30	interfere	interfere	VERB
ffhd-35	59	31	with	with	ADP
ffhd-35	59	32	blood	blood	NOUN
ffhd-35	59	33	clotting	clotting	NOUN
ffhd-35	59	34	and	and	CCONJ
ffhd-35	59	35	wound	wound	NOUN
ffhd-35	59	36	repair	repair	NOUN
ffhd-35	59	37	,	,	PUNCT
ffhd-35	59	38	as	as	ADV
ffhd-35	59	39	well	well	ADV
ffhd-35	59	40	as	as	ADP
ffhd-35	59	41	participants	participant	NOUN
ffhd-35	59	42	with	with	ADP
ffhd-35	59	43	infections	infection	NOUN
ffhd-35	59	44	including	include	VERB
ffhd-35	59	45	hiv	hiv	PROPN
ffhd-35	59	46	/	/	SYM
ffhd-35	59	47	aids	aid	NOUN
ffhd-35	59	48	or	or	CCONJ
ffhd-35	59	49	cancer	cancer	NOUN
ffhd-35	59	50	.	.	PUNCT
ffhd-35	60	1	2.4	2.4	NUM
ffhd-35	60	2	.	.	PUNCT
ffhd-35	60	3	approval	approval	NOUN
ffhd-35	60	4	and	and	CCONJ
ffhd-35	60	5	informed	informed	ADJ
ffhd-35	60	6	consent	consent	NOUN
ffhd-35	60	7	the	the	DET
ffhd-35	60	8	study	study	NOUN
ffhd-35	60	9	was	be	AUX
ffhd-35	60	10	approved	approve	VERB
ffhd-35	60	11	by	by	ADP
ffhd-35	60	12	the	the	DET
ffhd-35	60	13	local	local	ADJ
ffhd-35	60	14	ethical	ethical	PROPN
ffhd-35	60	15	committee	committee	NOUN
ffhd-35	60	16	(	(	PUNCT
ffhd-35	60	17	approval	approval	NOUN
ffhd-35	60	18	no	no	INTJ
ffhd-35	60	19	.	.	NOUN
ffhd-35	60	20	006	006	NUM
ffhd-35	60	21	/	/	SYM
ffhd-35	60	22	cne	cne	PROPN
ffhd-35	60	23	/	/	SYM
ffhd-35	60	24	mp/07	mp/07	PROPN
ffhd-35	60	25	)	)	PUNCT
ffhd-35	60	26	.	.	PUNCT
ffhd-35	61	1	the	the	DET
ffhd-35	61	2	purpose	purpose	NOUN
ffhd-35	61	3	,	,	PUNCT
ffhd-35	61	4	nature	nature	NOUN
ffhd-35	61	5	,	,	PUNCT
ffhd-35	61	6	and	and	CCONJ
ffhd-35	61	7	potential	potential	ADJ
ffhd-35	61	8	risks	risk	NOUN
ffhd-35	61	9	of	of	ADP
ffhd-35	61	10	the	the	DET
ffhd-35	61	11	study	study	NOUN
ffhd-35	61	12	were	be	AUX
ffhd-35	61	13	explained	explain	VERB
ffhd-35	61	14	to	to	ADP
ffhd-35	61	15	all	all	DET
ffhd-35	61	16	participants	participant	NOUN
ffhd-35	61	17	,	,	PUNCT
ffhd-35	61	18	who	who	PRON
ffhd-35	61	19	gave	give	VERB
ffhd-35	61	20	their	their	PRON
ffhd-35	61	21	written	write	VERB
ffhd-35	61	22	informed	inform	VERB
ffhd-35	61	23	consent	consent	NOUN
ffhd-35	61	24	before	before	ADP
ffhd-35	61	25	participation	participation	NOUN
ffhd-35	61	26	.	.	PUNCT
ffhd-35	62	1	the	the	DET
ffhd-35	62	2	study	study	NOUN
ffhd-35	62	3	was	be	AUX
ffhd-35	62	4	done	do	VERB
ffhd-35	62	5	in	in	ADP
ffhd-35	62	6	full	full	ADJ
ffhd-35	62	7	accordance	accordance	NOUN
ffhd-35	62	8	with	with	ADP
ffhd-35	62	9	the	the	DET
ffhd-35	62	10	ethical	ethical	ADJ
ffhd-35	62	11	provisions	provision	NOUN
ffhd-35	62	12	of	of	ADP
ffhd-35	62	13	the	the	DET
ffhd-35	62	14	world	world	PROPN
ffhd-35	62	15	medical	medical	PROPN
ffhd-35	62	16	association	association	PROPN
ffhd-35	62	17	declaration	declaration	PROPN
ffhd-35	62	18	of	of	ADP
ffhd-35	62	19	helsinki	helsinki	PROPN
ffhd-35	62	20	(	(	PUNCT
ffhd-35	62	21	as	as	SCONJ
ffhd-35	62	22	amended	amend	VERB
ffhd-35	62	23	by	by	ADP
ffhd-35	62	24	the	the	DET
ffhd-35	62	25	52nd	52nd	ADJ
ffhd-35	62	26	general	general	ADJ
ffhd-35	62	27	assembly	assembly	NOUN
ffhd-35	62	28	,	,	PUNCT
ffhd-35	62	29	edinburgh	edinburgh	PROPN
ffhd-35	62	30	,	,	PUNCT
ffhd-35	62	31	scotland	scotland	PROPN
ffhd-35	62	32	,	,	PUNCT
ffhd-35	62	33	october	october	PROPN
ffhd-35	62	34	2000	2000	NUM
ffhd-35	62	35	)	)	PUNCT
ffhd-35	62	36	.	.	PUNCT
ffhd-35	63	1	2.5	2.5	NUM
ffhd-35	63	2	.	.	PUNCT
ffhd-35	64	1	anthropometric	anthropometric	ADJ
ffhd-35	64	2	measurements	measurement	NOUN
ffhd-35	64	3	various	various	ADJ
ffhd-35	64	4	anthropometric	anthropometric	ADJ
ffhd-35	64	5	parameters	parameter	NOUN
ffhd-35	64	6	were	be	AUX
ffhd-35	64	7	measured	measure	VERB
ffhd-35	64	8	at	at	ADP
ffhd-35	64	9	baseline	baseline	NOUN
ffhd-35	64	10	and	and	CCONJ
ffhd-35	64	11	at	at	ADP
ffhd-35	64	12	biweekly	biweekly	ADJ
ffhd-35	64	13	follow	follow	NOUN
ffhd-35	64	14	-	-	PUNCT
ffhd-35	64	15	up	up	NOUN
ffhd-35	64	16	visits	visit	NOUN
ffhd-35	64	17	for	for	ADP
ffhd-35	64	18	the	the	DET
ffhd-35	64	19	8	8	NUM
ffhd-35	64	20	weeks	week	NOUN
ffhd-35	64	21	of	of	ADP
ffhd-35	64	22	treatment	treatment	NOUN
ffhd-35	64	23	.	.	PUNCT
ffhd-35	65	1	height	height	NOUN
ffhd-35	65	2	was	be	AUX
ffhd-35	65	3	measured	measure	VERB
ffhd-35	65	4	with	with	ADP
ffhd-35	65	5	a	a	DET
ffhd-35	65	6	harpenden	harpenden	ADJ
ffhd-35	65	7	™	™	ADJ
ffhd-35	65	8	stadiometer	stadiometer	NOUN
ffhd-35	65	9	(	(	PUNCT
ffhd-35	65	10	cranlea	cranlea	NOUN
ffhd-35	65	11	&	&	CCONJ
ffhd-35	65	12	company	company	NOUN
ffhd-35	65	13	,	,	PUNCT
ffhd-35	65	14	birmingham	birmingham	PROPN
ffhd-35	65	15	,	,	PUNCT
ffhd-35	65	16	uk	uk	PROPN
ffhd-35	65	17	)	)	PUNCT
ffhd-35	65	18	,	,	PUNCT
ffhd-35	65	19	which	which	PRON
ffhd-35	65	20	measures	measure	VERB
ffhd-35	65	21	height	height	NOUN
ffhd-35	65	22	to	to	ADP
ffhd-35	65	23	the	the	DET
ffhd-35	65	24	nearest	near	ADJ
ffhd-35	65	25	0.5	0.5	NUM
ffhd-35	65	26	cm	cm	NOUN
ffhd-35	65	27	.	.	PUNCT
ffhd-35	66	1	body	body	NOUN
ffhd-35	66	2	weight	weight	NOUN
ffhd-35	66	3	and	and	CCONJ
ffhd-35	66	4	percentage	percentage	NOUN
ffhd-35	66	5	body	body	NOUN
ffhd-35	66	6	fat	fat	NOUN
ffhd-35	66	7	were	be	AUX
ffhd-35	66	8	assessed	assess	VERB
ffhd-35	66	9	using	use	VERB
ffhd-35	66	10	a	a	DET
ffhd-35	66	11	tanita	tanita	NOUN
ffhd-35	66	12	tm	tm	PRON
ffhd-35	66	13	bc-418	bc-418	PROPN
ffhd-35	66	14	segmental	segmental	ADJ
ffhd-35	66	15	body	body	NOUN
ffhd-35	66	16	composition	composition	NOUN
ffhd-35	66	17	analyzer	analyzer	NOUN
ffhd-35	66	18	/	/	SYM
ffhd-35	66	19	scale	scale	NOUN
ffhd-35	66	20	(	(	PUNCT
ffhd-35	66	21	arlington	arlington	PROPN
ffhd-35	66	22	heights	heights	PROPN
ffhd-35	66	23	,	,	PUNCT
ffhd-35	66	24	illinois	illinois	PROPN
ffhd-35	66	25	,	,	PUNCT
ffhd-35	66	26	usa	usa	PROPN
ffhd-35	66	27	)	)	PUNCT
ffhd-35	66	28	that	that	PRON
ffhd-35	66	29	uses	use	VERB
ffhd-35	66	30	bioelectrical	bioelectrical	ADJ
ffhd-35	66	31	impedance	impedance	NOUN
ffhd-35	66	32	analysis	analysis	NOUN
ffhd-35	66	33	to	to	PART
ffhd-35	66	34	compute	compute	VERB
ffhd-35	66	35	body	body	NOUN
ffhd-35	66	36	composition	composition	NOUN
ffhd-35	66	37	.	.	PUNCT
ffhd-35	67	1	bmi	bmi	PROPN
ffhd-35	67	2	was	be	AUX
ffhd-35	67	3	calculated	calculate	VERB
ffhd-35	67	4	as	as	ADP
ffhd-35	67	5	the	the	DET
ffhd-35	67	6	ratio	ratio	NOUN
ffhd-35	67	7	of	of	ADP
ffhd-35	67	8	weight	weight	NOUN
ffhd-35	67	9	(	(	PUNCT
ffhd-35	67	10	kg	kg	NOUN
ffhd-35	67	11	)	)	PUNCT
ffhd-35	67	12	to	to	PART
ffhd-35	67	13	height	height	NOUN
ffhd-35	67	14	squared	squared	PROPN
ffhd-35	67	15	(	(	PUNCT
ffhd-35	67	16	m	m	PROPN
ffhd-35	67	17	2	2	NUM
ffhd-35	67	18	)	)	PUNCT
ffhd-35	67	19	.	.	PUNCT
ffhd-35	68	1	waist	waist	NOUN
ffhd-35	68	2	(	(	PUNCT
ffhd-35	68	3	average	average	NOUN
ffhd-35	68	4	of	of	ADP
ffhd-35	68	5	narrowest	narrowest	NOUN
ffhd-35	68	6	and	and	CCONJ
ffhd-35	68	7	the	the	DET
ffhd-35	68	8	widest	wide	ADJ
ffhd-35	68	9	parts	part	NOUN
ffhd-35	68	10	of	of	ADP
ffhd-35	68	11	the	the	DET
ffhd-35	68	12	trunk	trunk	NOUN
ffhd-35	68	13	)	)	PUNCT
ffhd-35	68	14	and	and	CCONJ
ffhd-35	68	15	hip	hip	NOUN
ffhd-35	68	16	(	(	PUNCT
ffhd-35	68	17	widest	widest	ADJ
ffhd-35	68	18	point	point	NOUN
ffhd-35	68	19	)	)	PUNCT
ffhd-35	68	20	circumferences	circumference	NOUN
ffhd-35	68	21	were	be	AUX
ffhd-35	68	22	measured	measure	VERB
ffhd-35	68	23	to	to	ADP
ffhd-35	68	24	the	the	DET
ffhd-35	68	25	nearest	near	ADJ
ffhd-35	68	26	0.1	0.1	NUM
ffhd-35	68	27	cm	cm	NOUN
ffhd-35	68	28	.	.	PUNCT
ffhd-35	69	1	the	the	DET
ffhd-35	69	2	participants	participant	NOUN
ffhd-35	69	3	were	be	AUX
ffhd-35	69	4	asked	ask	VERB
ffhd-35	69	5	to	to	PART
ffhd-35	69	6	fast	fast	VERB
ffhd-35	69	7	for	for	ADP
ffhd-35	69	8	12	12	NUM
ffhd-35	69	9	hours	hour	NOUN
ffhd-35	69	10	and	and	CCONJ
ffhd-35	69	11	to	to	PART
ffhd-35	69	12	wear	wear	VERB
ffhd-35	69	13	light	light	ADJ
ffhd-35	69	14	clothing	clothing	NOUN
ffhd-35	69	15	for	for	ADP
ffhd-35	69	16	visits	visit	NOUN
ffhd-35	69	17	when	when	SCONJ
ffhd-35	69	18	measurements	measurement	NOUN
ffhd-35	69	19	were	be	AUX
ffhd-35	69	20	taken	take	VERB
ffhd-35	69	21	.	.	PUNCT
ffhd-35	70	1	the	the	DET
ffhd-35	70	2	participants	participant	NOUN
ffhd-35	70	3	were	be	AUX
ffhd-35	70	4	measured	measure	VERB
ffhd-35	70	5	at	at	ADP
ffhd-35	70	6	approximately	approximately	ADV
ffhd-35	70	7	the	the	DET
ffhd-35	70	8	same	same	ADJ
ffhd-35	70	9	time	time	NOUN
ffhd-35	70	10	of	of	ADP
ffhd-35	70	11	day	day	NOUN
ffhd-35	70	12	and	and	CCONJ
ffhd-35	70	13	by	by	ADP
ffhd-35	70	14	the	the	DET
ffhd-35	70	15	same	same	ADJ
ffhd-35	70	16	technician	technician	NOUN
ffhd-35	70	17	across	across	ADP
ffhd-35	70	18	visits	visit	NOUN
ffhd-35	70	19	.	.	PUNCT
ffhd-35	71	1	2.6	2.6	NUM
ffhd-35	71	2	.	.	PUNCT
ffhd-35	71	3	blood	blood	NOUN
ffhd-35	71	4	pressure	pressure	NOUN
ffhd-35	71	5	as	as	ADP
ffhd-35	71	6	with	with	ADP
ffhd-35	71	7	the	the	DET
ffhd-35	71	8	anthropometric	anthropometric	ADJ
ffhd-35	71	9	measurements	measurement	NOUN
ffhd-35	71	10	,	,	PUNCT
ffhd-35	71	11	blood	blood	NOUN
ffhd-35	71	12	pressure	pressure	NOUN
ffhd-35	71	13	was	be	AUX
ffhd-35	71	14	recorded	record	VERB
ffhd-35	71	15	at	at	ADP
ffhd-35	71	16	baseline	baseline	NOUN
ffhd-35	71	17	and	and	CCONJ
ffhd-35	71	18	at	at	ADP
ffhd-35	71	19	biweekly	biweekly	ADJ
ffhd-35	71	20	follow	follow	NOUN
ffhd-35	71	21	-	-	PUNCT
ffhd-35	71	22	up	up	ADP
ffhd-35	71	23	visits	visit	NOUN
ffhd-35	71	24	.	.	PUNCT
ffhd-35	72	1	blood	blood	NOUN
ffhd-35	72	2	pressure	pressure	NOUN
ffhd-35	72	3	was	be	AUX
ffhd-35	72	4	measured	measure	VERB
ffhd-35	72	5	on	on	ADP
ffhd-35	72	6	the	the	DET
ffhd-35	72	7	left	left	ADJ
ffhd-35	72	8	arm	arm	NOUN
ffhd-35	72	9	after	after	ADP
ffhd-35	72	10	a	a	DET
ffhd-35	72	11	10	10	NUM
ffhd-35	72	12	-	-	PUNCT
ffhd-35	72	13	minute	minute	NOUN
ffhd-35	72	14	rest	rest	NOUN
ffhd-35	72	15	.	.	PUNCT
ffhd-35	73	1	triplicate	triplicate	VERB
ffhd-35	73	2	readings	reading	NOUN
ffhd-35	73	3	were	be	AUX
ffhd-35	73	4	taken	take	VERB
ffhd-35	73	5	over	over	ADP
ffhd-35	73	6	5	5	NUM
ffhd-35	73	7	-	-	PUNCT
ffhd-35	73	8	minute	minute	NOUN
ffhd-35	73	9	intervals	interval	NOUN
ffhd-35	73	10	and	and	CCONJ
ffhd-35	73	11	the	the	DET
ffhd-35	73	12	average	average	NOUN
ffhd-35	73	13	was	be	AUX
ffhd-35	73	14	recorded	record	VERB
ffhd-35	73	15	.	.	PUNCT
ffhd-35	74	1	2.7	2.7	NUM
ffhd-35	74	2	.	.	PUNCT
ffhd-35	74	3	sample	sample	NOUN
ffhd-35	74	4	collection	collection	NOUN
ffhd-35	74	5	at	at	ADP
ffhd-35	74	6	week	week	NOUN
ffhd-35	74	7	4	4	NUM
ffhd-35	74	8	and	and	CCONJ
ffhd-35	74	9	week	week	NOUN
ffhd-35	74	10	8	8	NUM
ffhd-35	74	11	,	,	PUNCT
ffhd-35	74	12	blood	blood	NOUN
ffhd-35	74	13	samples	sample	NOUN
ffhd-35	74	14	(	(	PUNCT
ffhd-35	74	15	5	5	NUM
ffhd-35	74	16	ml	ml	NOUN
ffhd-35	74	17	of	of	ADP
ffhd-35	74	18	blood	blood	NOUN
ffhd-35	74	19	)	)	PUNCT
ffhd-35	74	20	were	be	AUX
ffhd-35	74	21	collected	collect	VERB
ffhd-35	74	22	after	after	ADP
ffhd-35	74	23	a	a	DET
ffhd-35	74	24	12	12	NUM
ffhd-35	74	25	-	-	PUNCT
ffhd-35	74	26	hour	hour	NOUN
ffhd-35	74	27	overnight	overnight	ADV
ffhd-35	74	28	fast	fast	ADV
ffhd-35	74	29	.	.	PUNCT
ffhd-35	75	1	the	the	DET
ffhd-35	75	2	plasma	plasma	NOUN
ffhd-35	75	3	or	or	CCONJ
ffhd-35	75	4	serum	serum	NOUN
ffhd-35	75	5	obtained	obtain	VERB
ffhd-35	75	6	from	from	ADP
ffhd-35	75	7	each	each	DET
ffhd-35	75	8	blood	blood	NOUN
ffhd-35	75	9	sample	sample	NOUN
ffhd-35	75	10	were	be	AUX
ffhd-35	75	11	split	split	VERB
ffhd-35	75	12	into	into	ADP
ffhd-35	75	13	multiple	multiple	ADJ
ffhd-35	75	14	500	500	NUM
ffhd-35	75	15	µl	µl	ADP
ffhd-35	75	16	aliquots	aliquot	NOUN
ffhd-35	75	17	and	and	CCONJ
ffhd-35	75	18	stored	store	VERB
ffhd-35	75	19	at	at	ADP
ffhd-35	75	20	-20	-20	NUM
ffhd-35	75	21	°	°	ADP
ffhd-35	75	22	c	c	NOUN
ffhd-35	75	23	until	until	SCONJ
ffhd-35	75	24	needed	need	VERB
ffhd-35	75	25	.	.	PUNCT
ffhd-35	76	1	2.8	2.8	NUM
ffhd-35	76	2	.	.	PUNCT
ffhd-35	76	3	analytical	analytical	ADJ
ffhd-35	76	4	methods	method	NOUN
ffhd-35	76	5	this	this	DET
ffhd-35	76	6	study	study	NOUN
ffhd-35	76	7	used	use	VERB
ffhd-35	76	8	the	the	DET
ffhd-35	76	9	trinder	trinder	NOUN
ffhd-35	76	10	glucose	glucose	NOUN
ffhd-35	76	11	activity	activity	NOUN
ffhd-35	76	12	test	test	NOUN
ffhd-35	76	13	[	[	X
ffhd-35	76	14	21	21	NUM
ffhd-35	76	15	]	]	PUNCT
ffhd-35	76	16	,	,	PUNCT
ffhd-35	76	17	which	which	PRON
ffhd-35	76	18	determines	determine	VERB
ffhd-35	76	19	glucose	glucose	NOUN
ffhd-35	76	20	in	in	ADP
ffhd-35	76	21	the	the	DET
ffhd-35	76	22	blood	blood	NOUN
ffhd-35	76	23	using	use	VERB
ffhd-35	76	24	glucose	glucose	NOUN
ffhd-35	76	25	oxidase	oxidase	NOUN
ffhd-35	76	26	with	with	ADP
ffhd-35	76	27	an	an	DET
ffhd-35	76	28	alternative	alternative	ADJ
ffhd-35	76	29	oxygen	oxygen	NOUN
ffhd-35	76	30	receptor	receptor	NOUN
ffhd-35	76	31	.	.	PUNCT
ffhd-35	77	1	plasma	plasma	NOUN
ffhd-35	77	2	total	total	ADJ
ffhd-35	77	3	cholesterol	cholesterol	NOUN
ffhd-35	77	4	was	be	AUX
ffhd-35	77	5	assayed	assayed	ADJ
ffhd-35	77	6	functional	functional	ADJ
ffhd-35	77	7	foods	food	NOUN
ffhd-35	77	8	in	in	ADP
ffhd-35	77	9	health	health	NOUN
ffhd-35	77	10	and	and	CCONJ
ffhd-35	77	11	disease	disease	NOUN
ffhd-35	77	12	2013	2013	NUM
ffhd-35	77	13	;	;	PUNCT
ffhd-35	77	14	3(11):416	3(11):416	NUM
ffhd-35	77	15	-	-	SYM
ffhd-35	77	16	427	427	NUM
ffhd-35	77	17	page	page	NOUN
ffhd-35	77	18	420	420	NUM
ffhd-35	77	19	of	of	ADP
ffhd-35	77	20	427	427	NUM
ffhd-35	77	21	by	by	ADP
ffhd-35	77	22	the	the	DET
ffhd-35	77	23	cholesterol	cholesterol	NOUN
ffhd-35	77	24	oxidase	oxidase	NOUN
ffhd-35	77	25	method	method	NOUN
ffhd-35	77	26	[	[	X
ffhd-35	77	27	22	22	NUM
ffhd-35	77	28	]	]	PUNCT
ffhd-35	77	29	,	,	PUNCT
ffhd-35	77	30	while	while	SCONJ
ffhd-35	77	31	triglycerides	triglyceride	NOUN
ffhd-35	77	32	were	be	AUX
ffhd-35	77	33	assayed	assayed	ADJ
ffhd-35	77	34	following	follow	VERB
ffhd-35	77	35	the	the	DET
ffhd-35	77	36	method	method	NOUN
ffhd-35	77	37	described	describe	VERB
ffhd-35	77	38	by	by	ADP
ffhd-35	77	39	bucolo	bucolo	PROPN
ffhd-35	77	40	and	and	CCONJ
ffhd-35	77	41	david	david	PROPN
ffhd-35	78	1	[	[	X
ffhd-35	78	2	23	23	NUM
ffhd-35	78	3	]	]	PUNCT
ffhd-35	78	4	.	.	PUNCT
ffhd-35	79	1	hdl	hdl	PROPN
ffhd-35	79	2	cholesterol	cholesterol	PROPN
ffhd-35	79	3	was	be	AUX
ffhd-35	79	4	determined	determine	VERB
ffhd-35	79	5	using	use	VERB
ffhd-35	79	6	a	a	DET
ffhd-35	79	7	heparin	heparin	ADJ
ffhd-35	79	8	manganese	manganese	ADJ
ffhd-35	79	9	precipitation	precipitation	NOUN
ffhd-35	79	10	of	of	ADP
ffhd-35	79	11	apo	apo	PROPN
ffhd-35	79	12	b	b	X
ffhd-35	79	13	-	-	PUNCT
ffhd-35	79	14	containing	contain	VERB
ffhd-35	79	15	lipoproteins	lipoprotein	NOUN
ffhd-35	79	16	[	[	X
ffhd-35	79	17	24	24	NUM
ffhd-35	79	18	]	]	PUNCT
ffhd-35	79	19	,	,	PUNCT
ffhd-35	79	20	and	and	CCONJ
ffhd-35	79	21	ldl	ldl	NOUN
ffhd-35	79	22	cholesterol	cholesterol	NOUN
ffhd-35	79	23	was	be	AUX
ffhd-35	79	24	calculated	calculate	VERB
ffhd-35	79	25	using	use	VERB
ffhd-35	79	26	the	the	DET
ffhd-35	79	27	friedewald	friedewald	ADJ
ffhd-35	79	28	formula	formula	NOUN
ffhd-35	80	1	[	[	X
ffhd-35	80	2	25	25	NUM
ffhd-35	80	3	]	]	PUNCT
ffhd-35	80	4	.	.	PUNCT
ffhd-35	81	1	c	c	X
ffhd-35	81	2	-	-	PUNCT
ffhd-35	81	3	reactive	reactive	ADJ
ffhd-35	81	4	protein	protein	NOUN
ffhd-35	81	5	was	be	AUX
ffhd-35	81	6	measured	measure	VERB
ffhd-35	81	7	using	use	VERB
ffhd-35	81	8	an	an	DET
ffhd-35	81	9	elisa	elisa	NOUN
ffhd-35	81	10	method	method	NOUN
ffhd-35	81	11	(	(	PUNCT
ffhd-35	81	12	biocheck	biocheck	NOUN
ffhd-35	81	13	™	™	VERB
ffhd-35	81	14	hsc	hsc	PROPN
ffhd-35	81	15	reactive	reactive	ADJ
ffhd-35	81	16	protein	protein	NOUN
ffhd-35	81	17	elisa	elisa	PROPN
ffhd-35	81	18	kit	kit	PROPN
ffhd-35	81	19	,	,	PUNCT
ffhd-35	81	20	foster	foster	ADJ
ffhd-35	81	21	city	city	NOUN
ffhd-35	81	22	,	,	PUNCT
ffhd-35	81	23	ca	ca	PROPN
ffhd-35	81	24	usa	usa	PROPN
ffhd-35	81	25	)	)	PUNCT
ffhd-35	81	26	.	.	PUNCT
ffhd-35	81	27	.	.	PUNCT
ffhd-35	82	1	fasting	fast	VERB
ffhd-35	82	2	insulin	insulin	NOUN
ffhd-35	82	3	(	(	PUNCT
ffhd-35	82	4	miu	miu	PROPN
ffhd-35	82	5	/	/	SYM
ffhd-35	82	6	l	l	NOUN
ffhd-35	82	7	)	)	PUNCT
ffhd-35	82	8	was	be	AUX
ffhd-35	82	9	determined	determine	VERB
ffhd-35	82	10	using	use	VERB
ffhd-35	82	11	the	the	DET
ffhd-35	82	12	medgenic	medgenic	ADJ
ffhd-35	82	13	immunoenzymetric	immunoenzymetric	ADJ
ffhd-35	82	14	assay	assay	NOUN
ffhd-35	82	15	by	by	ADP
ffhd-35	82	16	biosource	biosource	NOUN
ffhd-35	82	17	-	-	PUNCT
ffhd-35	82	18	europe	europe	PROPN
ffhd-35	82	19	sa	sa	PROPN
ffhd-35	82	20	(	(	PUNCT
ffhd-35	82	21	nivelles	nivelle	NOUN
ffhd-35	82	22	,	,	PUNCT
ffhd-35	82	23	belgium	belgium	NOUN
ffhd-35	82	24	)	)	PUNCT
ffhd-35	82	25	.	.	PUNCT
ffhd-35	83	1	insulin	insulin	NOUN
ffhd-35	83	2	sensitivity	sensitivity	NOUN
ffhd-35	83	3	was	be	AUX
ffhd-35	83	4	assessed	assess	VERB
ffhd-35	83	5	by	by	ADP
ffhd-35	83	6	the	the	DET
ffhd-35	83	7	homeostasis	homeostasis	NOUN
ffhd-35	83	8	assessment	assessment	NOUN
ffhd-35	83	9	model	model	NOUN
ffhd-35	83	10	(	(	PUNCT
ffhd-35	83	11	homa	homa	NOUN
ffhd-35	83	12	-	-	PUNCT
ffhd-35	83	13	ir	ir	PROPN
ffhd-35	83	14	[	[	X
ffhd-35	83	15	mmol	mmol	NOUN
ffhd-35	83	16	/	/	SYM
ffhd-35	83	17	l	l	NOUN
ffhd-35	83	18	×	×	NOUN
ffhd-35	83	19	mu	mu	PROPN
ffhd-35	83	20	/	/	SYM
ffhd-35	83	21	l	l	NOUN
ffhd-35	83	22	]	]	X
ffhd-35	84	1	=	=	X
ffhd-35	84	2	(	(	PUNCT
ffhd-35	84	3	fasting	fast	VERB
ffhd-35	84	4	glucose	glucose	NOUN
ffhd-35	84	5	[	[	X
ffhd-35	84	6	mmol	mmol	NOUN
ffhd-35	84	7	/	/	SYM
ffhd-35	84	8	l	l	NOUN
ffhd-35	84	9	]	]	X
ffhd-35	84	10	×	×	NOUN
ffhd-35	84	11	fasting	fast	VERB
ffhd-35	84	12	insulin	insulin	NOUN
ffhd-35	84	13	[	[	X
ffhd-35	84	14	mu	mu	NOUN
ffhd-35	84	15	/	/	SYM
ffhd-35	84	16	l]/22.5	l]/22.5	PROPN
ffhd-35	84	17	)	)	PUNCT
ffhd-35	84	18	.	.	PUNCT
ffhd-35	85	1	fasting	fast	VERB
ffhd-35	85	2	serum	serum	NOUN
ffhd-35	85	3	adiponectin	adiponectin	NOUN
ffhd-35	85	4	was	be	AUX
ffhd-35	85	5	measured	measure	VERB
ffhd-35	85	6	using	use	VERB
ffhd-35	85	7	the	the	DET
ffhd-35	85	8	linco	linco	PROPN
ffhd-35	85	9	ria	ria	PROPN
ffhd-35	85	10	,	,	PUNCT
ffhd-35	85	11	and	and	CCONJ
ffhd-35	85	12	pai-1	pai-1	NUM
ffhd-35	85	13	concentrations	concentration	NOUN
ffhd-35	85	14	were	be	AUX
ffhd-35	85	15	assessed	assess	VERB
ffhd-35	85	16	by	by	ADP
ffhd-35	85	17	using	use	VERB
ffhd-35	85	18	an	an	DET
ffhd-35	85	19	enzyme	enzyme	NOUN
ffhd-35	85	20	-	-	PUNCT
ffhd-35	85	21	linked	link	VERB
ffhd-35	85	22	immunosorbent	immunosorbent	NOUN
ffhd-35	85	23	assay	assay	PROPN
ffhd-35	85	24	(	(	PUNCT
ffhd-35	85	25	diagnostica	diagnostica	PROPN
ffhd-35	85	26	stago	stago	PROPN
ffhd-35	85	27	,	,	PUNCT
ffhd-35	85	28	asnières	asnière	NOUN
ffhd-35	85	29	-	-	PUNCT
ffhd-35	85	30	surseine	surseine	NOUN
ffhd-35	85	31	,	,	PUNCT
ffhd-35	85	32	france	france	PROPN
ffhd-35	85	33	)	)	PUNCT
ffhd-35	85	34	.	.	PUNCT
ffhd-35	86	1	2.9	2.9	NUM
ffhd-35	86	2	.	.	PUNCT
ffhd-35	87	1	statistical	statistical	ADJ
ffhd-35	87	2	analysis	analysis	NOUN
ffhd-35	87	3	the	the	DET
ffhd-35	87	4	data	datum	NOUN
ffhd-35	87	5	were	be	AUX
ffhd-35	87	6	summarized	summarize	VERB
ffhd-35	87	7	(	(	PUNCT
ffhd-35	87	8	mean	mean	ADJ
ffhd-35	87	9	and	and	CCONJ
ffhd-35	87	10	standard	standard	ADJ
ffhd-35	87	11	error	error	NOUN
ffhd-35	87	12	)	)	PUNCT
ffhd-35	87	13	for	for	ADP
ffhd-35	87	14	week	week	NOUN
ffhd-35	87	15	0	0	NUM
ffhd-35	87	16	(	(	PUNCT
ffhd-35	87	17	baseline	baseline	NOUN
ffhd-35	87	18	)	)	PUNCT
ffhd-35	87	19	,	,	PUNCT
ffhd-35	87	20	week	week	NOUN
ffhd-35	87	21	4	4	NUM
ffhd-35	87	22	,	,	PUNCT
ffhd-35	87	23	and	and	CCONJ
ffhd-35	87	24	week	week	NOUN
ffhd-35	87	25	8	8	NUM
ffhd-35	87	26	(	(	PUNCT
ffhd-35	87	27	final	final	ADJ
ffhd-35	87	28	)	)	PUNCT
ffhd-35	87	29	,	,	PUNCT
ffhd-35	87	30	and	and	CCONJ
ffhd-35	87	31	the	the	DET
ffhd-35	87	32	intra	intra	ADJ
ffhd-35	87	33	-	-	ADJ
ffhd-35	87	34	group	group	NOUN
ffhd-35	87	35	variation	variation	NOUN
ffhd-35	87	36	and	and	CCONJ
ffhd-35	87	37	the	the	DET
ffhd-35	87	38	data	datum	NOUN
ffhd-35	87	39	were	be	AUX
ffhd-35	87	40	analyzed	analyze	VERB
ffhd-35	87	41	using	use	VERB
ffhd-35	87	42	spss	spss	PROPN
ffhd-35	87	43	16.0	16.0	NUM
ffhd-35	87	44	for	for	ADP
ffhd-35	87	45	windows	window	NOUN
ffhd-35	87	46	(	(	PUNCT
ffhd-35	87	47	spss	spss	PROPN
ffhd-35	87	48	inc	inc	PROPN
ffhd-35	87	49	.	.	PROPN
ffhd-35	87	50	,	,	PUNCT
ffhd-35	87	51	chicago	chicago	PROPN
ffhd-35	87	52	,	,	PUNCT
ffhd-35	87	53	il	il	PROPN
ffhd-35	87	54	,	,	PUNCT
ffhd-35	87	55	usa	usa	PROPN
ffhd-35	87	56	)	)	PUNCT
ffhd-35	87	57	.	.	PUNCT
ffhd-35	88	1	because	because	SCONJ
ffhd-35	88	2	the	the	DET
ffhd-35	88	3	repeated	repeat	VERB
ffhd-35	88	4	measurements	measurement	NOUN
ffhd-35	88	5	on	on	ADP
ffhd-35	88	6	each	each	DET
ffhd-35	88	7	participant	participant	NOUN
ffhd-35	88	8	were	be	AUX
ffhd-35	88	9	correlated	correlate	VERB
ffhd-35	88	10	in	in	ADP
ffhd-35	88	11	nature	nature	NOUN
ffhd-35	88	12	(	(	PUNCT
ffhd-35	88	13	covariance	covariance	NOUN
ffhd-35	88	14	)	)	PUNCT
ffhd-35	88	15	,	,	PUNCT
ffhd-35	88	16	a	a	DET
ffhd-35	88	17	mixedmodel	mixedmodel	ADJ
ffhd-35	88	18	approach	approach	NOUN
ffhd-35	88	19	was	be	AUX
ffhd-35	88	20	used	use	VERB
ffhd-35	88	21	to	to	PART
ffhd-35	88	22	characterize	characterize	VERB
ffhd-35	88	23	variation	variation	NOUN
ffhd-35	88	24	between	between	ADP
ffhd-35	88	25	patients	patient	NOUN
ffhd-35	88	26	and	and	CCONJ
ffhd-35	88	27	within	within	ADP
ffhd-35	88	28	patients	patient	NOUN
ffhd-35	88	29	because	because	SCONJ
ffhd-35	88	30	it	it	PRON
ffhd-35	88	31	is	be	AUX
ffhd-35	88	32	a	a	DET
ffhd-35	88	33	flexible	flexible	ADJ
ffhd-35	88	34	tool	tool	NOUN
ffhd-35	88	35	for	for	ADP
ffhd-35	88	36	analyzing	analyze	VERB
ffhd-35	88	37	repeated	repeat	VERB
ffhd-35	88	38	,	,	PUNCT
ffhd-35	88	39	longitudinal	longitudinal	ADJ
ffhd-35	88	40	treatments	treatment	NOUN
ffhd-35	88	41	.	.	PUNCT
ffhd-35	89	1	the	the	DET
ffhd-35	89	2	interaction	interaction	NOUN
ffhd-35	89	3	between	between	ADP
ffhd-35	89	4	time	time	NOUN
ffhd-35	89	5	and	and	CCONJ
ffhd-35	89	6	intervention	intervention	NOUN
ffhd-35	89	7	was	be	AUX
ffhd-35	89	8	tested	test	VERB
ffhd-35	89	9	at	at	ADP
ffhd-35	89	10	the	the	DET
ffhd-35	89	11	0.05	0.05	NUM
ffhd-35	89	12	level	level	NOUN
ffhd-35	89	13	of	of	ADP
ffhd-35	89	14	significance	significance	NOUN
ffhd-35	89	15	.	.	PUNCT
ffhd-35	90	1	if	if	SCONJ
ffhd-35	90	2	the	the	DET
ffhd-35	90	3	interaction	interaction	NOUN
ffhd-35	90	4	was	be	AUX
ffhd-35	90	5	significant	significant	ADJ
ffhd-35	90	6	,	,	PUNCT
ffhd-35	90	7	comparisons	comparison	NOUN
ffhd-35	90	8	were	be	AUX
ffhd-35	90	9	made	make	VERB
ffhd-35	90	10	between	between	ADP
ffhd-35	90	11	the	the	DET
ffhd-35	90	12	treatment	treatment	NOUN
ffhd-35	90	13	and	and	CCONJ
ffhd-35	90	14	placebo	placebo	NOUN
ffhd-35	90	15	groups	group	NOUN
ffhd-35	90	16	for	for	ADP
ffhd-35	90	17	each	each	DET
ffhd-35	90	18	month	month	NOUN
ffhd-35	90	19	.	.	PUNCT
ffhd-35	91	1	between	between	ADP
ffhd-35	91	2	-	-	PUNCT
ffhd-35	91	3	treatment	treatment	NOUN
ffhd-35	91	4	changes	change	NOUN
ffhd-35	91	5	were	be	AUX
ffhd-35	91	6	tested	test	VERB
ffhd-35	91	7	using	use	VERB
ffhd-35	91	8	oneway	oneway	ADJ
ffhd-35	91	9	analysis	analysis	NOUN
ffhd-35	91	10	of	of	ADP
ffhd-35	91	11	covariance	covariance	NOUN
ffhd-35	91	12	(	(	PUNCT
ffhd-35	91	13	ancova	ancova	NOUN
ffhd-35	91	14	)	)	PUNCT
ffhd-35	91	15	,	,	PUNCT
ffhd-35	91	16	adjusted	adjust	VERB
ffhd-35	91	17	for	for	ADP
ffhd-35	91	18	baseline	baseline	ADJ
ffhd-35	91	19	values	value	NOUN
ffhd-35	91	20	,	,	PUNCT
ffhd-35	91	21	with	with	ADP
ffhd-35	91	22	the	the	DET
ffhd-35	91	23	initial	initial	ADJ
ffhd-35	91	24	value	value	NOUN
ffhd-35	91	25	as	as	ADP
ffhd-35	91	26	a	a	DET
ffhd-35	91	27	covariate	covariate	NOUN
ffhd-35	91	28	.	.	PUNCT
ffhd-35	92	1	bilateral	bilateral	ADJ
ffhd-35	92	2	correlations	correlation	NOUN
ffhd-35	92	3	between	between	ADP
ffhd-35	92	4	variables	variable	NOUN
ffhd-35	92	5	were	be	AUX
ffhd-35	92	6	examined	examine	VERB
ffhd-35	92	7	using	use	VERB
ffhd-35	92	8	pearson	pearson	PROPN
ffhd-35	92	9	’s	’s	PART
ffhd-35	92	10	correlation	correlation	NOUN
ffhd-35	92	11	coefficients	coefficient	NOUN
ffhd-35	92	12	.	.	PUNCT
ffhd-35	93	1	p	p	NOUN
ffhd-35	93	2	values	value	NOUN
ffhd-35	93	3	less	less	ADJ
ffhd-35	93	4	than	than	ADP
ffhd-35	93	5	0.05	0.05	NUM
ffhd-35	93	6	were	be	AUX
ffhd-35	93	7	considered	consider	VERB
ffhd-35	93	8	to	to	PART
ffhd-35	93	9	be	be	AUX
ffhd-35	93	10	statistically	statistically	ADV
ffhd-35	93	11	significant	significant	ADJ
ffhd-35	93	12	.	.	PUNCT
ffhd-35	94	1	3	3	X
ffhd-35	94	2	.	.	X
ffhd-35	94	3	results	result	VERB
ffhd-35	94	4	3.1	3.1	NUM
ffhd-35	94	5	.	.	PUNCT
ffhd-35	94	6	baseline	baseline	PROPN
ffhd-35	94	7	characteristics	characteristic	NOUN
ffhd-35	94	8	a	a	DET
ffhd-35	94	9	total	total	NOUN
ffhd-35	94	10	of	of	ADP
ffhd-35	94	11	297	297	NUM
ffhd-35	94	12	individuals	individual	NOUN
ffhd-35	94	13	(	(	PUNCT
ffhd-35	94	14	154	154	NUM
ffhd-35	94	15	in	in	ADP
ffhd-35	94	16	the	the	DET
ffhd-35	94	17	dyglomera	dyglomera	NOUN
ffhd-35	94	18	®	®	NOUN
ffhd-35	94	19	treatment	treatment	NOUN
ffhd-35	94	20	group	group	NOUN
ffhd-35	94	21	and	and	CCONJ
ffhd-35	94	22	143	143	NUM
ffhd-35	94	23	in	in	ADP
ffhd-35	94	24	the	the	DET
ffhd-35	94	25	placebo	placebo	NOUN
ffhd-35	94	26	group	group	NOUN
ffhd-35	94	27	)	)	PUNCT
ffhd-35	94	28	out	out	ADP
ffhd-35	94	29	of	of	ADP
ffhd-35	94	30	318	318	NUM
ffhd-35	94	31	initial	initial	ADJ
ffhd-35	94	32	participants	participant	NOUN
ffhd-35	94	33	completed	complete	VERB
ffhd-35	94	34	the	the	DET
ffhd-35	94	35	study	study	NOUN
ffhd-35	94	36	(	(	PUNCT
ffhd-35	94	37	21	21	NUM
ffhd-35	94	38	participants	participant	NOUN
ffhd-35	94	39	dropped	drop	VERB
ffhd-35	94	40	out	out	ADP
ffhd-35	94	41	of	of	ADP
ffhd-35	94	42	the	the	DET
ffhd-35	94	43	study	study	NOUN
ffhd-35	94	44	)	)	PUNCT
ffhd-35	94	45	.	.	PUNCT
ffhd-35	95	1	the	the	DET
ffhd-35	95	2	number	number	NOUN
ffhd-35	95	3	of	of	ADP
ffhd-35	95	4	premature	premature	ADJ
ffhd-35	95	5	withdrawals	withdrawal	NOUN
ffhd-35	95	6	was	be	AUX
ffhd-35	95	7	higher	high	ADJ
ffhd-35	95	8	in	in	ADP
ffhd-35	95	9	the	the	DET
ffhd-35	95	10	placebo	placebo	NOUN
ffhd-35	95	11	group	group	NOUN
ffhd-35	95	12	than	than	ADP
ffhd-35	95	13	in	in	ADP
ffhd-35	95	14	the	the	DET
ffhd-35	95	15	dyglomera	dyglomera	NOUN
ffhd-35	95	16	®	®	NOUN
ffhd-35	95	17	group	group	NOUN
ffhd-35	95	18	(	(	PUNCT
ffhd-35	95	19	16	16	NUM
ffhd-35	95	20	vs	vs	ADP
ffhd-35	95	21	5	5	NUM
ffhd-35	95	22	)	)	PUNCT
ffhd-35	95	23	.	.	PUNCT
ffhd-35	96	1	the	the	DET
ffhd-35	96	2	baseline	baseline	PROPN
ffhd-35	96	3	(	(	PUNCT
ffhd-35	96	4	t0	t0	NOUN
ffhd-35	96	5	)	)	PUNCT
ffhd-35	96	6	anthropometric	anthropometric	ADJ
ffhd-35	96	7	,	,	PUNCT
ffhd-35	96	8	hemodynamic	hemodynamic	ADJ
ffhd-35	96	9	,	,	PUNCT
ffhd-35	96	10	and	and	CCONJ
ffhd-35	96	11	metabolic	metabolic	NOUN
ffhd-35	96	12	characteristics	characteristic	NOUN
ffhd-35	96	13	of	of	ADP
ffhd-35	96	14	the	the	DET
ffhd-35	96	15	two	two	NUM
ffhd-35	96	16	study	study	NOUN
ffhd-35	96	17	groups	group	NOUN
ffhd-35	96	18	are	be	AUX
ffhd-35	96	19	listed	list	VERB
ffhd-35	96	20	in	in	ADP
ffhd-35	96	21	tables	table	NOUN
ffhd-35	96	22	1–4	1–4	PROPN
ffhd-35	96	23	.	.	PUNCT
ffhd-35	96	24	plasma	plasma	NOUN
ffhd-35	96	25	tag	tag	NOUN
ffhd-35	96	26	,	,	PUNCT
ffhd-35	96	27	total	total	ADJ
ffhd-35	96	28	cholesterol	cholesterol	NOUN
ffhd-35	96	29	,	,	PUNCT
ffhd-35	96	30	plasma	plasma	NOUN
ffhd-35	96	31	glucose	glucose	NOUN
ffhd-35	96	32	,	,	PUNCT
ffhd-35	96	33	insulin	insulin	NOUN
ffhd-35	96	34	resistance	resistance	NOUN
ffhd-35	96	35	(	(	PUNCT
ffhd-35	96	36	homa	homa	NOUN
ffhd-35	96	37	-	-	PUNCT
ffhd-35	96	38	ir	ir	NOUN
ffhd-35	96	39	)	)	PUNCT
ffhd-35	96	40	,	,	PUNCT
ffhd-35	96	41	crp	crp	PROPN
ffhd-35	96	42	,	,	PUNCT
ffhd-35	96	43	and	and	CCONJ
ffhd-35	96	44	circulating	circulate	VERB
ffhd-35	96	45	pai-1	pai-1	PRON
ffhd-35	96	46	were	be	AUX
ffhd-35	96	47	slightly	slightly	ADV
ffhd-35	96	48	higher	high	ADJ
ffhd-35	96	49	at	at	ADP
ffhd-35	96	50	t0	t0	NOUN
ffhd-35	96	51	,	,	PUNCT
ffhd-35	96	52	whereas	whereas	SCONJ
ffhd-35	96	53	hdl	hdl	PROPN
ffhd-35	96	54	cholesterol	cholesterol	NOUN
ffhd-35	96	55	and	and	CCONJ
ffhd-35	96	56	adiponectin	adiponectin	NOUN
ffhd-35	96	57	were	be	AUX
ffhd-35	96	58	lower	low	ADJ
ffhd-35	96	59	at	at	ADP
ffhd-35	96	60	t0	t0	NUM
ffhd-35	96	61	than	than	ADP
ffhd-35	96	62	normal	normal	ADJ
ffhd-35	96	63	values	value	NOUN
ffhd-35	96	64	,	,	PUNCT
ffhd-35	96	65	which	which	PRON
ffhd-35	96	66	is	be	AUX
ffhd-35	96	67	reflective	reflective	ADJ
ffhd-35	96	68	of	of	ADP
ffhd-35	96	69	the	the	DET
ffhd-35	96	70	obese	obese	ADJ
ffhd-35	96	71	status	status	NOUN
ffhd-35	96	72	of	of	ADP
ffhd-35	96	73	the	the	DET
ffhd-35	96	74	patients	patient	NOUN
ffhd-35	96	75	in	in	ADP
ffhd-35	96	76	the	the	DET
ffhd-35	96	77	study	study	NOUN
ffhd-35	96	78	.	.	PUNCT
ffhd-35	97	1	the	the	DET
ffhd-35	97	2	baseline	baseline	PROPN
ffhd-35	97	3	characteristics	characteristic	NOUN
ffhd-35	97	4	across	across	ADP
ffhd-35	97	5	the	the	DET
ffhd-35	97	6	two	two	NUM
ffhd-35	97	7	experimental	experimental	ADJ
ffhd-35	97	8	groups	group	NOUN
ffhd-35	97	9	were	be	AUX
ffhd-35	97	10	not	not	PART
ffhd-35	97	11	significantly	significantly	ADV
ffhd-35	97	12	different	different	ADJ
ffhd-35	97	13	.	.	PUNCT
ffhd-35	98	1	3.2	3.2	NUM
ffhd-35	98	2	.	.	PUNCT
ffhd-35	98	3	anthropomorphic	anthropomorphic	ADJ
ffhd-35	98	4	characteristics	characteristic	NOUN
ffhd-35	98	5	and	and	CCONJ
ffhd-35	98	6	blood	blood	NOUN
ffhd-35	98	7	pressure	pressure	NOUN
ffhd-35	98	8	.	.	PUNCT
ffhd-35	99	1	table	table	NOUN
ffhd-35	99	2	1	1	NUM
ffhd-35	99	3	shows	show	VERB
ffhd-35	99	4	the	the	DET
ffhd-35	99	5	changes	change	NOUN
ffhd-35	99	6	in	in	ADP
ffhd-35	99	7	the	the	DET
ffhd-35	99	8	various	various	ADJ
ffhd-35	99	9	anthropometric	anthropometric	ADJ
ffhd-35	99	10	variables	variable	NOUN
ffhd-35	99	11	(	(	PUNCT
ffhd-35	99	12	body	body	NOUN
ffhd-35	99	13	weight	weight	NOUN
ffhd-35	99	14	,	,	PUNCT
ffhd-35	99	15	bmi	bmi	NOUN
ffhd-35	99	16	,	,	PUNCT
ffhd-35	99	17	waist	waist	NOUN
ffhd-35	99	18	and	and	CCONJ
ffhd-35	99	19	hip	hip	NOUN
ffhd-35	99	20	circumference	circumference	NOUN
ffhd-35	99	21	,	,	PUNCT
ffhd-35	99	22	and	and	CCONJ
ffhd-35	99	23	percent	percent	NOUN
ffhd-35	99	24	body	body	NOUN
ffhd-35	99	25	fat	fat	NOUN
ffhd-35	99	26	)	)	PUNCT
ffhd-35	99	27	over	over	ADP
ffhd-35	99	28	the	the	DET
ffhd-35	99	29	8	8	NUM
ffhd-35	99	30	-	-	PUNCT
ffhd-35	99	31	week	week	NOUN
ffhd-35	99	32	trial	trial	NOUN
ffhd-35	99	33	period	period	NOUN
ffhd-35	99	34	.	.	PUNCT
ffhd-35	100	1	functional	functional	ADJ
ffhd-35	100	2	foods	food	NOUN
ffhd-35	100	3	in	in	ADP
ffhd-35	100	4	health	health	NOUN
ffhd-35	100	5	and	and	CCONJ
ffhd-35	100	6	disease	disease	NOUN
ffhd-35	100	7	2013	2013	NUM
ffhd-35	100	8	;	;	PUNCT
ffhd-35	100	9	3(11):416	3(11):416	NUM
ffhd-35	100	10	-	-	SYM
ffhd-35	100	11	427	427	NUM
ffhd-35	100	12	page	page	NOUN
ffhd-35	100	13	421	421	NUM
ffhd-35	100	14	of	of	ADP
ffhd-35	100	15	427	427	NUM
ffhd-35	100	16	table	table	NOUN
ffhd-35	100	17	1	1	NUM
ffhd-35	100	18	.	.	PUNCT
ffhd-35	100	19	anthropometric	anthropometric	ADJ
ffhd-35	100	20	effects	effect	NOUN
ffhd-35	100	21	of	of	ADP
ffhd-35	100	22	dg	dg	NOUN
ffhd-35	100	23	in	in	ADP
ffhd-35	100	24	obese	obese	ADJ
ffhd-35	100	25	subjects	subject	NOUN
ffhd-35	100	26	with	with	ADP
ffhd-35	100	27	metabolic	metabolic	NOUN
ffhd-35	100	28	syndrome	syndrome	NOUN
ffhd-35	100	29	variable	variable	ADJ
ffhd-35	100	30	group	group	NOUN
ffhd-35	100	31	t0	t0	PROPN
ffhd-35	100	32	t4	t4	PROPN
ffhd-35	100	33	t8	t8	PROPN
ffhd-35	100	34	change	change	PROPN
ffhd-35	100	35	from	from	ADP
ffhd-35	100	36	baseline	baseline	PROPN
ffhd-35	100	37	(	(	PUNCT
ffhd-35	100	38	t8	t8	PROPN
ffhd-35	100	39	t0	t0	PROPN
ffhd-35	100	40	)	)	PUNCT
ffhd-35	100	41	(	(	PUNCT
ffhd-35	100	42	%	%	INTJ
ffhd-35	100	43	)	)	PUNCT
ffhd-35	100	44	weight	weight	NOUN
ffhd-35	100	45	(	(	PUNCT
ffhd-35	100	46	kg	kg	NOUN
ffhd-35	100	47	)	)	PUNCT
ffhd-35	100	48	dg	dg	PROPN
ffhd-35	100	49	99.26±	99.26±	NUM
ffhd-35	100	50	1.12	1.12	NUM
ffhd-35	100	51	93.73±	93.73±	NUM
ffhd-35	100	52	1.07	1.07	NUM
ffhd-35	100	53	a	a	DET
ffhd-35	100	54	88.12±	88.12±	NUM
ffhd-35	100	55	1.05	1.05	NUM
ffhd-35	100	56	b	b	NOUN
ffhd-35	100	57	-11.15±	-11.15±	NUM
ffhd-35	100	58	0.18	0.18	NUM
ffhd-35	100	59	(	(	PUNCT
ffhd-35	100	60	-11.33	-11.33	NOUN
ffhd-35	100	61	)	)	PUNCT
ffhd-35	100	62	†	†	NOUN
ffhd-35	100	63	placebo	placebo	NOUN
ffhd-35	100	64	98.69±	98.69±	NUM
ffhd-35	100	65	1.15	1.15	NUM
ffhd-35	100	66	98.72±	98.72±	NUM
ffhd-35	100	67	1.12	1.12	NUM
ffhd-35	100	68	98.17±	98.17±	NUM
ffhd-35	100	69	1.11	1.11	NUM
ffhd-35	100	70	-0.53±	-0.53±	PROPN
ffhd-35	100	71	0.11	0.11	NUM
ffhd-35	100	72	(	(	PUNCT
ffhd-35	100	73	-0.49	-0.49	NOUN
ffhd-35	100	74	)	)	PUNCT
ffhd-35	100	75	bmi	bmi	NOUN
ffhd-35	100	76	(	(	PUNCT
ffhd-35	100	77	kg	kg	NOUN
ffhd-35	100	78	/	/	SYM
ffhd-35	100	79	m	m	VERB
ffhd-35	100	80	2	2	NUM
ffhd-35	100	81	)	)	PUNCT
ffhd-35	100	82	dg	dg	PROPN
ffhd-35	100	83	36.63±	36.63±	NUM
ffhd-35	100	84	0.25	0.25	NUM
ffhd-35	100	85	34.59±	34.59±	NUM
ffhd-35	100	86	0.25	0.25	NUM
ffhd-35	100	87	a	a	DET
ffhd-35	100	88	32.51±0.26	32.51±0.26	NUM
ffhd-35	100	89	b	b	PROPN
ffhd-35	100	90	-4.13±	-4.13±	PROPN
ffhd-35	100	91	0.06	0.06	NUM
ffhd-35	100	92	(	(	PUNCT
ffhd-35	100	93	-11.33	-11.33	PROPN
ffhd-35	100	94	)	)	PUNCT
ffhd-35	100	95	†	†	PROPN
ffhd-35	100	96	placebo	placebo	NOUN
ffhd-35	100	97	36.02±	36.02±	NUM
ffhd-35	100	98	0.26	0.26	NUM
ffhd-35	100	99	36.04±	36.04±	NUM
ffhd-35	100	100	0.26	0.26	NUM
ffhd-35	100	101	35.84±	35.84±	NUM
ffhd-35	100	102	0.26	0.26	NUM
ffhd-35	100	103	-0.18±	-0.18±	NOUN
ffhd-35	100	104	0.04	0.04	NUM
ffhd-35	100	105	(	(	PUNCT
ffhd-35	100	106	-0.49	-0.49	NOUN
ffhd-35	100	107	)	)	PUNCT
ffhd-35	100	108	waist	waist	NOUN
ffhd-35	100	109	(	(	PUNCT
ffhd-35	100	110	cm	cm	NOUN
ffhd-35	100	111	)	)	PUNCT
ffhd-35	100	112	dg	dg	PROPN
ffhd-35	101	1	106.20±	106.20±	NUM
ffhd-35	101	2	0.88	0.88	NUM
ffhd-35	101	3	99.79±	99.79±	NUM
ffhd-35	102	1	0.98	0.98	NUM
ffhd-35	102	2	b	b	NOUN
ffhd-35	102	3	95.48±	95.48±	NUM
ffhd-35	102	4	0.99	0.99	NUM
ffhd-35	102	5	b	b	PROPN
ffhd-35	102	6	-10.72±	-10.72±	PROPN
ffhd-35	102	7	0.28	0.28	NUM
ffhd-35	102	8	†	†	X
ffhd-35	102	9	(	(	PUNCT
ffhd-35	102	10	-10.23	-10.23	INTJ
ffhd-35	102	11	)	)	PUNCT
ffhd-35	102	12	†	†	PROPN
ffhd-35	102	13	placebo	placebo	NOUN
ffhd-35	102	14	105.43±	105.43±	NUM
ffhd-35	102	15	1.00	1.00	NUM
ffhd-35	102	16	105.49±	105.49±	NUM
ffhd-35	102	17	0.97	0.97	NUM
ffhd-35	102	18	104.65±	104.65±	NUM
ffhd-35	102	19	0.97	0.97	NUM
ffhd-35	102	20	-0.77±	-0.77±	PROPN
ffhd-35	102	21	0.08	0.08	NUM
ffhd-35	102	22	(	(	PUNCT
ffhd-35	102	23	-0.70	-0.70	NOUN
ffhd-35	102	24	)	)	PUNCT
ffhd-35	102	25	hip	hip	NOUN
ffhd-35	102	26	(	(	PUNCT
ffhd-35	102	27	cm	cm	NOUN
ffhd-35	102	28	)	)	PUNCT
ffhd-35	102	29	dg	dg	PROPN
ffhd-35	103	1	127.37±	127.37±	NUM
ffhd-35	103	2	0.73	0.73	NUM
ffhd-35	103	3	122.92±	122.92±	NUM
ffhd-35	103	4	0.75	0.75	NUM
ffhd-35	103	5	a	a	DET
ffhd-35	103	6	118.34±	118.34±	NUM
ffhd-35	103	7	0.73	0.73	NUM
ffhd-35	103	8	b	b	X
ffhd-35	103	9	-9.03±	-9.03±	NOUN
ffhd-35	103	10	0.22	0.22	NUM
ffhd-35	103	11	(	(	PUNCT
ffhd-35	103	12	-7.10	-7.10	NUM
ffhd-35	103	13	)	)	PUNCT
ffhd-35	103	14	†	†	PROPN
ffhd-35	103	15	placebo	placebo	NOUN
ffhd-35	103	16	126.52±	126.52±	NUM
ffhd-35	103	17	0.82	0.82	NUM
ffhd-35	103	18	126.34±	126.34±	NUM
ffhd-35	103	19	0.85	0.85	NUM
ffhd-35	104	1	125.88±	125.88±	NUM
ffhd-35	104	2	0.84	0.84	NUM
ffhd-35	104	3	-0.64±	-0.64±	PROPN
ffhd-35	104	4	0.21	0.21	NUM
ffhd-35	104	5	(	(	PUNCT
ffhd-35	104	6	-0.51	-0.51	NOUN
ffhd-35	104	7	)	)	PUNCT
ffhd-35	104	8	body	body	NOUN
ffhd-35	104	9	fat	fat	NOUN
ffhd-35	104	10	(	(	PUNCT
ffhd-35	104	11	%	%	INTJ
ffhd-35	104	12	)	)	PUNCT
ffhd-35	104	13	dg	dg	PROPN
ffhd-35	104	14	44.88±	44.88±	NUM
ffhd-35	104	15	0.58	0.58	NUM
ffhd-35	104	16	42.32±	42.32±	NUM
ffhd-35	104	17	0.56	0.56	NUM
ffhd-35	104	18	a	a	DET
ffhd-35	104	19	40.15±	40.15±	NUM
ffhd-35	104	20	0.55	0.55	NUM
ffhd-35	104	21	b	b	NOUN
ffhd-35	104	22	-4.73±	-4.73±	PROPN
ffhd-35	104	23	0.11	0.11	NUM
ffhd-35	104	24	(	(	PUNCT
ffhd-35	104	25	-10.68	-10.68	PROPN
ffhd-35	104	26	)	)	PUNCT
ffhd-35	104	27	†	†	PROPN
ffhd-35	104	28	placebo	placebo	NOUN
ffhd-35	104	29	44.28±	44.28±	NUM
ffhd-35	104	30	0.61	0.61	NUM
ffhd-35	104	31	44.37±	44.37±	NUM
ffhd-35	104	32	0.60	0.60	NUM
ffhd-35	104	33	44.08±	44.08±	NUM
ffhd-35	104	34	0.59	0.59	NUM
ffhd-35	104	35	-0.20±	-0.20±	PROPN
ffhd-35	104	36	0.10	0.10	NUM
ffhd-35	104	37	(	(	PUNCT
ffhd-35	104	38	-0.37	-0.37	NUM
ffhd-35	104	39	)	)	PUNCT
ffhd-35	104	40	a	a	DET
ffhd-35	104	41	p	p	X
ffhd-35	104	42	<	<	X
ffhd-35	104	43	0.05	0.05	NUM
ffhd-35	104	44	compared	compare	VERB
ffhd-35	104	45	with	with	ADP
ffhd-35	104	46	placebo	placebo	NOUN
ffhd-35	104	47	,	,	PUNCT
ffhd-35	104	48	adjusted	adjust	VERB
ffhd-35	104	49	for	for	ADP
ffhd-35	104	50	baseline	baseline	NOUN
ffhd-35	104	51	b	b	NOUN
ffhd-35	104	52	p	p	X
ffhd-35	104	53	<	<	X
ffhd-35	104	54	0.001	0.001	NUM
ffhd-35	104	55	compared	compare	VERB
ffhd-35	104	56	with	with	ADP
ffhd-35	104	57	placebo	placebo	NOUN
ffhd-35	104	58	,	,	PUNCT
ffhd-35	104	59	adjusted	adjust	VERB
ffhd-35	104	60	for	for	ADP
ffhd-35	104	61	baseline	baseline	NOUN
ffhd-35	104	62	†	†	PROPN
ffhd-35	104	63	p	p	X
ffhd-35	104	64	<	<	X
ffhd-35	104	65	0.05	0.05	NUM
ffhd-35	104	66	compared	compare	VERB
ffhd-35	104	67	with	with	ADP
ffhd-35	104	68	baseline	baseline	NOUN
ffhd-35	104	69	,	,	PUNCT
ffhd-35	104	70	intra	intra	ADJ
ffhd-35	104	71	-	-	ADJ
ffhd-35	104	72	group	group	NOUN
ffhd-35	104	73	analysis	analysis	NOUN
ffhd-35	104	74	compared	compare	VERB
ffhd-35	104	75	to	to	ADP
ffhd-35	104	76	the	the	DET
ffhd-35	104	77	placebo	placebo	NOUN
ffhd-35	104	78	group	group	NOUN
ffhd-35	104	79	,	,	PUNCT
ffhd-35	104	80	the	the	DET
ffhd-35	104	81	dyglomera	dyglomera	NOUN
ffhd-35	104	82	®	®	NOUN
ffhd-35	104	83	treatment	treatment	NOUN
ffhd-35	104	84	group	group	NOUN
ffhd-35	104	85	showed	show	VERB
ffhd-35	104	86	a	a	DET
ffhd-35	104	87	significant	significant	ADJ
ffhd-35	104	88	average	average	ADJ
ffhd-35	104	89	weight	weight	NOUN
ffhd-35	104	90	reduction	reduction	NOUN
ffhd-35	104	91	of	of	ADP
ffhd-35	104	92	11.15	11.15	NUM
ffhd-35	104	93	kg	kg	NOUN
ffhd-35	104	94	(	(	PUNCT
ffhd-35	104	95	-11.33	-11.33	ADJ
ffhd-35	104	96	%	%	NOUN
ffhd-35	104	97	of	of	ADP
ffhd-35	104	98	total	total	ADJ
ffhd-35	104	99	body	body	NOUN
ffhd-35	104	100	weight	weight	NOUN
ffhd-35	104	101	)	)	PUNCT
ffhd-35	105	1	(	(	PUNCT
ffhd-35	105	2	p	p	X
ffhd-35	105	3	<	<	X
ffhd-35	105	4	0.001	0.001	NUM
ffhd-35	105	5	)	)	PUNCT
ffhd-35	105	6	after	after	ADP
ffhd-35	105	7	8	8	NUM
ffhd-35	105	8	weeks	week	NOUN
ffhd-35	105	9	of	of	ADP
ffhd-35	105	10	treatment	treatment	NOUN
ffhd-35	105	11	with	with	ADP
ffhd-35	105	12	dyglomera	dyglomera	NOUN
ffhd-35	105	13	®	®	NOUN
ffhd-35	105	14	.	.	PUNCT
ffhd-35	106	1	the	the	DET
ffhd-35	106	2	amount	amount	NOUN
ffhd-35	106	3	of	of	ADP
ffhd-35	106	4	weight	weight	NOUN
ffhd-35	106	5	loss	loss	NOUN
ffhd-35	106	6	achieved	achieve	VERB
ffhd-35	106	7	in	in	ADP
ffhd-35	106	8	the	the	DET
ffhd-35	106	9	current	current	ADJ
ffhd-35	106	10	study	study	NOUN
ffhd-35	106	11	using	use	VERB
ffhd-35	106	12	dyglomera	dyglomera	NOUN
ffhd-35	106	13	®	®	NOUN
ffhd-35	106	14	was	be	AUX
ffhd-35	106	15	higher	high	ADJ
ffhd-35	106	16	than	than	ADP
ffhd-35	106	17	that	that	PRON
ffhd-35	106	18	obtained	obtain	VERB
ffhd-35	106	19	with	with	ADP
ffhd-35	106	20	whole	whole	NOUN
ffhd-35	106	21	,	,	PUNCT
ffhd-35	106	22	ground	ground	NOUN
ffhd-35	106	23	dg	dg	NOUN
ffhd-35	106	24	in	in	ADP
ffhd-35	106	25	a	a	DET
ffhd-35	106	26	previous	previous	ADJ
ffhd-35	106	27	study[19	study[19	NOUN
ffhd-35	106	28	]	]	PUNCT
ffhd-35	106	29	.	.	PUNCT
ffhd-35	107	1	this	this	DET
ffhd-35	107	2	reduction	reduction	NOUN
ffhd-35	107	3	in	in	ADP
ffhd-35	107	4	weight	weight	NOUN
ffhd-35	107	5	was	be	AUX
ffhd-35	107	6	accompanied	accompany	VERB
ffhd-35	107	7	by	by	ADP
ffhd-35	107	8	a	a	DET
ffhd-35	107	9	loss	loss	NOUN
ffhd-35	107	10	of	of	ADP
ffhd-35	107	11	visceral	visceral	ADJ
ffhd-35	107	12	fat	fat	NOUN
ffhd-35	107	13	as	as	SCONJ
ffhd-35	107	14	measured	measure	VERB
ffhd-35	107	15	by	by	ADP
ffhd-35	107	16	waist	waist	NOUN
ffhd-35	107	17	circumference	circumference	NOUN
ffhd-35	107	18	(	(	PUNCT
ffhd-35	107	19	-10.23	-10.23	INTJ
ffhd-35	107	20	%	%	NOUN
ffhd-35	107	21	)	)	PUNCT
ffhd-35	107	22	.	.	PUNCT
ffhd-35	108	1	in	in	ADP
ffhd-35	108	2	general	general	ADJ
ffhd-35	108	3	,	,	PUNCT
ffhd-35	108	4	changes	change	NOUN
ffhd-35	108	5	to	to	ADP
ffhd-35	108	6	bmi	bmi	PROPN
ffhd-35	108	7	,	,	PUNCT
ffhd-35	108	8	waist	waist	NOUN
ffhd-35	108	9	and	and	CCONJ
ffhd-35	108	10	hip	hip	NOUN
ffhd-35	108	11	circumferences	circumference	NOUN
ffhd-35	108	12	,	,	PUNCT
ffhd-35	108	13	and	and	CCONJ
ffhd-35	108	14	body	body	NOUN
ffhd-35	108	15	fat	fat	NOUN
ffhd-35	108	16	paralleled	parallel	VERB
ffhd-35	108	17	the	the	DET
ffhd-35	108	18	loss	loss	NOUN
ffhd-35	108	19	in	in	ADP
ffhd-35	108	20	weight	weight	NOUN
ffhd-35	108	21	.	.	PUNCT
ffhd-35	109	1	similarly	similarly	ADV
ffhd-35	109	2	,	,	PUNCT
ffhd-35	109	3	blood	blood	NOUN
ffhd-35	109	4	pressure	pressure	NOUN
ffhd-35	109	5	also	also	ADV
ffhd-35	109	6	decreased	decrease	VERB
ffhd-35	109	7	significantly	significantly	ADV
ffhd-35	109	8	in	in	ADP
ffhd-35	109	9	the	the	DET
ffhd-35	109	10	dyglomera	dyglomera	NOUN
ffhd-35	109	11	®	®	NOUN
ffhd-35	109	12	treatment	treatment	NOUN
ffhd-35	109	13	group	group	NOUN
ffhd-35	109	14	compared	compare	VERB
ffhd-35	109	15	with	with	ADP
ffhd-35	109	16	the	the	DET
ffhd-35	109	17	placebo	placebo	NOUN
ffhd-35	109	18	group	group	NOUN
ffhd-35	109	19	(	(	PUNCT
ffhd-35	109	20	p	p	X
ffhd-35	109	21	<	<	X
ffhd-35	109	22	0.001	0.001	NUM
ffhd-35	109	23	)	)	PUNCT
ffhd-35	109	24	(	(	PUNCT
ffhd-35	109	25	table	table	NOUN
ffhd-35	109	26	2	2	NUM
ffhd-35	109	27	)	)	PUNCT
ffhd-35	109	28	.	.	PUNCT
ffhd-35	110	1	table	table	NOUN
ffhd-35	110	2	2	2	NUM
ffhd-35	110	3	.	.	PUNCT
ffhd-35	110	4	effects	effect	NOUN
ffhd-35	110	5	of	of	ADP
ffhd-35	110	6	dg	dg	NOUN
ffhd-35	110	7	on	on	ADP
ffhd-35	110	8	blood	blood	NOUN
ffhd-35	110	9	pressure	pressure	NOUN
ffhd-35	110	10	in	in	ADP
ffhd-35	110	11	obese	obese	ADJ
ffhd-35	110	12	subjects	subject	NOUN
ffhd-35	110	13	with	with	ADP
ffhd-35	110	14	metabolic	metabolic	NOUN
ffhd-35	110	15	syndrome	syndrome	NOUN
ffhd-35	110	16	variable	variable	ADJ
ffhd-35	110	17	group	group	NOUN
ffhd-35	110	18	t0	t0	PROPN
ffhd-35	110	19	t4	t4	PROPN
ffhd-35	110	20	t8	t8	PROPN
ffhd-35	110	21	change	change	PROPN
ffhd-35	110	22	from	from	ADP
ffhd-35	110	23	baseline	baseline	PROPN
ffhd-35	110	24	(	(	PUNCT
ffhd-35	110	25	t8	t8	PROPN
ffhd-35	110	26	t0	t0	PROPN
ffhd-35	110	27	)	)	PUNCT
ffhd-35	110	28	(	(	PUNCT
ffhd-35	110	29	%	%	INTJ
ffhd-35	110	30	)	)	PUNCT
ffhd-35	110	31	sbp	sbp	NOUN
ffhd-35	110	32	(	(	PUNCT
ffhd-35	110	33	mm	mm	PROPN
ffhd-35	110	34	hg	hg	NOUN
ffhd-35	110	35	)	)	PUNCT
ffhd-35	110	36	dg	dg	PROPN
ffhd-35	110	37	143.93±	143.93±	NUM
ffhd-35	110	38	0.48	0.48	NUM
ffhd-35	110	39	122.51±	122.51±	NUM
ffhd-35	110	40	1.07	1.07	NUM
ffhd-35	110	41	b	b	X
ffhd-35	110	42	119.75±	119.75±	NUM
ffhd-35	110	43	0.92	0.92	NUM
ffhd-35	110	44	b	b	NOUN
ffhd-35	110	45	-24.18±	-24.18±	PROPN
ffhd-35	110	46	1.00	1.00	NUM
ffhd-35	110	47	(	(	PUNCT
ffhd-35	110	48	-16.69	-16.69	NOUN
ffhd-35	110	49	)	)	PUNCT
ffhd-35	110	50	†	†	NOUN
ffhd-35	110	51	placebo	placebo	NOUN
ffhd-35	110	52	142.60±	142.60±	NUM
ffhd-35	110	53	0.54	0.54	NUM
ffhd-35	110	54	142.92±	142.92±	NUM
ffhd-35	110	55	0.83	0.83	NUM
ffhd-35	110	56	144.29±	144.29±	NUM
ffhd-35	110	57	0.95	0.95	NUM
ffhd-35	110	58	1.69±0.83	1.69±0.83	NUM
ffhd-35	110	59	(	(	PUNCT
ffhd-35	110	60	+1.22	+1.22	PROPN
ffhd-35	110	61	)	)	PUNCT
ffhd-35	110	62	dbp	dbp	PROPN
ffhd-35	110	63	(	(	PUNCT
ffhd-35	110	64	mm	mm	PROPN
ffhd-35	110	65	hg	hg	NOUN
ffhd-35	110	66	)	)	PUNCT
ffhd-35	110	67	dg	dg	VERB
ffhd-35	110	68	93.43±	93.43±	NUM
ffhd-35	110	69	0.52	0.52	NUM
ffhd-35	110	70	85.62±	85.62±	NUM
ffhd-35	110	71	0.6	0.6	NUM
ffhd-35	110	72	b	b	NOUN
ffhd-35	110	73	82.25±	82.25±	NUM
ffhd-35	110	74	0.69	0.69	NUM
ffhd-35	110	75	b	b	NOUN
ffhd-35	110	76	-11.18±	-11.18±	NOUN
ffhd-35	110	77	0.66	0.66	NUM
ffhd-35	110	78	(	(	PUNCT
ffhd-35	110	79	-11.81	-11.81	NOUN
ffhd-35	110	80	)	)	PUNCT
ffhd-35	110	81	†	†	PROPN
ffhd-35	110	82	placebo	placebo	NOUN
ffhd-35	110	83	93.29±	93.29±	NUM
ffhd-35	110	84	0.54	0.54	NUM
ffhd-35	110	85	94.77±	94.77±	NUM
ffhd-35	110	86	0.61	0.61	NUM
ffhd-35	110	87	95.27±	95.27±	NUM
ffhd-35	110	88	0.68	0.68	NUM
ffhd-35	110	89	1.99±	1.99±	NUM
ffhd-35	110	90	0.47	0.47	NUM
ffhd-35	110	91	(	(	PUNCT
ffhd-35	110	92	2.19	2.19	NUM
ffhd-35	110	93	)	)	PUNCT
ffhd-35	110	94	a	a	DET
ffhd-35	110	95	p	p	X
ffhd-35	110	96	<	<	X
ffhd-35	110	97	0.05	0.05	NUM
ffhd-35	110	98	compared	compare	VERB
ffhd-35	110	99	with	with	ADP
ffhd-35	110	100	placebo	placebo	NOUN
ffhd-35	110	101	,	,	PUNCT
ffhd-35	110	102	adjusted	adjust	VERB
ffhd-35	110	103	for	for	ADP
ffhd-35	110	104	baseline	baseline	NOUN
ffhd-35	110	105	b	b	NOUN
ffhd-35	110	106	p	p	X
ffhd-35	110	107	<	<	X
ffhd-35	110	108	0.001	0.001	NUM
ffhd-35	110	109	compared	compare	VERB
ffhd-35	110	110	with	with	ADP
ffhd-35	110	111	placebo	placebo	NOUN
ffhd-35	110	112	,	,	PUNCT
ffhd-35	110	113	adjusted	adjust	VERB
ffhd-35	110	114	for	for	ADP
ffhd-35	110	115	baseline	baseline	NOUN
ffhd-35	110	116	†	†	PROPN
ffhd-35	110	117	p	p	X
ffhd-35	110	118	<	<	X
ffhd-35	110	119	0.05	0.05	NUM
ffhd-35	110	120	compared	compare	VERB
ffhd-35	110	121	with	with	ADP
ffhd-35	110	122	baseline	baseline	NOUN
ffhd-35	110	123	,	,	PUNCT
ffhd-35	110	124	intra	intra	ADJ
ffhd-35	110	125	-	-	NOUN
ffhd-35	110	126	group	group	NOUN
ffhd-35	110	127	analysis	analysis	NOUN
ffhd-35	110	128	3.3	3.3	NUM
ffhd-35	110	129	.	.	PUNCT
ffhd-35	111	1	blood	blood	NOUN
ffhd-35	111	2	parameters	parameter	NOUN
ffhd-35	111	3	:	:	PUNCT
ffhd-35	111	4	as	as	SCONJ
ffhd-35	111	5	shown	show	VERB
ffhd-35	111	6	in	in	ADP
ffhd-35	111	7	table	table	NOUN
ffhd-35	111	8	3	3	NUM
ffhd-35	111	9	,	,	PUNCT
ffhd-35	111	10	there	there	PRON
ffhd-35	111	11	were	be	VERB
ffhd-35	111	12	significant	significant	ADJ
ffhd-35	111	13	variations	variation	NOUN
ffhd-35	111	14	in	in	ADP
ffhd-35	111	15	the	the	DET
ffhd-35	111	16	lipid	lipid	NOUN
ffhd-35	111	17	profile	profile	NOUN
ffhd-35	111	18	from	from	ADP
ffhd-35	111	19	baseline	baseline	NOUN
ffhd-35	111	20	to	to	ADP
ffhd-35	111	21	week	week	NOUN
ffhd-35	111	22	8	8	NUM
ffhd-35	111	23	of	of	ADP
ffhd-35	111	24	dyglomera	dyglomera	NOUN
ffhd-35	111	25	®	®	NOUN
ffhd-35	111	26	treatment	treatment	NOUN
ffhd-35	111	27	in	in	ADP
ffhd-35	111	28	tag	tag	NOUN
ffhd-35	111	29	,	,	PUNCT
ffhd-35	111	30	tc	tc	NOUN
ffhd-35	111	31	,	,	PUNCT
ffhd-35	111	32	hdl	hdl	NOUN
ffhd-35	111	33	and	and	CCONJ
ffhd-35	111	34	ldl	ldl	NOUN
ffhd-35	111	35	concentrations	concentration	NOUN
ffhd-35	111	36	.	.	PUNCT
ffhd-35	112	1	functional	functional	ADJ
ffhd-35	112	2	foods	food	NOUN
ffhd-35	112	3	in	in	ADP
ffhd-35	112	4	health	health	NOUN
ffhd-35	112	5	and	and	CCONJ
ffhd-35	112	6	disease	disease	NOUN
ffhd-35	112	7	2013	2013	NUM
ffhd-35	112	8	;	;	PUNCT
ffhd-35	112	9	3(11):416	3(11):416	NUM
ffhd-35	112	10	-	-	SYM
ffhd-35	112	11	427	427	NUM
ffhd-35	112	12	page	page	NOUN
ffhd-35	112	13	422	422	NUM
ffhd-35	112	14	of	of	ADP
ffhd-35	112	15	427	427	NUM
ffhd-35	112	16	table	table	NOUN
ffhd-35	112	17	3	3	NUM
ffhd-35	112	18	.	.	PUNCT
ffhd-35	112	19	effects	effect	NOUN
ffhd-35	112	20	of	of	ADP
ffhd-35	112	21	dg	dg	NOUN
ffhd-35	112	22	on	on	ADP
ffhd-35	112	23	blood	blood	NOUN
ffhd-35	112	24	glucose	glucose	NOUN
ffhd-35	112	25	and	and	CCONJ
ffhd-35	112	26	lipid	lipid	NOUN
ffhd-35	112	27	parameters	parameter	NOUN
ffhd-35	112	28	in	in	ADP
ffhd-35	112	29	obese	obese	ADJ
ffhd-35	112	30	subjects	subject	NOUN
ffhd-35	112	31	with	with	ADP
ffhd-35	112	32	metabolic	metabolic	NOUN
ffhd-35	112	33	syndrome	syndrome	NOUN
ffhd-35	112	34	variable	variable	ADJ
ffhd-35	112	35	group	group	NOUN
ffhd-35	112	36	t0	t0	PROPN
ffhd-35	112	37	t4	t4	PROPN
ffhd-35	112	38	t8	t8	PROPN
ffhd-35	112	39	change	change	PROPN
ffhd-35	112	40	from	from	ADP
ffhd-35	112	41	baseline	baseline	PROPN
ffhd-35	112	42	(	(	PUNCT
ffhd-35	112	43	t8	t8	PROPN
ffhd-35	112	44	t0	t0	PROPN
ffhd-35	112	45	)	)	PUNCT
ffhd-35	112	46	(	(	PUNCT
ffhd-35	112	47	%	%	INTJ
ffhd-35	112	48	)	)	PUNCT
ffhd-35	112	49	glucose	glucose	NOUN
ffhd-35	112	50	(	(	PUNCT
ffhd-35	112	51	mg	mg	PROPN
ffhd-35	112	52	/	/	SYM
ffhd-35	112	53	dl	dl	PROPN
ffhd-35	112	54	)	)	PUNCT
ffhd-35	112	55	dg	dg	PROPN
ffhd-35	112	56	110.25±	110.25±	NUM
ffhd-35	112	57	0.48	0.48	NUM
ffhd-35	112	58	85.82±	85.82±	NUM
ffhd-35	112	59	0.82	0.82	NUM
ffhd-35	112	60	a	a	DET
ffhd-35	112	61	79.55±	79.55±	NUM
ffhd-35	112	62	0.51	0.51	NUM
ffhd-35	112	63	b	b	NOUN
ffhd-35	112	64	-30.70±	-30.70±	NUM
ffhd-35	112	65	0.66	0.66	NUM
ffhd-35	112	66	(	(	PUNCT
ffhd-35	112	67	-27.67	-27.67	PROPN
ffhd-35	112	68	)	)	PUNCT
ffhd-35	112	69	†	†	NOUN
ffhd-35	112	70	placebo	placebo	NOUN
ffhd-35	112	71	108.99±	108.99±	NUM
ffhd-35	112	72	0.74	0.74	NUM
ffhd-35	112	73	110.54±	110.54±	NUM
ffhd-35	112	74	0.68	0.68	NUM
ffhd-35	112	75	111.75±	111.75±	NUM
ffhd-35	112	76	0.77	0.77	NUM
ffhd-35	112	77	2.76±	2.76±	NUM
ffhd-35	112	78	0.59	0.59	NUM
ffhd-35	112	79	(	(	PUNCT
ffhd-35	112	80	+2.72	+2.72	NOUN
ffhd-35	112	81	)	)	PUNCT
ffhd-35	112	82	tag	tag	NOUN
ffhd-35	112	83	(	(	PUNCT
ffhd-35	112	84	mg	mg	PROPN
ffhd-35	112	85	/	/	SYM
ffhd-35	112	86	dl	dl	NOUN
ffhd-35	112	87	)	)	PUNCT
ffhd-35	112	88	dg	dg	PROPN
ffhd-35	112	89	151.92±	151.92±	NUM
ffhd-35	112	90	3.01	3.01	NUM
ffhd-35	112	91	46.80±	46.80±	NUM
ffhd-35	112	92	2.48	2.48	NUM
ffhd-35	112	93	a	a	DET
ffhd-35	112	94	44.01±	44.01±	NUM
ffhd-35	112	95	1.86	1.86	NUM
ffhd-35	112	96	b	b	NOUN
ffhd-35	112	97	-105.12±	-105.12±	PUNCT
ffhd-35	112	98	3.54(-69.49	3.54(-69.49	NOUN
ffhd-35	112	99	)	)	PUNCT
ffhd-35	112	100	†	†	PROPN
ffhd-35	112	101	placebo	placebo	NOUN
ffhd-35	112	102	150.79±	150.79±	NUM
ffhd-35	112	103	1.78	1.78	NUM
ffhd-35	112	104	156.11±	156.11±	NUM
ffhd-35	112	105	3.04	3.04	NUM
ffhd-35	112	106	151.77±	151.77±	NUM
ffhd-35	112	107	2.39	2.39	NUM
ffhd-35	112	108	0.98±	0.98±	NOUN
ffhd-35	112	109	2.91	2.91	NUM
ffhd-35	112	110	(	(	PUNCT
ffhd-35	112	111	+4.33	+4.33	PROPN
ffhd-35	112	112	)	)	PUNCT
ffhd-35	112	113	tc	tc	NOUN
ffhd-35	112	114	(	(	PUNCT
ffhd-35	112	115	mg	mg	PROPN
ffhd-35	112	116	/	/	SYM
ffhd-35	112	117	dl	dl	PROPN
ffhd-35	112	118	)	)	PUNCT
ffhd-35	112	119	dg	dg	PROPN
ffhd-35	112	120	219.57±	219.57±	NUM
ffhd-35	112	121	1.82	1.82	NUM
ffhd-35	112	122	137.84±	137.84±	NUM
ffhd-35	112	123	2.73	2.73	NUM
ffhd-35	112	124	b	b	NOUN
ffhd-35	112	125	122.76±	122.76±	NUM
ffhd-35	112	126	3.36	3.36	NUM
ffhd-35	112	127	b	b	PROPN
ffhd-35	112	128	-96.82±	-96.82±	X
ffhd-35	112	129	3.65	3.65	NUM
ffhd-35	112	130	(	(	PUNCT
ffhd-35	112	131	-43.67	-43.67	PROPN
ffhd-35	112	132	)	)	PUNCT
ffhd-35	112	133	†	†	NOUN
ffhd-35	112	134	placebo	placebo	NOUN
ffhd-35	112	135	216.47±	216.47±	NUM
ffhd-35	112	136	3.26	3.26	NUM
ffhd-35	112	137	217.91±	217.91±	NUM
ffhd-35	112	138	2.98	2.98	NUM
ffhd-35	112	139	216.35±	216.35±	NUM
ffhd-35	112	140	3.16	3.16	NUM
ffhd-35	112	141	-0.12±	-0.12±	NOUN
ffhd-35	112	142	1.88	1.88	NUM
ffhd-35	112	143	(	(	PUNCT
ffhd-35	112	144	+0.63	+0.63	PROPN
ffhd-35	112	145	)	)	PUNCT
ffhd-35	112	146	hdl	hdl	NOUN
ffhd-35	112	147	(	(	PUNCT
ffhd-35	112	148	mg	mg	PROPN
ffhd-35	112	149	/	/	SYM
ffhd-35	112	150	dl	dl	PROPN
ffhd-35	112	151	)	)	PUNCT
ffhd-35	112	152	dg	dg	VERB
ffhd-35	112	153	37.68±	37.68±	NUM
ffhd-35	112	154	0.54	0.54	NUM
ffhd-35	112	155	50.39±	50.39±	NUM
ffhd-35	112	156	1.58	1.58	NUM
ffhd-35	112	157	a	a	DET
ffhd-35	112	158	58.23±	58.23±	NUM
ffhd-35	112	159	1.07	1.07	NUM
ffhd-35	112	160	b	b	NOUN
ffhd-35	112	161	20.55±	20.55±	NUM
ffhd-35	112	162	0.84	0.84	NUM
ffhd-35	112	163	(	(	PUNCT
ffhd-35	112	164	+55.52	+55.52	NOUN
ffhd-35	112	165	)	)	PUNCT
ffhd-35	112	166	†	†	PROPN
ffhd-35	112	167	placebo	placebo	NOUN
ffhd-35	112	168	27.24±	27.24±	NUM
ffhd-35	112	169	0.99	0.99	NUM
ffhd-35	112	170	19.87±	19.87±	NUM
ffhd-35	112	171	1.09	1.09	NUM
ffhd-35	112	172	24.92±	24.92±	NUM
ffhd-35	112	173	1.13	1.13	NUM
ffhd-35	112	174	-2.32±	-2.32±	NOUN
ffhd-35	112	175	1.05	1.05	NUM
ffhd-35	112	176	(	(	PUNCT
ffhd-35	112	177	+0.41	+0.41	NOUN
ffhd-35	112	178	)	)	PUNCT
ffhd-35	112	179	ldl	ldl	NOUN
ffhd-35	112	180	(	(	PUNCT
ffhd-35	112	181	mg	mg	PROPN
ffhd-35	112	182	/	/	SYM
ffhd-35	112	183	dl	dl	PROPN
ffhd-35	112	184	)	)	PUNCT
ffhd-35	112	185	dg	dg	PROPN
ffhd-35	112	186	151.51±	151.51±	NUM
ffhd-35	112	187	1.96	1.96	NUM
ffhd-35	112	188	78.09±	78.09±	NUM
ffhd-35	112	189	3.02	3.02	NUM
ffhd-35	112	190	a	a	DET
ffhd-35	112	191	76.27±	76.27±	NUM
ffhd-35	112	192	3.44	3.44	NUM
ffhd-35	112	193	b	b	NOUN
ffhd-35	112	194	-75.23±	-75.23±	NUM
ffhd-35	112	195	3.60	3.60	NUM
ffhd-35	112	196	(	(	PUNCT
ffhd-35	112	197	-49.18	-49.18	NOUN
ffhd-35	112	198	)	)	PUNCT
ffhd-35	112	199	†	†	NOUN
ffhd-35	112	200	placebo	placebo	NOUN
ffhd-35	112	201	159.07±	159.07±	NUM
ffhd-35	112	202	3.26	3.26	NUM
ffhd-35	112	203	166.82±	166.82±	NUM
ffhd-35	112	204	3.12	3.12	NUM
ffhd-35	112	205	161.07±3.39	161.07±3.39	NUM
ffhd-35	112	206	2.00±	2.00±	NOUN
ffhd-35	112	207	2.26	2.26	NUM
ffhd-35	112	208	(	(	PUNCT
ffhd-35	112	209	+1.61	+1.61	PROPN
ffhd-35	112	210	)	)	PUNCT
ffhd-35	112	211	a	a	DET
ffhd-35	112	212	p	p	X
ffhd-35	112	213	<	<	X
ffhd-35	112	214	0.05	0.05	NUM
ffhd-35	112	215	compared	compare	VERB
ffhd-35	112	216	with	with	ADP
ffhd-35	112	217	placebo	placebo	NOUN
ffhd-35	112	218	,	,	PUNCT
ffhd-35	112	219	adjusted	adjust	VERB
ffhd-35	112	220	for	for	ADP
ffhd-35	112	221	baseline	baseline	NOUN
ffhd-35	112	222	b	b	NOUN
ffhd-35	112	223	p	p	X
ffhd-35	112	224	<	<	X
ffhd-35	112	225	0.001	0.001	NUM
ffhd-35	112	226	compared	compare	VERB
ffhd-35	112	227	with	with	ADP
ffhd-35	112	228	placebo	placebo	NOUN
ffhd-35	112	229	,	,	PUNCT
ffhd-35	112	230	adjusted	adjust	VERB
ffhd-35	112	231	for	for	ADP
ffhd-35	112	232	baseline	baseline	NOUN
ffhd-35	112	233	†	†	PROPN
ffhd-35	112	234	p	p	X
ffhd-35	112	235	<	<	X
ffhd-35	112	236	0.05	0.05	NUM
ffhd-35	112	237	compared	compare	VERB
ffhd-35	112	238	with	with	ADP
ffhd-35	112	239	baseline	baseline	NOUN
ffhd-35	112	240	,	,	PUNCT
ffhd-35	112	241	intra	intra	ADJ
ffhd-35	112	242	-	-	ADJ
ffhd-35	112	243	group	group	NOUN
ffhd-35	112	244	analysis	analysis	NOUN
ffhd-35	112	245	these	these	DET
ffhd-35	112	246	variations	variation	NOUN
ffhd-35	112	247	were	be	AUX
ffhd-35	112	248	significant	significant	ADJ
ffhd-35	112	249	compared	compare	VERB
ffhd-35	112	250	with	with	ADP
ffhd-35	112	251	the	the	DET
ffhd-35	112	252	placebo	placebo	NOUN
ffhd-35	112	253	group	group	NOUN
ffhd-35	112	254	(	(	PUNCT
ffhd-35	112	255	p	p	X
ffhd-35	112	256	<	<	X
ffhd-35	112	257	0.001	0.001	NUM
ffhd-35	112	258	)	)	PUNCT
ffhd-35	112	259	.	.	PUNCT
ffhd-35	113	1	there	there	PRON
ffhd-35	113	2	was	be	VERB
ffhd-35	113	3	also	also	ADV
ffhd-35	113	4	a	a	DET
ffhd-35	113	5	significant	significant	ADJ
ffhd-35	113	6	reduction	reduction	NOUN
ffhd-35	113	7	of	of	ADP
ffhd-35	113	8	blood	blood	NOUN
ffhd-35	113	9	glucose	glucose	NOUN
ffhd-35	113	10	by	by	ADP
ffhd-35	113	11	27.67	27.67	NUM
ffhd-35	113	12	%	%	NOUN
ffhd-35	113	13	in	in	ADP
ffhd-35	113	14	the	the	DET
ffhd-35	113	15	dyglomera	dyglomera	NOUN
ffhd-35	113	16	®	®	NOUN
ffhd-35	113	17	group	group	NOUN
ffhd-35	113	18	from	from	ADP
ffhd-35	113	19	baseline	baseline	NOUN
ffhd-35	113	20	to	to	ADP
ffhd-35	113	21	week	week	NOUN
ffhd-35	113	22	8	8	NUM
ffhd-35	113	23	(	(	PUNCT
ffhd-35	113	24	p	p	X
ffhd-35	113	25	<	<	X
ffhd-35	113	26	0.001	0.001	NUM
ffhd-35	113	27	)	)	PUNCT
ffhd-35	113	28	(	(	PUNCT
ffhd-35	113	29	table	table	NOUN
ffhd-35	113	30	3	3	NUM
ffhd-35	113	31	)	)	PUNCT
ffhd-35	113	32	.	.	PUNCT
ffhd-35	114	1	as	as	SCONJ
ffhd-35	114	2	shown	show	VERB
ffhd-35	114	3	in	in	ADP
ffhd-35	114	4	table	table	NOUN
ffhd-35	114	5	4	4	NUM
ffhd-35	114	6	,	,	PUNCT
ffhd-35	114	7	the	the	DET
ffhd-35	114	8	dyglomera	dyglomera	NOUN
ffhd-35	114	9	®	®	NOUN
ffhd-35	114	10	group	group	NOUN
ffhd-35	114	11	demonstrated	demonstrate	VERB
ffhd-35	114	12	significant	significant	ADJ
ffhd-35	114	13	reductions	reduction	NOUN
ffhd-35	114	14	in	in	ADP
ffhd-35	114	15	insulin	insulin	NOUN
ffhd-35	114	16	and	and	CCONJ
ffhd-35	114	17	insulin	insulin	NOUN
ffhd-35	114	18	resistance	resistance	NOUN
ffhd-35	114	19	(	(	PUNCT
ffhd-35	114	20	homa	homa	NOUN
ffhd-35	114	21	-	-	PUNCT
ffhd-35	114	22	ir	ir	NOUN
ffhd-35	114	23	)	)	PUNCT
ffhd-35	114	24	respectively	respectively	ADV
ffhd-35	114	25	by	by	ADP
ffhd-35	114	26	10.38	10.38	NUM
ffhd-35	114	27	%	%	NOUN
ffhd-35	114	28	and	and	CCONJ
ffhd-35	114	29	35.11	35.11	NUM
ffhd-35	114	30	%	%	NOUN
ffhd-35	114	31	,	,	PUNCT
ffhd-35	114	32	crp	crp	PROPN
ffhd-35	114	33	by	by	ADP
ffhd-35	114	34	17.16	17.16	NUM
ffhd-35	114	35	%	%	NOUN
ffhd-35	114	36	,	,	PUNCT
ffhd-35	114	37	pai-1	pai-1	NUM
ffhd-35	114	38	by	by	ADP
ffhd-35	114	39	39.61	39.61	NUM
ffhd-35	114	40	%	%	NOUN
ffhd-35	114	41	in	in	ADP
ffhd-35	114	42	response	response	NOUN
ffhd-35	114	43	to	to	ADP
ffhd-35	114	44	the	the	DET
ffhd-35	114	45	weight	weight	NOUN
ffhd-35	114	46	loss	loss	NOUN
ffhd-35	114	47	during	during	ADP
ffhd-35	114	48	the	the	DET
ffhd-35	114	49	dyglomera	dyglomera	NOUN
ffhd-35	114	50	®	®	NOUN
ffhd-35	114	51	supplementation	supplementation	NOUN
ffhd-35	114	52	from	from	ADP
ffhd-35	114	53	baseline	baseline	NOUN
ffhd-35	114	54	to	to	ADP
ffhd-35	114	55	week	week	NOUN
ffhd-35	114	56	8	8	NUM
ffhd-35	114	57	(	(	PUNCT
ffhd-35	114	58	p	p	X
ffhd-35	114	59	<	<	X
ffhd-35	114	60	0.001	0.001	NUM
ffhd-35	114	61	)	)	PUNCT
ffhd-35	114	62	.	.	PUNCT
ffhd-35	115	1	inverse	inverse	NOUN
ffhd-35	115	2	to	to	ADP
ffhd-35	115	3	the	the	DET
ffhd-35	115	4	change	change	NOUN
ffhd-35	115	5	in	in	ADP
ffhd-35	115	6	body	body	NOUN
ffhd-35	115	7	weight	weight	NOUN
ffhd-35	115	8	,	,	PUNCT
ffhd-35	115	9	adiponectin	adiponectin	NOUN
ffhd-35	115	10	levels	level	NOUN
ffhd-35	115	11	increased	increase	VERB
ffhd-35	115	12	by	by	ADP
ffhd-35	115	13	21.86	21.86	NUM
ffhd-35	115	14	%	%	NOUN
ffhd-35	115	15	in	in	ADP
ffhd-35	115	16	the	the	DET
ffhd-35	115	17	dyglomera	dyglomera	NOUN
ffhd-35	115	18	®	®	NOUN
ffhd-35	115	19	group	group	NOUN
ffhd-35	115	20	from	from	ADP
ffhd-35	115	21	baseline	baseline	NOUN
ffhd-35	115	22	to	to	ADP
ffhd-35	115	23	week	week	NOUN
ffhd-35	115	24	8	8	NUM
ffhd-35	115	25	.	.	PUNCT
ffhd-35	115	26	table	table	NOUN
ffhd-35	115	27	4	4	NUM
ffhd-35	115	28	.	.	PUNCT
ffhd-35	115	29	effects	effect	NOUN
ffhd-35	115	30	of	of	ADP
ffhd-35	115	31	dg	dg	NOUN
ffhd-35	115	32	on	on	ADP
ffhd-35	115	33	insulin	insulin	NOUN
ffhd-35	115	34	resistance	resistance	NOUN
ffhd-35	115	35	and	and	CCONJ
ffhd-35	115	36	circulating	circulate	VERB
ffhd-35	115	37	markers	marker	NOUN
ffhd-35	115	38	of	of	ADP
ffhd-35	115	39	inflammation	inflammation	NOUN
ffhd-35	115	40	and	and	CCONJ
ffhd-35	115	41	blood	blood	NOUN
ffhd-35	115	42	coagulation	coagulation	NOUN
ffhd-35	115	43	in	in	ADP
ffhd-35	115	44	obese	obese	ADJ
ffhd-35	115	45	subjects	subject	NOUN
ffhd-35	115	46	with	with	ADP
ffhd-35	115	47	metabolic	metabolic	NOUN
ffhd-35	115	48	syndrome	syndrome	NOUN
ffhd-35	115	49	variable	variable	ADJ
ffhd-35	115	50	group	group	NOUN
ffhd-35	115	51	t0	t0	PROPN
ffhd-35	115	52	t4	t4	PROPN
ffhd-35	115	53	t8	t8	PROPN
ffhd-35	115	54	change	change	PROPN
ffhd-35	115	55	from	from	ADP
ffhd-35	115	56	baseline	baseline	PROPN
ffhd-35	115	57	(	(	PUNCT
ffhd-35	115	58	t8	t8	PROPN
ffhd-35	115	59	t0	t0	PROPN
ffhd-35	115	60	)	)	PUNCT
ffhd-35	115	61	(	(	PUNCT
ffhd-35	115	62	%	%	INTJ
ffhd-35	115	63	)	)	PUNCT
ffhd-35	115	64	insulin	insulin	NOUN
ffhd-35	115	65	(	(	PUNCT
ffhd-35	115	66	miu	miu	PROPN
ffhd-35	115	67	/	/	SYM
ffhd-35	115	68	l	l	NOUN
ffhd-35	115	69	)	)	PUNCT
ffhd-35	115	70	dg	dg	VERB
ffhd-35	115	71	13.01±	13.01±	NUM
ffhd-35	115	72	0.15	0.15	NUM
ffhd-35	115	73	12.27±	12.27±	NUM
ffhd-35	115	74	0.13	0.13	NUM
ffhd-35	115	75	a	a	DET
ffhd-35	115	76	11.67±	11.67±	NUM
ffhd-35	115	77	0.15	0.15	NUM
ffhd-35	115	78	a	a	DET
ffhd-35	115	79	-1.34±	-1.34±	PROPN
ffhd-35	115	80	0.10	0.10	NUM
ffhd-35	115	81	(	(	PUNCT
ffhd-35	115	82	-10.38	-10.38	NOUN
ffhd-35	115	83	)	)	PUNCT
ffhd-35	115	84	†	†	PROPN
ffhd-35	115	85	placebo	placebo	NOUN
ffhd-35	115	86	13.80±	13.80±	NUM
ffhd-35	115	87	0.74	0.74	NUM
ffhd-35	115	88	13.71±	13.71±	NUM
ffhd-35	115	89	0.17	0.17	NUM
ffhd-35	115	90	13.66±	13.66±	NUM
ffhd-35	115	91	0.19	0.19	NUM
ffhd-35	115	92	-0.15±	-0.15±	NOUN
ffhd-35	115	93	0.11	0.11	NUM
ffhd-35	115	94	(	(	PUNCT
ffhd-35	115	95	-1.05	-1.05	NOUN
ffhd-35	115	96	)	)	PUNCT
ffhd-35	115	97	homa	homa	NOUN
ffhd-35	115	98	-	-	PUNCT
ffhd-35	115	99	ir	ir	PROPN
ffhd-35	115	100	(	(	PUNCT
ffhd-35	115	101	mmol	mmol	NOUN
ffhd-35	115	102	/	/	SYM
ffhd-35	115	103	l×mu	l×mu	PROPN
ffhd-35	115	104	/	/	SYM
ffhd-35	115	105	l	l	NOUN
ffhd-35	115	106	)	)	PUNCT
ffhd-35	115	107	dg	dg	VERB
ffhd-35	115	108	3.55±	3.55±	NUM
ffhd-35	115	109	0.04	0.04	NUM
ffhd-35	115	110	2.60±	2.60±	NOUN
ffhd-35	115	111	0.04	0.04	NUM
ffhd-35	115	112	a	a	DET
ffhd-35	115	113	2.30±	2.30±	NUM
ffhd-35	115	114	0.03	0.03	NUM
ffhd-35	115	115	a	a	DET
ffhd-35	115	116	-1.25±	-1.25±	PROPN
ffhd-35	115	117	0.03	0.03	NUM
ffhd-35	115	118	(	(	PUNCT
ffhd-35	115	119	-35.11	-35.11	NOUN
ffhd-35	115	120	)	)	PUNCT
ffhd-35	115	121	†	†	NOUN
ffhd-35	115	122	placebo	placebo	NOUN
ffhd-35	115	123	3.71±	3.71±	NUM
ffhd-35	115	124	0.05	0.05	NUM
ffhd-35	115	125	3.74±	3.74±	NUM
ffhd-35	115	126	0.05	0.05	NUM
ffhd-35	115	127	3.77±	3.77±	NUM
ffhd-35	115	128	0.06	0.06	NUM
ffhd-35	115	129	0.06±	0.06±	NOUN
ffhd-35	115	130	0.04	0.04	NUM
ffhd-35	115	131	(	(	PUNCT
ffhd-35	115	132	+1.65	+1.65	PROPN
ffhd-35	115	133	)	)	PUNCT
ffhd-35	115	134	adiponectin	adiponectin	NOUN
ffhd-35	115	135	(	(	PUNCT
ffhd-35	115	136	µg	µg	NOUN
ffhd-35	115	137	/	/	SYM
ffhd-35	115	138	ml	ml	NOUN
ffhd-35	115	139	)	)	PUNCT
ffhd-35	115	140	dg	dg	VERB
ffhd-35	115	141	5.80±	5.80±	NUM
ffhd-35	115	142	0.11	0.11	NUM
ffhd-35	115	143	6.51±	6.51±	NUM
ffhd-35	115	144	0.14	0.14	NUM
ffhd-35	115	145	a	a	DET
ffhd-35	115	146	7.08±	7.08±	NUM
ffhd-35	115	147	0.17	0.17	NUM
ffhd-35	115	148	b	b	NOUN
ffhd-35	115	149	1.28±	1.28±	NUM
ffhd-35	115	150	0.10	0.10	NUM
ffhd-35	115	151	(	(	PUNCT
ffhd-35	115	152	21.86	21.86	NUM
ffhd-35	115	153	)	)	PUNCT
ffhd-35	115	154	†	†	PROPN
ffhd-35	115	155	placebo	placebo	NOUN
ffhd-35	115	156	5.48±	5.48±	NUM
ffhd-35	115	157	0.15	0.15	NUM
ffhd-35	115	158	5.51±	5.51±	NUM
ffhd-35	115	159	0.19	0.19	NUM
ffhd-35	115	160	5.54±	5.54±	NOUN
ffhd-35	115	161	0.19	0.19	NUM
ffhd-35	115	162	0.05±	0.05±	NOUN
ffhd-35	115	163	0.11	0.11	NUM
ffhd-35	115	164	(	(	PUNCT
ffhd-35	115	165	+0.40	+0.40	PROPN
ffhd-35	115	166	)	)	PUNCT
ffhd-35	115	167	crp	crp	NOUN
ffhd-35	115	168	(	(	PUNCT
ffhd-35	115	169	mg	mg	PROPN
ffhd-35	115	170	/	/	SYM
ffhd-35	115	171	l	l	NOUN
ffhd-35	115	172	)	)	PUNCT
ffhd-35	115	173	dg	dg	VERB
ffhd-35	115	174	6.43±	6.43±	NOUN
ffhd-35	115	175	0.14	0.14	NUM
ffhd-35	115	176	5.80±	5.80±	NUM
ffhd-35	115	177	0.07	0.07	NUM
ffhd-35	115	178	a	a	DET
ffhd-35	115	179	5.10±	5.10±	NOUN
ffhd-35	115	180	0.11	0.11	NUM
ffhd-35	115	181	b	b	NOUN
ffhd-35	115	182	-1.32±	-1.32±	PROPN
ffhd-35	115	183	0.14	0.14	NUM
ffhd-35	115	184	(	(	PUNCT
ffhd-35	115	185	-17.16	-17.16	PROPN
ffhd-35	115	186	)	)	PUNCT
ffhd-35	115	187	†	†	PROPN
ffhd-35	115	188	placebo	placebo	NOUN
ffhd-35	115	189	6.12±	6.12±	NUM
ffhd-35	115	190	0.99	0.99	NUM
ffhd-35	115	191	6.25±	6.25±	NUM
ffhd-35	115	192	0.21	0.21	NUM
ffhd-35	115	193	6.07±	6.07±	NOUN
ffhd-35	115	194	0.21	0.21	NUM
ffhd-35	115	195	-0.05±	-0.05±	PROPN
ffhd-35	115	196	0.14	0.14	NUM
ffhd-35	115	197	(	(	PUNCT
ffhd-35	115	198	-1.73	-1.73	NUM
ffhd-35	115	199	)	)	PUNCT
ffhd-35	115	200	pai-1	pai-1	NUM
ffhd-35	115	201	(	(	PUNCT
ffhd-35	115	202	ng	ng	PROPN
ffhd-35	115	203	/	/	SYM
ffhd-35	115	204	l	l	NOUN
ffhd-35	115	205	)	)	PUNCT
ffhd-35	115	206	dg	dg	PROPN
ffhd-35	115	207	32.58±	32.58±	NUM
ffhd-35	115	208	0.22	0.22	NUM
ffhd-35	115	209	26.25±	26.25±	NUM
ffhd-35	115	210	0.34	0.34	NUM
ffhd-35	115	211	a	a	DET
ffhd-35	115	212	19.81±	19.81±	NUM
ffhd-35	115	213	0.37	0.37	NUM
ffhd-35	115	214	b	b	NOUN
ffhd-35	115	215	-12.77±	-12.77±	NUM
ffhd-35	115	216	0.26	0.26	NUM
ffhd-35	115	217	(	(	PUNCT
ffhd-35	115	218	-39.61	-39.61	NOUN
ffhd-35	115	219	)	)	PUNCT
ffhd-35	115	220	†	†	NOUN
ffhd-35	115	221	placebo	placebo	NOUN
ffhd-35	115	222	33.14±	33.14±	NUM
ffhd-35	115	223	0.26	0.26	NUM
ffhd-35	115	224	32.39±	32.39±	NUM
ffhd-35	115	225	0.28	0.28	NUM
ffhd-35	116	1	32.31±0.28	32.31±0.28	NUM
ffhd-35	116	2	-0.83±	-0.83±	PROPN
ffhd-35	116	3	0.09	0.09	NUM
ffhd-35	116	4	(	(	PUNCT
ffhd-35	116	5	-2.52	-2.52	NOUN
ffhd-35	116	6	)	)	PUNCT
ffhd-35	116	7	a	a	DET
ffhd-35	116	8	p	p	X
ffhd-35	116	9	<	<	X
ffhd-35	116	10	0.05	0.05	NUM
ffhd-35	116	11	compared	compare	VERB
ffhd-35	116	12	with	with	ADP
ffhd-35	116	13	placebo	placebo	NOUN
ffhd-35	116	14	,	,	PUNCT
ffhd-35	116	15	adjusted	adjust	VERB
ffhd-35	116	16	for	for	ADP
ffhd-35	116	17	baseline	baseline	NOUN
ffhd-35	116	18	b	b	NOUN
ffhd-35	116	19	p	p	X
ffhd-35	116	20	<	<	X
ffhd-35	116	21	0.001	0.001	NUM
ffhd-35	116	22	compared	compare	VERB
ffhd-35	116	23	with	with	ADP
ffhd-35	116	24	placebo	placebo	NOUN
ffhd-35	116	25	,	,	PUNCT
ffhd-35	116	26	adjusted	adjust	VERB
ffhd-35	116	27	for	for	ADP
ffhd-35	116	28	baseline	baseline	NOUN
ffhd-35	116	29	†	†	PROPN
ffhd-35	117	1	p	p	X
ffhd-35	117	2	<	<	X
ffhd-35	117	3	0.05	0.05	NUM
ffhd-35	117	4	compared	compare	VERB
ffhd-35	117	5	with	with	ADP
ffhd-35	117	6	baseline	baseline	NOUN
ffhd-35	117	7	,	,	PUNCT
ffhd-35	117	8	intra	intra	ADJ
ffhd-35	117	9	-	-	ADJ
ffhd-35	117	10	group	group	NOUN
ffhd-35	117	11	analysis	analysis	NOUN
ffhd-35	117	12	functional	functional	ADJ
ffhd-35	117	13	foods	food	NOUN
ffhd-35	117	14	in	in	ADP
ffhd-35	117	15	health	health	NOUN
ffhd-35	117	16	and	and	CCONJ
ffhd-35	117	17	disease	disease	NOUN
ffhd-35	117	18	2013	2013	NUM
ffhd-35	117	19	;	;	PUNCT
ffhd-35	117	20	3(11):416	3(11):416	NUM
ffhd-35	117	21	-	-	SYM
ffhd-35	117	22	427	427	NUM
ffhd-35	117	23	page	page	NOUN
ffhd-35	117	24	423	423	NUM
ffhd-35	117	25	of	of	ADP
ffhd-35	117	26	427	427	NUM
ffhd-35	117	27	with	with	ADP
ffhd-35	117	28	regard	regard	NOUN
ffhd-35	117	29	to	to	ADP
ffhd-35	117	30	lipid	lipid	NOUN
ffhd-35	117	31	profiles	profile	NOUN
ffhd-35	117	32	,	,	PUNCT
ffhd-35	117	33	this	this	DET
ffhd-35	117	34	study	study	NOUN
ffhd-35	117	35	confirms	confirm	VERB
ffhd-35	117	36	the	the	DET
ffhd-35	117	37	strong	strong	ADJ
ffhd-35	117	38	hypolipidemic	hypolipidemic	ADJ
ffhd-35	117	39	effects	effect	NOUN
ffhd-35	117	40	of	of	ADP
ffhd-35	117	41	dyglomera	dyglomera	NOUN
ffhd-35	117	42	®	®	NOUN
ffhd-35	117	43	and	and	CCONJ
ffhd-35	117	44	suggests	suggest	VERB
ffhd-35	117	45	it	it	PRON
ffhd-35	117	46	could	could	AUX
ffhd-35	117	47	protect	protect	VERB
ffhd-35	117	48	against	against	ADP
ffhd-35	117	49	mets	met	NOUN
ffhd-35	117	50	through	through	ADP
ffhd-35	117	51	reduced	reduce	VERB
ffhd-35	117	52	tc	tc	NOUN
ffhd-35	117	53	(	(	PUNCT
ffhd-35	117	54	mean	mean	NOUN
ffhd-35	117	55	=	=	SYM
ffhd-35	117	56	96.82	96.82	NUM
ffhd-35	117	57	mg	mg	PROPN
ffhd-35	117	58	/	/	SYM
ffhd-35	117	59	dl	dl	PROPN
ffhd-35	117	60	(	(	PUNCT
ffhd-35	117	61	-43.67	-43.67	PROPN
ffhd-35	117	62	%	%	NOUN
ffhd-35	117	63	)	)	PUNCT
ffhd-35	117	64	)	)	PUNCT
ffhd-35	117	65	,	,	PUNCT
ffhd-35	117	66	reduced	reduce	VERB
ffhd-35	117	67	ldl	ldl	NOUN
ffhd-35	117	68	(	(	PUNCT
ffhd-35	117	69	mean	mean	NOUN
ffhd-35	117	70	=	=	SYM
ffhd-35	117	71	75.23	75.23	NUM
ffhd-35	117	72	mg	mg	PROPN
ffhd-35	117	73	/	/	SYM
ffhd-35	117	74	dl	dl	PROPN
ffhd-35	117	75	(	(	PUNCT
ffhd-35	117	76	-49.18	-49.18	PROPN
ffhd-35	117	77	%	%	NOUN
ffhd-35	117	78	)	)	PUNCT
ffhd-35	117	79	)	)	PUNCT
ffhd-35	117	80	,	,	PUNCT
ffhd-35	117	81	reduced	reduce	VERB
ffhd-35	117	82	tag	tag	NOUN
ffhd-35	117	83	(	(	PUNCT
ffhd-35	117	84	mean	mean	NOUN
ffhd-35	117	85	=	=	SYM
ffhd-35	117	86	105.12	105.12	NUM
ffhd-35	117	87	mg	mg	PROPN
ffhd-35	117	88	/	/	SYM
ffhd-35	117	89	dl	dl	PROPN
ffhd-35	117	90	(	(	PUNCT
ffhd-35	117	91	-69.49	-69.49	PROPN
ffhd-35	117	92	%	%	NOUN
ffhd-35	117	93	)	)	PUNCT
ffhd-35	117	94	)	)	PUNCT
ffhd-35	117	95	and	and	CCONJ
ffhd-35	117	96	increased	increase	VERB
ffhd-35	117	97	hdl	hdl	NOUN
ffhd-35	117	98	(	(	PUNCT
ffhd-35	117	99	mean	mean	NOUN
ffhd-35	117	100	=	=	SYM
ffhd-35	117	101	20.55	20.55	NUM
ffhd-35	117	102	mg	mg	PROPN
ffhd-35	117	103	/	/	SYM
ffhd-35	117	104	dl	dl	PROPN
ffhd-35	117	105	(	(	PUNCT
ffhd-35	117	106	+55.52	+55.52	PROPN
ffhd-35	117	107	%	%	NOUN
ffhd-35	117	108	)	)	PUNCT
ffhd-35	117	109	)	)	PUNCT
ffhd-35	117	110	.	.	PUNCT
ffhd-35	118	1	3.4	3.4	NUM
ffhd-35	118	2	.	.	PUNCT
ffhd-35	118	3	correlation	correlation	NOUN
ffhd-35	118	4	of	of	ADP
ffhd-35	118	5	select	select	ADJ
ffhd-35	118	6	anthropometric	anthropometric	ADJ
ffhd-35	118	7	changes	change	NOUN
ffhd-35	118	8	with	with	ADP
ffhd-35	118	9	metabolic	metabolic	NOUN
ffhd-35	118	10	parameters	parameter	NOUN
ffhd-35	118	11	and	and	CCONJ
ffhd-35	118	12	adipocytokines	adipocytokine	NOUN
ffhd-35	118	13	before	before	ADP
ffhd-35	118	14	and	and	CCONJ
ffhd-35	118	15	after	after	ADP
ffhd-35	118	16	weight	weight	NOUN
ffhd-35	118	17	loss	loss	NOUN
ffhd-35	118	18	.	.	PUNCT
ffhd-35	119	1	pearson	pearson	PROPN
ffhd-35	119	2	correlations	correlation	NOUN
ffhd-35	119	3	between	between	ADP
ffhd-35	119	4	outcome	outcome	NOUN
ffhd-35	119	5	variables	variable	NOUN
ffhd-35	119	6	are	be	AUX
ffhd-35	119	7	presented	present	VERB
ffhd-35	119	8	in	in	ADP
ffhd-35	119	9	table	table	NOUN
ffhd-35	119	10	5	5	NUM
ffhd-35	119	11	and	and	CCONJ
ffhd-35	119	12	they	they	PRON
ffhd-35	119	13	reveal	reveal	VERB
ffhd-35	119	14	that	that	SCONJ
ffhd-35	119	15	the	the	DET
ffhd-35	119	16	change	change	NOUN
ffhd-35	119	17	in	in	ADP
ffhd-35	119	18	bmi	bmi	PROPN
ffhd-35	119	19	was	be	AUX
ffhd-35	119	20	significantly	significantly	ADV
ffhd-35	119	21	associated	associate	VERB
ffhd-35	119	22	with	with	ADP
ffhd-35	119	23	changes	change	NOUN
ffhd-35	119	24	in	in	ADP
ffhd-35	119	25	insulin	insulin	NOUN
ffhd-35	119	26	,	,	PUNCT
ffhd-35	119	27	hdl	hdl	PROPN
ffhd-35	119	28	,	,	PUNCT
ffhd-35	119	29	ldl	ldl	PROPN
ffhd-35	119	30	,	,	PUNCT
ffhd-35	119	31	crp	crp	PROPN
ffhd-35	119	32	,	,	PUNCT
ffhd-35	119	33	adiponectin	adiponectin	NOUN
ffhd-35	119	34	,	,	PUNCT
ffhd-35	119	35	insulin	insulin	NOUN
ffhd-35	119	36	and	and	CCONJ
ffhd-35	119	37	pai-1	pai-1	NUM
ffhd-35	119	38	levels	level	NOUN
ffhd-35	119	39	(	(	PUNCT
ffhd-35	119	40	p	p	X
ffhd-35	119	41	<	<	X
ffhd-35	119	42	0.01	0.01	NUM
ffhd-35	119	43	)	)	PUNCT
ffhd-35	119	44	.	.	PUNCT
ffhd-35	120	1	similarly	similarly	ADV
ffhd-35	120	2	,	,	PUNCT
ffhd-35	120	3	waist	waist	NOUN
ffhd-35	120	4	circumference	circumference	NOUN
ffhd-35	120	5	reduction	reduction	NOUN
ffhd-35	120	6	was	be	AUX
ffhd-35	120	7	significantly	significantly	ADV
ffhd-35	120	8	associated	associate	VERB
ffhd-35	120	9	with	with	ADP
ffhd-35	120	10	the	the	DET
ffhd-35	120	11	all	all	DET
ffhd-35	120	12	the	the	DET
ffhd-35	120	13	above	above	ADV
ffhd-35	120	14	mentioned	mention	VERB
ffhd-35	120	15	parameters	parameter	NOUN
ffhd-35	120	16	except	except	SCONJ
ffhd-35	120	17	adiponectin	adiponectin	NOUN
ffhd-35	120	18	.	.	PUNCT
ffhd-35	121	1	while	while	SCONJ
ffhd-35	121	2	there	there	PRON
ffhd-35	121	3	was	be	VERB
ffhd-35	121	4	no	no	DET
ffhd-35	121	5	significant	significant	ADJ
ffhd-35	121	6	correlation	correlation	NOUN
ffhd-35	121	7	between	between	ADP
ffhd-35	121	8	the	the	DET
ffhd-35	121	9	adipocytokines	adipocytokine	NOUN
ffhd-35	121	10	adiponectin	adiponectin	VERB
ffhd-35	121	11	and	and	CCONJ
ffhd-35	121	12	pai-1	pai-1	NUM
ffhd-35	121	13	,	,	PUNCT
ffhd-35	121	14	increased	increase	VERB
ffhd-35	121	15	hdl	hdl	PROPN
ffhd-35	121	16	was	be	AUX
ffhd-35	121	17	positively	positively	ADV
ffhd-35	121	18	correlated	correlate	VERB
ffhd-35	121	19	with	with	ADP
ffhd-35	121	20	adiponectin	adiponectin	NOUN
ffhd-35	121	21	levels	level	NOUN
ffhd-35	121	22	and	and	CCONJ
ffhd-35	121	23	was	be	AUX
ffhd-35	121	24	negatively	negatively	ADV
ffhd-35	121	25	correlated	correlate	VERB
ffhd-35	121	26	with	with	ADP
ffhd-35	121	27	other	other	ADJ
ffhd-35	121	28	anthropometric	anthropometric	ADJ
ffhd-35	121	29	and	and	CCONJ
ffhd-35	121	30	biochemical	biochemical	ADJ
ffhd-35	121	31	parameters	parameter	NOUN
ffhd-35	121	32	.	.	PUNCT
ffhd-35	122	1	table	table	NOUN
ffhd-35	122	2	5	5	NUM
ffhd-35	122	3	.	.	PUNCT
ffhd-35	122	4	correlation	correlation	NOUN
ffhd-35	122	5	between	between	ADP
ffhd-35	122	6	bmi	bmi	NOUN
ffhd-35	122	7	,	,	PUNCT
ffhd-35	122	8	waist	waist	NOUN
ffhd-35	122	9	circumference	circumference	NOUN
ffhd-35	122	10	,	,	PUNCT
ffhd-35	122	11	cholesterol	cholesterol	NOUN
ffhd-35	122	12	and	and	CCONJ
ffhd-35	122	13	circulating	circulate	VERB
ffhd-35	122	14	markers	marker	NOUN
ffhd-35	122	15	of	of	ADP
ffhd-35	122	16	inflammation	inflammation	NOUN
ffhd-35	122	17	and	and	CCONJ
ffhd-35	122	18	coagulation	coagulation	NOUN
ffhd-35	122	19	in	in	ADP
ffhd-35	122	20	obese	obese	ADJ
ffhd-35	122	21	subjects	subject	NOUN
ffhd-35	122	22	with	with	ADP
ffhd-35	122	23	metabolic	metabolic	NOUN
ffhd-35	122	24	syndrome	syndrome	NOUN
ffhd-35	122	25	correlations	correlation	NOUN
ffhd-35	122	26	parameters	parameter	NOUN
ffhd-35	122	27	bmi	bmi	VERB
ffhd-35	122	28	waist	waist	PROPN
ffhd-35	122	29	hdl	hdl	PROPN
ffhd-35	122	30	ldl	ldl	PROPN
ffhd-35	122	31	crp	crp	PROPN
ffhd-35	122	32	adiponectin	adiponectin	NOUN
ffhd-35	122	33	insulin	insulin	PROPN
ffhd-35	122	34	pai-1	pai-1	PUNCT
ffhd-35	122	35	bmi	bmi	PROPN
ffhd-35	122	36	pearson	pearson	PROPN
ffhd-35	122	37	correlation	correlation	NOUN
ffhd-35	122	38	1	1	NUM
ffhd-35	122	39	0.474	0.474	NUM
ffhd-35	122	40	*	*	PUNCT
ffhd-35	122	41	*	*	PUNCT
ffhd-35	122	42	-0.260	-0.260	PUNCT
ffhd-35	122	43	*	*	PUNCT
ffhd-35	122	44	*	*	NOUN
ffhd-35	122	45	0.351	0.351	NUM
ffhd-35	122	46	*	*	PUNCT
ffhd-35	122	47	*	*	PUNCT
ffhd-35	122	48	0.221	0.221	NUM
ffhd-35	122	49	*	*	PUNCT
ffhd-35	122	50	*	*	PUNCT
ffhd-35	123	1	-0.180	-0.180	PUNCT
ffhd-35	124	1	*	*	PUNCT
ffhd-35	124	2	*	*	PUNCT
ffhd-35	124	3	0.160	0.160	NUM
ffhd-35	124	4	*	*	PUNCT
ffhd-35	124	5	*	*	PUNCT
ffhd-35	124	6	0.365	0.365	NUM
ffhd-35	124	7	*	*	PUNCT
ffhd-35	124	8	*	*	PUNCT
ffhd-35	124	9	sig	sig	X
ffhd-35	124	10	.	.	PUNCT
ffhd-35	125	1	(	(	PUNCT
ffhd-35	125	2	2	2	NUM
ffhd-35	125	3	-	-	PUNCT
ffhd-35	125	4	tailed	tailed	ADJ
ffhd-35	125	5	)	)	PUNCT
ffhd-35	126	1	0.000	0.000	NUM
ffhd-35	126	2	0.000	0.000	NUM
ffhd-35	127	1	0.000	0.000	NUM
ffhd-35	127	2	0.000	0.000	NUM
ffhd-35	127	3	0.000	0.000	NUM
ffhd-35	127	4	0.001	0.001	NUM
ffhd-35	127	5	0.000	0.000	NUM
ffhd-35	127	6	waist	waist	NOUN
ffhd-35	127	7	pearson	pearson	NOUN
ffhd-35	127	8	correlation	correlation	NOUN
ffhd-35	127	9	0.474	0.474	NUM
ffhd-35	127	10	*	*	PUNCT
ffhd-35	127	11	*	*	SYM
ffhd-35	127	12	1	1	NUM
ffhd-35	127	13	-0.128	-0.128	PUNCT
ffhd-35	127	14	*	*	PUNCT
ffhd-35	127	15	*	*	NOUN
ffhd-35	128	1	0.092	0.092	NUM
ffhd-35	128	2	*	*	PUNCT
ffhd-35	128	3	0.176	0.176	NUM
ffhd-35	128	4	*	*	PUNCT
ffhd-35	128	5	*	*	PUNCT
ffhd-35	128	6	-0.041	-0.041	PRON
ffhd-35	128	7	0.159	0.159	NUM
ffhd-35	128	8	*	*	PUNCT
ffhd-35	128	9	*	*	PUNCT
ffhd-35	128	10	0.307	0.307	NUM
ffhd-35	128	11	*	*	PUNCT
ffhd-35	128	12	*	*	PUNCT
ffhd-35	128	13	sig	sig	X
ffhd-35	128	14	.	.	PUNCT
ffhd-35	129	1	(	(	PUNCT
ffhd-35	129	2	2	2	NUM
ffhd-35	129	3	-	-	PUNCT
ffhd-35	129	4	tailed	tailed	ADJ
ffhd-35	129	5	)	)	PUNCT
ffhd-35	130	1	0.000	0.000	NUM
ffhd-35	130	2	0.006	0.006	NUM
ffhd-35	130	3	0.048	0.048	NUM
ffhd-35	130	4	0.000	0.000	NUM
ffhd-35	130	5	0.378	0.378	NUM
ffhd-35	130	6	0.001	0.001	NUM
ffhd-35	130	7	0.000	0.000	NUM
ffhd-35	130	8	hdl	hdl	PROPN
ffhd-35	130	9	-	-	PUNCT
ffhd-35	130	10	c	c	PROPN
ffhd-35	130	11	pearson	pearson	NOUN
ffhd-35	130	12	correlation	correlation	NOUN
ffhd-35	130	13	-0.260	-0.260	PUNCT
ffhd-35	130	14	*	*	PUNCT
ffhd-35	130	15	*	*	PUNCT
ffhd-35	130	16	-0.128	-0.128	PUNCT
ffhd-35	131	1	*	*	PUNCT
ffhd-35	131	2	*	*	NOUN
ffhd-35	131	3	1	1	NUM
ffhd-35	131	4	-0.475	-0.475	NOUN
ffhd-35	131	5	*	*	PUNCT
ffhd-35	131	6	*	*	PUNCT
ffhd-35	131	7	-0.188	-0.188	PUNCT
ffhd-35	131	8	*	*	PUNCT
ffhd-35	131	9	*	*	PUNCT
ffhd-35	131	10	0.184	0.184	NUM
ffhd-35	131	11	*	*	PUNCT
ffhd-35	131	12	*	*	PUNCT
ffhd-35	131	13	-0.135	-0.135	PUNCT
ffhd-35	131	14	*	*	PUNCT
ffhd-35	131	15	*	*	PUNCT
ffhd-35	131	16	-0.402	-0.402	PUNCT
ffhd-35	132	1	*	*	PUNCT
ffhd-35	132	2	*	*	PUNCT
ffhd-35	132	3	sig	sig	X
ffhd-35	132	4	.	.	PUNCT
ffhd-35	133	1	(	(	PUNCT
ffhd-35	133	2	2	2	NUM
ffhd-35	133	3	-	-	PUNCT
ffhd-35	133	4	tailed	tailed	ADJ
ffhd-35	133	5	)	)	PUNCT
ffhd-35	134	1	0.000	0.000	NUM
ffhd-35	134	2	0.006	0.006	NUM
ffhd-35	134	3	0.000	0.000	NUM
ffhd-35	134	4	0.000	0.000	NUM
ffhd-35	134	5	0.000	0.000	NUM
ffhd-35	134	6	0.004	0.004	NUM
ffhd-35	134	7	0.000	0.000	NUM
ffhd-35	134	8	ldl	ldl	PROPN
ffhd-35	134	9	-	-	PUNCT
ffhd-35	134	10	c	c	PROPN
ffhd-35	134	11	pearson	pearson	NOUN
ffhd-35	134	12	correlation	correlation	NOUN
ffhd-35	134	13	0.351	0.351	NUM
ffhd-35	134	14	*	*	PUNCT
ffhd-35	134	15	*	*	PUNCT
ffhd-35	134	16	0.092	0.092	NUM
ffhd-35	134	17	*	*	PUNCT
ffhd-35	135	1	-0.475	-0.475	NOUN
ffhd-35	135	2	*	*	PUNCT
ffhd-35	135	3	*	*	PUNCT
ffhd-35	135	4	1	1	NUM
ffhd-35	135	5	0.246	0.246	NUM
ffhd-35	135	6	*	*	PUNCT
ffhd-35	135	7	*	*	PUNCT
ffhd-35	135	8	-0.225	-0.225	PUNCT
ffhd-35	136	1	*	*	PUNCT
ffhd-35	136	2	*	*	PUNCT
ffhd-35	136	3	0.161	0.161	NUM
ffhd-35	136	4	*	*	PUNCT
ffhd-35	136	5	*	*	PUNCT
ffhd-35	136	6	0.501	0.501	NUM
ffhd-35	136	7	*	*	PUNCT
ffhd-35	136	8	*	*	PUNCT
ffhd-35	136	9	sig	sig	X
ffhd-35	136	10	.	.	PUNCT
ffhd-35	137	1	(	(	PUNCT
ffhd-35	137	2	2	2	NUM
ffhd-35	137	3	-	-	PUNCT
ffhd-35	137	4	tailed	tailed	ADJ
ffhd-35	137	5	)	)	PUNCT
ffhd-35	137	6	0.000	0.000	NUM
ffhd-35	138	1	0.048	0.048	NUM
ffhd-35	138	2	0.000	0.000	NUM
ffhd-35	138	3	0.000	0.000	NUM
ffhd-35	138	4	0.000	0.000	NUM
ffhd-35	138	5	0.000	0.000	NUM
ffhd-35	138	6	0.000	0.000	NUM
ffhd-35	138	7	crp	crp	NOUN
ffhd-35	138	8	pearson	pearson	NOUN
ffhd-35	138	9	correlation	correlation	NOUN
ffhd-35	138	10	0.221	0.221	NUM
ffhd-35	138	11	*	*	PUNCT
ffhd-35	138	12	*	*	PUNCT
ffhd-35	138	13	0.176	0.176	NUM
ffhd-35	138	14	*	*	PUNCT
ffhd-35	138	15	*	*	PUNCT
ffhd-35	138	16	-0.188	-0.188	PUNCT
ffhd-35	138	17	*	*	PUNCT
ffhd-35	138	18	*	*	PUNCT
ffhd-35	138	19	0.246	0.246	NUM
ffhd-35	139	1	*	*	PUNCT
ffhd-35	139	2	*	*	PUNCT
ffhd-35	139	3	1	1	NUM
ffhd-35	139	4	0.308	0.308	NUM
ffhd-35	139	5	*	*	PUNCT
ffhd-35	139	6	*	*	PUNCT
ffhd-35	139	7	0.552	0.552	NUM
ffhd-35	139	8	*	*	PUNCT
ffhd-35	139	9	*	*	PUNCT
ffhd-35	139	10	0.495	0.495	NUM
ffhd-35	139	11	*	*	PUNCT
ffhd-35	139	12	*	*	PUNCT
ffhd-35	139	13	sig	sig	X
ffhd-35	139	14	.	.	PUNCT
ffhd-35	140	1	(	(	PUNCT
ffhd-35	140	2	2	2	NUM
ffhd-35	140	3	-	-	PUNCT
ffhd-35	140	4	tailed	tailed	ADJ
ffhd-35	140	5	)	)	PUNCT
ffhd-35	141	1	0.000	0.000	NUM
ffhd-35	141	2	0.000	0.000	NUM
ffhd-35	142	1	0.000	0.000	NUM
ffhd-35	142	2	0.000	0.000	NUM
ffhd-35	143	1	0.000	0.000	NUM
ffhd-35	143	2	0.000	0.000	NUM
ffhd-35	143	3	0.000	0.000	NUM
ffhd-35	143	4	adiponectin	adiponectin	NOUN
ffhd-35	143	5	pearson	pearson	NOUN
ffhd-35	143	6	correlation	correlation	NOUN
ffhd-35	143	7	-0.180	-0.180	INTJ
ffhd-35	144	1	*	*	PUNCT
ffhd-35	144	2	*	*	PUNCT
ffhd-35	145	1	-0.041	-0.041	DET
ffhd-35	145	2	0.184	0.184	NUM
ffhd-35	145	3	*	*	PUNCT
ffhd-35	145	4	*	*	PUNCT
ffhd-35	145	5	-0.225	-0.225	PUNCT
ffhd-35	145	6	*	*	PUNCT
ffhd-35	145	7	*	*	PUNCT
ffhd-35	145	8	0.308	0.308	NUM
ffhd-35	145	9	*	*	PUNCT
ffhd-35	145	10	*	*	PUNCT
ffhd-35	145	11	1	1	NUM
ffhd-35	145	12	0.557	0.557	NUM
ffhd-35	145	13	*	*	PUNCT
ffhd-35	145	14	*	*	X
ffhd-35	145	15	0.001	0.001	NUM
ffhd-35	145	16	sig	sig	NOUN
ffhd-35	145	17	.	.	PUNCT
ffhd-35	146	1	(	(	PUNCT
ffhd-35	146	2	2	2	NUM
ffhd-35	146	3	-	-	PUNCT
ffhd-35	146	4	tailed	tailed	ADJ
ffhd-35	146	5	)	)	PUNCT
ffhd-35	146	6	0.000	0.000	NUM
ffhd-35	146	7	0.378	0.378	NUM
ffhd-35	146	8	0.000	0.000	NUM
ffhd-35	146	9	0.000	0.000	NUM
ffhd-35	146	10	0.000	0.000	NUM
ffhd-35	146	11	0.000	0.000	NUM
ffhd-35	146	12	0.988	0.988	NUM
ffhd-35	146	13	insulin	insulin	NOUN
ffhd-35	146	14	pearson	pearson	NOUN
ffhd-35	146	15	correlation	correlation	NOUN
ffhd-35	146	16	0.160	0.160	NUM
ffhd-35	146	17	*	*	PUNCT
ffhd-35	146	18	*	*	PUNCT
ffhd-35	147	1	0.159	0.159	NUM
ffhd-35	147	2	*	*	PUNCT
ffhd-35	147	3	*	*	PUNCT
ffhd-35	147	4	-0.135	-0.135	PUNCT
ffhd-35	147	5	*	*	PUNCT
ffhd-35	147	6	*	*	PUNCT
ffhd-35	147	7	0.161	0.161	NUM
ffhd-35	147	8	*	*	PUNCT
ffhd-35	147	9	*	*	PUNCT
ffhd-35	147	10	0.552	0.552	NUM
ffhd-35	147	11	*	*	PUNCT
ffhd-35	147	12	*	*	PUNCT
ffhd-35	147	13	0.557	0.557	NUM
ffhd-35	147	14	*	*	PUNCT
ffhd-35	147	15	*	*	PUNCT
ffhd-35	147	16	1	1	NUM
ffhd-35	147	17	0.471	0.471	NUM
ffhd-35	147	18	*	*	PUNCT
ffhd-35	147	19	*	*	PUNCT
ffhd-35	147	20	sig	sig	X
ffhd-35	147	21	.	.	PUNCT
ffhd-35	148	1	(	(	PUNCT
ffhd-35	148	2	2	2	NUM
ffhd-35	148	3	-	-	PUNCT
ffhd-35	148	4	tailed	tailed	ADJ
ffhd-35	148	5	)	)	PUNCT
ffhd-35	148	6	0.001	0.001	NUM
ffhd-35	148	7	0.001	0.001	NUM
ffhd-35	148	8	0.004	0.004	NUM
ffhd-35	148	9	0.000	0.000	NUM
ffhd-35	148	10	0.000	0.000	NUM
ffhd-35	148	11	0.000	0.000	NUM
ffhd-35	148	12	0.000	0.000	NUM
ffhd-35	148	13	functional	functional	ADJ
ffhd-35	148	14	foods	food	NOUN
ffhd-35	148	15	in	in	ADP
ffhd-35	148	16	health	health	NOUN
ffhd-35	148	17	and	and	CCONJ
ffhd-35	148	18	disease	disease	NOUN
ffhd-35	148	19	2013	2013	NUM
ffhd-35	148	20	;	;	PUNCT
ffhd-35	148	21	3(11):416	3(11):416	NUM
ffhd-35	148	22	-	-	SYM
ffhd-35	148	23	427	427	NUM
ffhd-35	148	24	page	page	NOUN
ffhd-35	148	25	424	424	NUM
ffhd-35	148	26	of	of	ADP
ffhd-35	148	27	427	427	NUM
ffhd-35	148	28	pai-1	pai-1	NUM
ffhd-35	148	29	pearson	pearson	NOUN
ffhd-35	148	30	correlation	correlation	NOUN
ffhd-35	148	31	0.365	0.365	NUM
ffhd-35	148	32	*	*	PUNCT
ffhd-35	148	33	*	*	PUNCT
ffhd-35	148	34	0.307	0.307	NUM
ffhd-35	148	35	*	*	PUNCT
ffhd-35	148	36	*	*	PUNCT
ffhd-35	148	37	-0.402	-0.402	PUNCT
ffhd-35	149	1	*	*	PUNCT
ffhd-35	150	1	*	*	PUNCT
ffhd-35	150	2	0.501	0.501	NUM
ffhd-35	150	3	*	*	PUNCT
ffhd-35	150	4	*	*	PUNCT
ffhd-35	150	5	0.495	0.495	NUM
ffhd-35	150	6	*	*	PUNCT
ffhd-35	150	7	*	*	NOUN
ffhd-35	150	8	0.001	0.001	NUM
ffhd-35	150	9	0.471	0.471	NUM
ffhd-35	150	10	*	*	PUNCT
ffhd-35	150	11	*	*	PUNCT
ffhd-35	150	12	1	1	NUM
ffhd-35	150	13	sig	sig	NOUN
ffhd-35	150	14	.	.	PUNCT
ffhd-35	151	1	(	(	PUNCT
ffhd-35	151	2	2	2	NUM
ffhd-35	151	3	-	-	PUNCT
ffhd-35	151	4	tailed	tailed	ADJ
ffhd-35	151	5	)	)	PUNCT
ffhd-35	152	1	0.000	0.000	NUM
ffhd-35	152	2	0.000	0.000	NUM
ffhd-35	152	3	0.000	0.000	NUM
ffhd-35	152	4	0.000	0.000	NUM
ffhd-35	152	5	0.000	0.000	NUM
ffhd-35	152	6	0.988	0.988	NUM
ffhd-35	152	7	0.000	0.000	NUM
ffhd-35	152	8	*	*	PUNCT
ffhd-35	152	9	*	*	PUNCT
ffhd-35	152	10	correlation	correlation	NOUN
ffhd-35	152	11	is	be	AUX
ffhd-35	152	12	significant	significant	ADJ
ffhd-35	152	13	at	at	ADP
ffhd-35	152	14	p	p	X
ffhd-35	152	15	<	<	X
ffhd-35	152	16	0.01	0.01	NUM
ffhd-35	152	17	(	(	PUNCT
ffhd-35	152	18	2	2	NUM
ffhd-35	152	19	-	-	PUNCT
ffhd-35	152	20	tailed	tailed	ADJ
ffhd-35	152	21	)	)	PUNCT
ffhd-35	152	22	.	.	PUNCT
ffhd-35	153	1	*	*	PUNCT
ffhd-35	153	2	correlation	correlation	NOUN
ffhd-35	153	3	is	be	AUX
ffhd-35	153	4	significant	significant	ADJ
ffhd-35	153	5	at	at	ADP
ffhd-35	153	6	p	p	X
ffhd-35	153	7	<	<	X
ffhd-35	153	8	0.05	0.05	NUM
ffhd-35	153	9	(	(	PUNCT
ffhd-35	153	10	2	2	NUM
ffhd-35	153	11	-	-	PUNCT
ffhd-35	153	12	tailed	tailed	ADJ
ffhd-35	153	13	)	)	PUNCT
ffhd-35	153	14	4	4	NUM
ffhd-35	153	15	.	.	X
ffhd-35	153	16	discussion	discussion	VERB
ffhd-35	153	17	the	the	DET
ffhd-35	153	18	purpose	purpose	NOUN
ffhd-35	153	19	of	of	ADP
ffhd-35	153	20	this	this	DET
ffhd-35	153	21	study	study	NOUN
ffhd-35	153	22	was	be	AUX
ffhd-35	153	23	to	to	PART
ffhd-35	153	24	evaluate	evaluate	VERB
ffhd-35	153	25	the	the	DET
ffhd-35	153	26	effects	effect	NOUN
ffhd-35	153	27	of	of	ADP
ffhd-35	153	28	an	an	DET
ffhd-35	153	29	extract	extract	NOUN
ffhd-35	153	30	of	of	ADP
ffhd-35	153	31	dg	dg	PROPN
ffhd-35	153	32	(	(	PUNCT
ffhd-35	153	33	dyglomera	dyglomera	NOUN
ffhd-35	153	34	®	®	NOUN
ffhd-35	153	35	)	)	PUNCT
ffhd-35	153	36	on	on	ADP
ffhd-35	153	37	anthropometric	anthropometric	ADJ
ffhd-35	153	38	parameters	parameter	NOUN
ffhd-35	153	39	,	,	PUNCT
ffhd-35	153	40	blood	blood	NOUN
ffhd-35	153	41	lipids	lipid	NOUN
ffhd-35	153	42	,	,	PUNCT
ffhd-35	153	43	and	and	CCONJ
ffhd-35	153	44	other	other	ADJ
ffhd-35	153	45	variables	variable	NOUN
ffhd-35	153	46	in	in	ADP
ffhd-35	153	47	obese	obese	ADJ
ffhd-35	153	48	patients	patient	NOUN
ffhd-35	153	49	with	with	ADP
ffhd-35	153	50	mets	met	NOUN
ffhd-35	153	51	.	.	PUNCT
ffhd-35	154	1	because	because	SCONJ
ffhd-35	154	2	obesity	obesity	NOUN
ffhd-35	154	3	results	result	NOUN
ffhd-35	154	4	in	in	ADP
ffhd-35	154	5	increased	increase	VERB
ffhd-35	154	6	visceral	visceral	ADJ
ffhd-35	154	7	fat	fat	ADJ
ffhd-35	154	8	deposits	deposit	NOUN
ffhd-35	154	9	that	that	PRON
ffhd-35	154	10	promote	promote	VERB
ffhd-35	154	11	insulin	insulin	NOUN
ffhd-35	154	12	resistance	resistance	NOUN
ffhd-35	154	13	and	and	CCONJ
ffhd-35	154	14	inflammation	inflammation	NOUN
ffhd-35	154	15	through	through	ADP
ffhd-35	154	16	alteration	alteration	NOUN
ffhd-35	154	17	of	of	ADP
ffhd-35	154	18	adipokine	adipokine	ADJ
ffhd-35	154	19	secretion	secretion	NOUN
ffhd-35	154	20	,	,	PUNCT
ffhd-35	154	21	even	even	ADV
ffhd-35	154	22	modest	modest	ADJ
ffhd-35	154	23	reductions	reduction	NOUN
ffhd-35	154	24	to	to	ADP
ffhd-35	154	25	weight	weight	NOUN
ffhd-35	154	26	and	and	CCONJ
ffhd-35	154	27	waist	waist	NOUN
ffhd-35	154	28	circumference	circumference	NOUN
ffhd-35	154	29	are	be	AUX
ffhd-35	154	30	associated	associate	VERB
ffhd-35	154	31	with	with	ADP
ffhd-35	154	32	favorable	favorable	ADJ
ffhd-35	154	33	changes	change	NOUN
ffhd-35	154	34	in	in	ADP
ffhd-35	154	35	serum	serum	NOUN
ffhd-35	154	36	adipocytokines	adipocytokine	NOUN
ffhd-35	154	37	[	[	X
ffhd-35	154	38	6	6	NUM
ffhd-35	154	39	]	]	PUNCT
ffhd-35	154	40	.	.	PUNCT
ffhd-35	155	1	compared	compare	VERB
ffhd-35	155	2	to	to	ADP
ffhd-35	155	3	whole	whole	ADJ
ffhd-35	155	4	,	,	PUNCT
ffhd-35	155	5	ground	ground	NOUN
ffhd-35	155	6	powder	powder	NOUN
ffhd-35	155	7	[	[	X
ffhd-35	155	8	19	19	NUM
ffhd-35	155	9	]	]	PUNCT
ffhd-35	155	10	,	,	PUNCT
ffhd-35	155	11	the	the	DET
ffhd-35	155	12	extract	extract	NOUN
ffhd-35	155	13	(	(	PUNCT
ffhd-35	155	14	dyglomera	dyglomera	NOUN
ffhd-35	155	15	®	®	NOUN
ffhd-35	155	16	)	)	PUNCT
ffhd-35	155	17	induced	induce	VERB
ffhd-35	155	18	a	a	DET
ffhd-35	155	19	greater	great	ADJ
ffhd-35	155	20	reduction	reduction	NOUN
ffhd-35	155	21	in	in	ADP
ffhd-35	155	22	weight	weight	NOUN
ffhd-35	155	23	(	(	PUNCT
ffhd-35	155	24	11.15	11.15	NUM
ffhd-35	155	25	kg	kg	NOUN
ffhd-35	155	26	vs.	vs.	ADP
ffhd-35	155	27	7.67	7.67	NUM
ffhd-35	155	28	kg	kg	NOUN
ffhd-35	155	29	)	)	PUNCT
ffhd-35	155	30	,	,	PUNCT
ffhd-35	155	31	bmi	bmi	X
ffhd-35	155	32	(	(	PUNCT
ffhd-35	155	33	4.13	4.13	NUM
ffhd-35	155	34	kg	kg	NOUN
ffhd-35	155	35	/	/	SYM
ffhd-35	155	36	m	m	PROPN
ffhd-35	155	37	2	2	NUM
ffhd-35	155	38	vs.	vs.	ADP
ffhd-35	155	39	3.00	3.00	NUM
ffhd-35	155	40	kg	kg	NOUN
ffhd-35	155	41	/	/	SYM
ffhd-35	155	42	m	m	PROPN
ffhd-35	155	43	2	2	NUM
ffhd-35	155	44	)	)	PUNCT
ffhd-35	155	45	,	,	PUNCT
ffhd-35	155	46	abdominal	abdominal	ADJ
ffhd-35	155	47	circumference	circumference	NOUN
ffhd-35	155	48	(	(	PUNCT
ffhd-35	155	49	10.72	10.72	NUM
ffhd-35	155	50	cm	cm	NOUN
ffhd-35	155	51	vs.	vs.	ADP
ffhd-35	155	52	7.17	7.17	NUM
ffhd-35	155	53	cm	cm	NOUN
ffhd-35	155	54	)	)	PUNCT
ffhd-35	155	55	,	,	PUNCT
ffhd-35	155	56	body	body	NOUN
ffhd-35	155	57	fat	fat	NOUN
ffhd-35	155	58	(	(	PUNCT
ffhd-35	155	59	4.43	4.43	NUM
ffhd-35	155	60	%	%	NOUN
ffhd-35	155	61	vs.	vs.	ADP
ffhd-35	155	62	3.20	3.20	NUM
ffhd-35	155	63	%	%	NOUN
ffhd-35	155	64	)	)	PUNCT
ffhd-35	155	65	,	,	PUNCT
ffhd-35	155	66	systolic	systolic	ADJ
ffhd-35	155	67	blood	blood	NOUN
ffhd-35	155	68	pressure	pressure	NOUN
ffhd-35	155	69	(	(	PUNCT
ffhd-35	155	70	24.8	24.8	NUM
ffhd-35	155	71	mm	mm	NOUN
ffhd-35	155	72	hg	hg	NOUN
ffhd-35	155	73	vs.	vs.	ADP
ffhd-35	155	74	13.09	13.09	NUM
ffhd-35	155	75	mm	mm	PROPN
ffhd-35	155	76	hg	hg	NOUN
ffhd-35	155	77	)	)	PUNCT
ffhd-35	155	78	,	,	PUNCT
ffhd-35	155	79	and	and	CCONJ
ffhd-35	155	80	fasting	fast	VERB
ffhd-35	155	81	blood	blood	NOUN
ffhd-35	155	82	glucose	glucose	NOUN
ffhd-35	155	83	(	(	PUNCT
ffhd-35	155	84	30.7	30.7	NUM
ffhd-35	155	85	mg	mg	PROPN
ffhd-35	155	86	/	/	SYM
ffhd-35	155	87	dl	dl	PROPN
ffhd-35	155	88	vs.	vs.	ADP
ffhd-35	155	89	28.91	28.91	NUM
ffhd-35	155	90	mg	mg	PROPN
ffhd-35	155	91	/	/	SYM
ffhd-35	155	92	dl	dl	PROPN
ffhd-35	155	93	)	)	PUNCT
ffhd-35	155	94	.	.	PUNCT
ffhd-35	156	1	weight	weight	NOUN
ffhd-35	156	2	loss	loss	NOUN
ffhd-35	156	3	in	in	ADP
ffhd-35	156	4	overweight	overweight	NOUN
ffhd-35	156	5	and	and	CCONJ
ffhd-35	156	6	obese	obese	ADJ
ffhd-35	156	7	individuals	individual	NOUN
ffhd-35	156	8	reduces	reduce	VERB
ffhd-35	156	9	mortality	mortality	NOUN
ffhd-35	156	10	and	and	CCONJ
ffhd-35	156	11	morbidity	morbidity	NOUN
ffhd-35	156	12	,	,	PUNCT
ffhd-35	156	13	and	and	CCONJ
ffhd-35	156	14	is	be	AUX
ffhd-35	156	15	important	important	ADJ
ffhd-35	156	16	in	in	ADP
ffhd-35	156	17	the	the	DET
ffhd-35	156	18	treatment	treatment	NOUN
ffhd-35	156	19	of	of	ADP
ffhd-35	156	20	obese	obese	ADJ
ffhd-35	156	21	patients	patient	NOUN
ffhd-35	156	22	.	.	PUNCT
ffhd-35	157	1	the	the	DET
ffhd-35	157	2	current	current	ADJ
ffhd-35	157	3	data	datum	NOUN
ffhd-35	157	4	suggest	suggest	VERB
ffhd-35	157	5	that	that	SCONJ
ffhd-35	157	6	weight	weight	NOUN
ffhd-35	157	7	loss	loss	NOUN
ffhd-35	157	8	per	per	X
ffhd-35	157	9	se	se	X
ffhd-35	157	10	leads	lead	VERB
ffhd-35	157	11	to	to	ADP
ffhd-35	157	12	significant	significant	ADJ
ffhd-35	157	13	improvement	improvement	NOUN
ffhd-35	157	14	in	in	ADP
ffhd-35	157	15	numerous	numerous	ADJ
ffhd-35	157	16	cardiometabolic	cardiometabolic	ADJ
ffhd-35	157	17	risk	risk	NOUN
ffhd-35	157	18	factors	factor	NOUN
ffhd-35	157	19	.	.	PUNCT
ffhd-35	158	1	in	in	ADP
ffhd-35	158	2	particular	particular	ADJ
ffhd-35	158	3	the	the	DET
ffhd-35	158	4	dyglomera	dyglomera	NOUN
ffhd-35	158	5	®	®	NOUN
ffhd-35	158	6	-treated	-treate	VERB
ffhd-35	158	7	subjects	subject	NOUN
ffhd-35	158	8	exhibited	exhibit	VERB
ffhd-35	158	9	significant	significant	ADJ
ffhd-35	158	10	decreases	decrease	NOUN
ffhd-35	158	11	in	in	ADP
ffhd-35	158	12	pai-1	pai-1	NUM
ffhd-35	158	13	,	,	PUNCT
ffhd-35	158	14	crp	crp	NOUN
ffhd-35	158	15	,	,	PUNCT
ffhd-35	158	16	and	and	CCONJ
ffhd-35	158	17	fasting	fast	VERB
ffhd-35	158	18	insulin	insulin	NOUN
ffhd-35	158	19	levels	level	NOUN
ffhd-35	158	20	.	.	PUNCT
ffhd-35	159	1	in	in	ADP
ffhd-35	159	2	addition	addition	NOUN
ffhd-35	159	3	,	,	PUNCT
ffhd-35	159	4	they	they	PRON
ffhd-35	159	5	showed	show	VERB
ffhd-35	159	6	a	a	DET
ffhd-35	159	7	significant	significant	ADJ
ffhd-35	159	8	increase	increase	NOUN
ffhd-35	159	9	in	in	ADP
ffhd-35	159	10	adiponectin	adiponectin	NOUN
ffhd-35	159	11	concentrations	concentration	NOUN
ffhd-35	159	12	,	,	PUNCT
ffhd-35	159	13	an	an	DET
ffhd-35	159	14	adipokine	adipokine	NOUN
ffhd-35	159	15	whose	whose	DET
ffhd-35	159	16	plasma	plasma	NOUN
ffhd-35	159	17	concentrations	concentration	NOUN
ffhd-35	159	18	correlate	correlate	VERB
ffhd-35	159	19	positively	positively	ADV
ffhd-35	159	20	with	with	ADP
ffhd-35	159	21	insulin	insulin	NOUN
ffhd-35	159	22	sensitivity	sensitivity	NOUN
ffhd-35	159	23	,	,	PUNCT
ffhd-35	159	24	and	and	CCONJ
ffhd-35	159	25	levels	level	NOUN
ffhd-35	159	26	of	of	ADP
ffhd-35	159	27	which	which	PRON
ffhd-35	159	28	are	be	AUX
ffhd-35	159	29	lower	low	ADJ
ffhd-35	159	30	both	both	CCONJ
ffhd-35	159	31	in	in	ADP
ffhd-35	159	32	obese	obese	NOUN
ffhd-35	159	33	and	and	CCONJ
ffhd-35	159	34	type	type	NOUN
ffhd-35	159	35	2	2	NUM
ffhd-35	159	36	diabetic	diabetic	ADJ
ffhd-35	159	37	patients	patient	NOUN
ffhd-35	159	38	than	than	ADP
ffhd-35	159	39	in	in	ADP
ffhd-35	159	40	lean	lean	ADJ
ffhd-35	159	41	,	,	PUNCT
ffhd-35	159	42	healthy	healthy	ADJ
ffhd-35	159	43	individuals	individual	NOUN
ffhd-35	159	44	[	[	X
ffhd-35	159	45	26	26	NUM
ffhd-35	159	46	]	]	PUNCT
ffhd-35	159	47	.	.	PUNCT
ffhd-35	160	1	hypoadiponectinemia	hypoadiponectinemia	NOUN
ffhd-35	160	2	is	be	AUX
ffhd-35	160	3	independently	independently	ADV
ffhd-35	160	4	associated	associate	VERB
ffhd-35	160	5	with	with	ADP
ffhd-35	160	6	the	the	DET
ffhd-35	160	7	development	development	NOUN
ffhd-35	160	8	of	of	ADP
ffhd-35	160	9	obesity	obesity	NOUN
ffhd-35	160	10	-	-	PUNCT
ffhd-35	160	11	related	relate	VERB
ffhd-35	160	12	mets	met	NOUN
ffhd-35	160	13	,	,	PUNCT
ffhd-35	160	14	as	as	ADV
ffhd-35	160	15	well	well	ADV
ffhd-35	160	16	as	as	ADP
ffhd-35	160	17	insulin	insulin	NOUN
ffhd-35	160	18	-	-	PUNCT
ffhd-35	160	19	resistant	resistant	ADJ
ffhd-35	160	20	diabetes	diabetes	NOUN
ffhd-35	160	21	and	and	CCONJ
ffhd-35	160	22	atherosclerosis	atherosclerosis	NOUN
ffhd-35	160	23	[	[	X
ffhd-35	160	24	27	27	NUM
ffhd-35	160	25	]	]	PUNCT
ffhd-35	160	26	,	,	PUNCT
ffhd-35	160	27	and	and	CCONJ
ffhd-35	160	28	this	this	DET
ffhd-35	160	29	relationship	relationship	NOUN
ffhd-35	160	30	is	be	AUX
ffhd-35	160	31	stronger	strong	ADJ
ffhd-35	160	32	than	than	ADP
ffhd-35	160	33	that	that	PRON
ffhd-35	160	34	of	of	ADP
ffhd-35	160	35	any	any	DET
ffhd-35	160	36	other	other	ADJ
ffhd-35	160	37	inflammatory	inflammatory	ADJ
ffhd-35	160	38	marker	marker	NOUN
ffhd-35	161	1	[	[	X
ffhd-35	161	2	28	28	NUM
ffhd-35	161	3	]	]	PUNCT
ffhd-35	161	4	.	.	PUNCT
ffhd-35	162	1	mechanisms	mechanism	NOUN
ffhd-35	162	2	of	of	ADP
ffhd-35	162	3	action	action	NOUN
ffhd-35	162	4	of	of	ADP
ffhd-35	162	5	dyglomera	dyglomera	NOUN
ffhd-35	162	6	®	®	NOUN
ffhd-35	162	7	may	may	AUX
ffhd-35	162	8	include	include	VERB
ffhd-35	162	9	antioxidant	antioxidant	ADJ
ffhd-35	162	10	activity	activity	NOUN
ffhd-35	162	11	and	and	CCONJ
ffhd-35	162	12	inhibition	inhibition	NOUN
ffhd-35	162	13	of	of	ADP
ffhd-35	162	14	ldl	ldl	NOUN
ffhd-35	162	15	oxidation	oxidation	NOUN
ffhd-35	162	16	[	[	X
ffhd-35	162	17	17	17	NUM
ffhd-35	162	18	]	]	PUNCT
ffhd-35	162	19	as	as	ADV
ffhd-35	162	20	well	well	ADV
ffhd-35	162	21	as	as	ADP
ffhd-35	162	22	modulation	modulation	NOUN
ffhd-35	162	23	of	of	ADP
ffhd-35	162	24	blood	blood	NOUN
ffhd-35	162	25	glucose	glucose	NOUN
ffhd-35	162	26	and	and	CCONJ
ffhd-35	162	27	hba1c	hba1c	PROPN
ffhd-35	162	28	levels	level	NOUN
ffhd-35	162	29	[	[	X
ffhd-35	162	30	19	19	NUM
ffhd-35	162	31	]	]	PUNCT
ffhd-35	162	32	,	,	PUNCT
ffhd-35	162	33	all	all	PRON
ffhd-35	162	34	of	of	ADP
ffhd-35	162	35	which	which	PRON
ffhd-35	162	36	may	may	AUX
ffhd-35	162	37	have	have	AUX
ffhd-35	162	38	contributed	contribute	VERB
ffhd-35	162	39	to	to	ADP
ffhd-35	162	40	the	the	DET
ffhd-35	162	41	effects	effect	NOUN
ffhd-35	162	42	conferred	confer	VERB
ffhd-35	162	43	by	by	ADP
ffhd-35	162	44	dyglomera	dyglomera	NOUN
ffhd-35	162	45	®	®	NOUN
ffhd-35	162	46	treatment	treatment	NOUN
ffhd-35	162	47	in	in	ADP
ffhd-35	162	48	the	the	DET
ffhd-35	162	49	present	present	ADJ
ffhd-35	162	50	study	study	NOUN
ffhd-35	162	51	.	.	PUNCT
ffhd-35	163	1	dyslipidemia	dyslipidemia	NOUN
ffhd-35	163	2	is	be	AUX
ffhd-35	163	3	a	a	DET
ffhd-35	163	4	component	component	NOUN
ffhd-35	163	5	of	of	ADP
ffhd-35	163	6	mets	met	NOUN
ffhd-35	163	7	,	,	PUNCT
ffhd-35	163	8	which	which	PRON
ffhd-35	163	9	has	have	VERB
ffhd-35	163	10	an	an	DET
ffhd-35	163	11	underlying	underlying	ADJ
ffhd-35	163	12	cause	cause	NOUN
ffhd-35	163	13	of	of	ADP
ffhd-35	163	14	altered	altered	ADJ
ffhd-35	163	15	metabolism	metabolism	NOUN
ffhd-35	163	16	of	of	ADP
ffhd-35	163	17	triglyceride	triglyceride	ADJ
ffhd-35	163	18	-	-	PUNCT
ffhd-35	163	19	rich	rich	ADJ
ffhd-35	163	20	lipoproteins	lipoprotein	NOUN
ffhd-35	163	21	such	such	ADJ
ffhd-35	163	22	as	as	ADP
ffhd-35	163	23	vldl	vldl	NOUN
ffhd-35	163	24	and	and	CCONJ
ffhd-35	163	25	idl	idl	NOUN
ffhd-35	163	26	remnants	remnant	NOUN
ffhd-35	163	27	[	[	X
ffhd-35	163	28	29,30	29,30	NUM
ffhd-35	163	29	]	]	PUNCT
ffhd-35	163	30	.	.	PUNCT
ffhd-35	164	1	elevated	elevated	ADJ
ffhd-35	164	2	tag	tag	NOUN
ffhd-35	164	3	levels	level	NOUN
ffhd-35	164	4	are	be	AUX
ffhd-35	164	5	also	also	ADV
ffhd-35	164	6	very	very	ADV
ffhd-35	164	7	common	common	ADJ
ffhd-35	164	8	in	in	ADP
ffhd-35	164	9	both	both	CCONJ
ffhd-35	164	10	mets	met	NOUN
ffhd-35	164	11	and	and	CCONJ
ffhd-35	164	12	the	the	DET
ffhd-35	164	13	general	general	ADJ
ffhd-35	164	14	population	population	NOUN
ffhd-35	165	1	[	[	X
ffhd-35	165	2	31	31	NUM
ffhd-35	165	3	]	]	PUNCT
ffhd-35	165	4	.	.	PUNCT
ffhd-35	166	1	the	the	DET
ffhd-35	166	2	use	use	NOUN
ffhd-35	166	3	of	of	ADP
ffhd-35	166	4	dyglomera	dyglomera	NOUN
ffhd-35	166	5	®	®	NOUN
ffhd-35	166	6	by	by	ADP
ffhd-35	166	7	the	the	DET
ffhd-35	166	8	general	general	ADJ
ffhd-35	166	9	population	population	NOUN
ffhd-35	166	10	could	could	AUX
ffhd-35	166	11	therefore	therefore	ADV
ffhd-35	166	12	have	have	VERB
ffhd-35	166	13	a	a	DET
ffhd-35	166	14	preventive	preventive	ADJ
ffhd-35	166	15	effect	effect	NOUN
ffhd-35	166	16	on	on	ADP
ffhd-35	166	17	dyslipidemia	dyslipidemia	NOUN
ffhd-35	166	18	and	and	CCONJ
ffhd-35	166	19	mets	met	NOUN
ffhd-35	166	20	.	.	PUNCT
ffhd-35	167	1	reducing	reduce	VERB
ffhd-35	167	2	ldl	ldl	NOUN
ffhd-35	167	3	levels	level	NOUN
ffhd-35	167	4	is	be	AUX
ffhd-35	167	5	generally	generally	ADV
ffhd-35	167	6	considered	consider	VERB
ffhd-35	167	7	a	a	DET
ffhd-35	167	8	key	key	ADJ
ffhd-35	167	9	factor	factor	NOUN
ffhd-35	167	10	in	in	ADP
ffhd-35	167	11	the	the	DET
ffhd-35	167	12	management	management	NOUN
ffhd-35	167	13	of	of	ADP
ffhd-35	167	14	cardiovascular	cardiovascular	ADJ
ffhd-35	167	15	risk	risk	NOUN
ffhd-35	167	16	because	because	SCONJ
ffhd-35	167	17	ldl	ldl	NOUN
ffhd-35	167	18	particles	particle	NOUN
ffhd-35	167	19	are	be	AUX
ffhd-35	167	20	the	the	DET
ffhd-35	167	21	main	main	ADJ
ffhd-35	167	22	carriers	carrier	NOUN
ffhd-35	167	23	of	of	ADP
ffhd-35	167	24	circulating	circulate	VERB
ffhd-35	167	25	cholesterol	cholesterol	NOUN
ffhd-35	167	26	and	and	CCONJ
ffhd-35	167	27	play	play	VERB
ffhd-35	167	28	a	a	DET
ffhd-35	167	29	key	key	ADJ
ffhd-35	167	30	role	role	NOUN
ffhd-35	167	31	in	in	ADP
ffhd-35	167	32	cholesterol	cholesterol	NOUN
ffhd-35	167	33	transfer	transfer	NOUN
ffhd-35	167	34	and	and	CCONJ
ffhd-35	167	35	metabolism	metabolism	NOUN
ffhd-35	168	1	[	[	X
ffhd-35	168	2	32	32	NUM
ffhd-35	168	3	]	]	PUNCT
ffhd-35	168	4	.	.	PUNCT
ffhd-35	169	1	the	the	DET
ffhd-35	169	2	guidelines	guideline	NOUN
ffhd-35	169	3	in	in	ADP
ffhd-35	169	4	the	the	DET
ffhd-35	169	5	third	third	ADJ
ffhd-35	169	6	report	report	NOUN
ffhd-35	169	7	of	of	ADP
ffhd-35	169	8	the	the	DET
ffhd-35	169	9	national	national	ADJ
ffhd-35	169	10	cholesterol	cholesterol	PROPN
ffhd-35	169	11	education	education	NOUN
ffhd-35	169	12	program	program	NOUN
ffhd-35	169	13	(	(	PUNCT
ffhd-35	169	14	adult	adult	NOUN
ffhd-35	169	15	treatment	treatment	NOUN
ffhd-35	169	16	panel	panel	NOUN
ffhd-35	169	17	iii	iii	PROPN
ffhd-35	169	18	)	)	PUNCT
ffhd-35	169	19	(	(	PUNCT
ffhd-35	169	20	ncep	ncep	PROPN
ffhd-35	169	21	atp	atp	PROPN
ffhd-35	169	22	iii	iii	PROPN
ffhd-35	169	23	)	)	PUNCT
ffhd-35	169	24	focus	focus	NOUN
ffhd-35	169	25	on	on	ADP
ffhd-35	169	26	ldl	ldl	NOUN
ffhd-35	169	27	levels	level	NOUN
ffhd-35	169	28	as	as	ADP
ffhd-35	169	29	the	the	DET
ffhd-35	169	30	primary	primary	ADJ
ffhd-35	169	31	target	target	NOUN
ffhd-35	169	32	of	of	ADP
ffhd-35	169	33	cholesterol	cholesterol	NOUN
ffhd-35	169	34	-	-	PUNCT
ffhd-35	169	35	lowering	lower	VERB
ffhd-35	169	36	therapy	therapy	NOUN
ffhd-35	169	37	[	[	X
ffhd-35	169	38	20	20	NUM
ffhd-35	169	39	]	]	PUNCT
ffhd-35	169	40	.	.	PUNCT
ffhd-35	170	1	supplementation	supplementation	NOUN
ffhd-35	170	2	with	with	ADP
ffhd-35	170	3	dyglomera	dyglomera	NOUN
ffhd-35	170	4	®	®	NOUN
ffhd-35	170	5	could	could	AUX
ffhd-35	170	6	therefore	therefore	ADV
ffhd-35	170	7	be	be	AUX
ffhd-35	170	8	a	a	DET
ffhd-35	170	9	useful	useful	ADJ
ffhd-35	170	10	strategy	strategy	NOUN
ffhd-35	170	11	to	to	PART
ffhd-35	170	12	lower	lower	VERB
ffhd-35	170	13	ldl	ldl	NOUN
ffhd-35	170	14	levels	level	NOUN
ffhd-35	170	15	.	.	PUNCT
ffhd-35	171	1	in	in	ADP
ffhd-35	171	2	summary	summary	NOUN
ffhd-35	171	3	,	,	PUNCT
ffhd-35	171	4	dyglomera	dyglomera	NOUN
ffhd-35	171	5	®	®	NOUN
ffhd-35	171	6	reduces	reduce	VERB
ffhd-35	171	7	the	the	DET
ffhd-35	171	8	weight	weight	NOUN
ffhd-35	171	9	and	and	CCONJ
ffhd-35	171	10	improves	improve	VERB
ffhd-35	171	11	the	the	DET
ffhd-35	171	12	atherogenic	atherogenic	ADJ
ffhd-35	171	13	risk	risk	NOUN
ffhd-35	171	14	factors	factor	NOUN
ffhd-35	171	15	associated	associate	VERB
ffhd-35	171	16	with	with	ADP
ffhd-35	171	17	mets	met	NOUN
ffhd-35	171	18	after	after	ADP
ffhd-35	171	19	8	8	NUM
ffhd-35	171	20	weeks	week	NOUN
ffhd-35	171	21	of	of	ADP
ffhd-35	171	22	treatment	treatment	NOUN
ffhd-35	171	23	.	.	PUNCT
ffhd-35	172	1	the	the	DET
ffhd-35	172	2	effects	effect	NOUN
ffhd-35	172	3	in	in	ADP
ffhd-35	172	4	the	the	DET
ffhd-35	172	5	current	current	ADJ
ffhd-35	172	6	study	study	NOUN
ffhd-35	172	7	,	,	PUNCT
ffhd-35	172	8	which	which	PRON
ffhd-35	172	9	focused	focus	VERB
ffhd-35	172	10	on	on	ADP
ffhd-35	172	11	the	the	DET
ffhd-35	172	12	extract	extract	NOUN
ffhd-35	172	13	of	of	ADP
ffhd-35	172	14	dg	dg	PROPN
ffhd-35	172	15	(	(	PUNCT
ffhd-35	172	16	dyglomera	dyglomera	NOUN
ffhd-35	172	17	®	®	PROPN
ffhd-35	172	18	)	)	PUNCT
ffhd-35	172	19	,	,	PUNCT
ffhd-35	172	20	appears	appear	VERB
ffhd-35	172	21	to	to	PART
ffhd-35	172	22	be	be	AUX
ffhd-35	172	23	stronger	strong	ADJ
ffhd-35	172	24	than	than	ADP
ffhd-35	172	25	those	those	PRON
ffhd-35	172	26	observed	observe	VERB
ffhd-35	172	27	in	in	ADP
ffhd-35	172	28	previous	previous	ADJ
ffhd-35	172	29	functional	functional	ADJ
ffhd-35	172	30	foods	food	NOUN
ffhd-35	172	31	in	in	ADP
ffhd-35	172	32	health	health	NOUN
ffhd-35	172	33	and	and	CCONJ
ffhd-35	172	34	disease	disease	NOUN
ffhd-35	172	35	2013	2013	NUM
ffhd-35	172	36	;	;	PUNCT
ffhd-35	172	37	3(11):416	3(11):416	NUM
ffhd-35	172	38	-	-	SYM
ffhd-35	172	39	427	427	NUM
ffhd-35	172	40	page	page	NOUN
ffhd-35	172	41	425	425	NUM
ffhd-35	172	42	of	of	ADP
ffhd-35	172	43	427	427	NUM
ffhd-35	172	44	studies	study	NOUN
ffhd-35	172	45	using	use	VERB
ffhd-35	172	46	whole	whole	NOUN
ffhd-35	172	47	,	,	PUNCT
ffhd-35	172	48	ground	ground	NOUN
ffhd-35	172	49	dg	dg	NOUN
ffhd-35	172	50	,	,	PUNCT
ffhd-35	172	51	thus	thus	ADV
ffhd-35	172	52	conferring	confer	VERB
ffhd-35	172	53	a	a	DET
ffhd-35	172	54	superior	superior	ADJ
ffhd-35	172	55	anti	anti	ADJ
ffhd-35	172	56	-	-	ADJ
ffhd-35	172	57	atherogenic	atherogenic	ADJ
ffhd-35	172	58	capacity	capacity	NOUN
ffhd-35	172	59	on	on	ADP
ffhd-35	172	60	dyglomera	dyglomera	NOUN
ffhd-35	172	61	®	®	NOUN
ffhd-35	172	62	.	.	PUNCT
ffhd-35	173	1	competing	compete	VERB
ffhd-35	173	2	interests	interest	NOUN
ffhd-35	173	3	the	the	DET
ffhd-35	173	4	authors	author	NOUN
ffhd-35	173	5	declare	declare	VERB
ffhd-35	173	6	that	that	SCONJ
ffhd-35	173	7	they	they	PRON
ffhd-35	173	8	have	have	VERB
ffhd-35	173	9	no	no	DET
ffhd-35	173	10	competing	compete	VERB
ffhd-35	173	11	interests	interest	NOUN
ffhd-35	173	12	.	.	PUNCT
ffhd-35	174	1	authors	author	NOUN
ffhd-35	174	2	’	'	PUNCT
ffhd-35	174	3	contributions	contribution	NOUN
ffhd-35	174	4	julius	julius	PROPN
ffhd-35	174	5	oben	oben	NOUN
ffhd-35	174	6	conceived	conceive	VERB
ffhd-35	174	7	and	and	CCONJ
ffhd-35	174	8	coordinated	coordinate	VERB
ffhd-35	174	9	the	the	DET
ffhd-35	174	10	study	study	NOUN
ffhd-35	174	11	,	,	PUNCT
ffhd-35	174	12	and	and	CCONJ
ffhd-35	174	13	prepared	prepare	VERB
ffhd-35	174	14	the	the	DET
ffhd-35	174	15	manuscript	manuscript	NOUN
ffhd-35	174	16	.	.	PUNCT
ffhd-35	175	1	ngondi	ngondi	PROPN
ffhd-35	175	2	judith	judith	PROPN
ffhd-35	175	3	laure	laure	PROPN
ffhd-35	175	4	co	co	PROPN
ffhd-35	175	5	-	-	VERB
ffhd-35	175	6	designed	design	VERB
ffhd-35	175	7	and	and	CCONJ
ffhd-35	175	8	worked	work	VERB
ffhd-35	175	9	on	on	ADP
ffhd-35	175	10	the	the	DET
ffhd-35	175	11	initial	initial	ADJ
ffhd-35	175	12	draft	draft	NOUN
ffhd-35	175	13	of	of	ADP
ffhd-35	175	14	the	the	DET
ffhd-35	175	15	manuscript	manuscript	NOUN
ffhd-35	175	16	.	.	PUNCT
ffhd-35	176	1	dieudonne	dieudonne	PROPN
ffhd-35	176	2	kuate	kuate	PROPN
ffhd-35	176	3	carried	carry	VERB
ffhd-35	176	4	out	out	ADP
ffhd-35	176	5	anthropometric	anthropometric	ADJ
ffhd-35	176	6	measurements	measurement	NOUN
ffhd-35	176	7	,	,	PUNCT
ffhd-35	176	8	analytical	analytical	ADJ
ffhd-35	176	9	work	work	NOUN
ffhd-35	176	10	,	,	PUNCT
ffhd-35	176	11	statistical	statistical	ADJ
ffhd-35	176	12	analyses	analysis	NOUN
ffhd-35	176	13	and	and	CCONJ
ffhd-35	176	14	prepared	prepare	VERB
ffhd-35	176	15	the	the	DET
ffhd-35	176	16	draft	draft	NOUN
ffhd-35	176	17	of	of	ADP
ffhd-35	176	18	the	the	DET
ffhd-35	176	19	manuscript	manuscript	NOUN
ffhd-35	176	20	.	.	PUNCT
ffhd-35	177	1	blanche	blanche	PROPN
ffhd-35	177	2	co	co	PROPN
ffhd-35	177	3	etoundi	etoundi	NOUN
ffhd-35	177	4	carried	carry	VERB
ffhd-35	177	5	out	out	ADP
ffhd-35	177	6	anthropometric	anthropometric	ADJ
ffhd-35	177	7	measurements	measurement	NOUN
ffhd-35	177	8	,	,	PUNCT
ffhd-35	177	9	analytical	analytical	ADJ
ffhd-35	177	10	work	work	NOUN
ffhd-35	177	11	and	and	CCONJ
ffhd-35	177	12	processed	process	VERB
ffhd-35	177	13	results	result	NOUN
ffhd-35	177	14	.	.	PUNCT
ffhd-35	178	1	all	all	DET
ffhd-35	178	2	authors	author	NOUN
ffhd-35	178	3	read	read	VERB
ffhd-35	178	4	and	and	CCONJ
ffhd-35	178	5	approved	approve	VERB
ffhd-35	178	6	the	the	DET
ffhd-35	178	7	final	final	ADJ
ffhd-35	178	8	manuscript	manuscript	NOUN
ffhd-35	178	9	.	.	PUNCT
ffhd-35	179	1	references	reference	NOUN
ffhd-35	179	2	:	:	PUNCT
ffhd-35	179	3	1	1	X
ffhd-35	179	4	.	.	X
ffhd-35	179	5	centers	center	NOUN
ffhd-35	179	6	for	for	ADP
ffhd-35	179	7	disease	disease	NOUN
ffhd-35	179	8	control	control	NOUN
ffhd-35	179	9	and	and	CCONJ
ffhd-35	179	10	prevention	prevention	NOUN
ffhd-35	179	11	(	(	PUNCT
ffhd-35	179	12	cdc	cdc	PROPN
ffhd-35	179	13	)	)	PUNCT
ffhd-35	179	14	.	.	PUNCT
ffhd-35	180	1	behavioral	behavioral	ADJ
ffhd-35	180	2	risk	risk	NOUN
ffhd-35	180	3	factor	factor	NOUN
ffhd-35	180	4	surveillance	surveillance	NOUN
ffhd-35	180	5	system	system	NOUN
ffhd-35	180	6	survey	survey	NOUN
ffhd-35	180	7	data	data	PROPN
ffhd-35	180	8	.	.	PUNCT
ffhd-35	181	1	atlanta	atlanta	PROPN
ffhd-35	181	2	,	,	PUNCT
ffhd-35	181	3	georgia	georgia	PROPN
ffhd-35	181	4	:	:	PUNCT
ffhd-35	181	5	u.s	u.s	PROPN
ffhd-35	181	6	.	.	PROPN
ffhd-35	181	7	department	department	PROPN
ffhd-35	181	8	of	of	ADP
ffhd-35	181	9	health	health	PROPN
ffhd-35	181	10	and	and	CCONJ
ffhd-35	181	11	human	human	PROPN
ffhd-35	181	12	services	service	NOUN
ffhd-35	181	13	,	,	PUNCT
ffhd-35	181	14	centers	center	NOUN
ffhd-35	181	15	for	for	ADP
ffhd-35	181	16	disease	disease	NOUN
ffhd-35	181	17	control	control	NOUN
ffhd-35	181	18	and	and	CCONJ
ffhd-35	181	19	prevention	prevention	NOUN
ffhd-35	181	20	,	,	PUNCT
ffhd-35	181	21	2010	2010	NUM
ffhd-35	181	22	.	.	PUNCT
ffhd-35	182	1	2	2	NUM
ffhd-35	182	2	.	.	X
ffhd-35	182	3	eckel	eckel	PROPN
ffhd-35	182	4	rh	rh	PROPN
ffhd-35	182	5	,	,	PUNCT
ffhd-35	182	6	grundy	grundy	PROPN
ffhd-35	182	7	sm	sm	PROPN
ffhd-35	182	8	,	,	PUNCT
ffhd-35	182	9	zimmet	zimmet	NOUN
ffhd-35	182	10	pz	pz	NOUN
ffhd-35	182	11	.	.	PUNCT
ffhd-35	183	1	the	the	DET
ffhd-35	183	2	metabolic	metabolic	NOUN
ffhd-35	183	3	syndrome	syndrome	NOUN
ffhd-35	183	4	.	.	PUNCT
ffhd-35	184	1	lancet	lancet	PROPN
ffhd-35	184	2	2005	2005	NUM
ffhd-35	184	3	;	;	PUNCT
ffhd-35	184	4	365	365	NUM
ffhd-35	184	5	:	:	PUNCT
ffhd-35	184	6	1415–28	1415–28	NUM
ffhd-35	184	7	.	.	PUNCT
ffhd-35	185	1	3	3	X
ffhd-35	185	2	.	.	X
ffhd-35	185	3	ritchie	ritchie	PROPN
ffhd-35	185	4	sa	sa	PROPN
ffhd-35	185	5	,	,	PUNCT
ffhd-35	185	6	connell	connell	PROPN
ffhd-35	185	7	jmc	jmc	PROPN
ffhd-35	185	8	.	.	PUNCT
ffhd-35	186	1	the	the	DET
ffhd-35	186	2	link	link	NOUN
ffhd-35	186	3	between	between	ADP
ffhd-35	186	4	abdominal	abdominal	ADJ
ffhd-35	186	5	obesity	obesity	NOUN
ffhd-35	186	6	,	,	PUNCT
ffhd-35	186	7	metabolic	metabolic	NOUN
ffhd-35	186	8	syndrome	syndrome	NOUN
ffhd-35	186	9	and	and	CCONJ
ffhd-35	186	10	cardiovascular	cardiovascular	ADJ
ffhd-35	186	11	disease	disease	NOUN
ffhd-35	186	12	.	.	PUNCT
ffhd-35	187	1	nutr	nutr	PROPN
ffhd-35	187	2	metabol	metabol	PROPN
ffhd-35	187	3	cardiovasc	cardiovasc	PROPN
ffhd-35	187	4	dis	dis	PROPN
ffhd-35	187	5	2007	2007	NUM
ffhd-35	187	6	;	;	PUNCT
ffhd-35	187	7	17:319	17:319	PROPN
ffhd-35	187	8	-	-	SYM
ffhd-35	187	9	26	26	NUM
ffhd-35	187	10	.	.	PUNCT
ffhd-35	188	1	4	4	NUM
ffhd-35	188	2	.	.	X
ffhd-35	188	3	kadowaki	kadowaki	PROPN
ffhd-35	188	4	t	t	PROPN
ffhd-35	188	5	,	,	PUNCT
ffhd-35	188	6	yamauchi	yamauchi	PROPN
ffhd-35	188	7	t	t	PROPN
ffhd-35	188	8	,	,	PUNCT
ffhd-35	188	9	kubota	kubota	PROPN
ffhd-35	188	10	n	n	CCONJ
ffhd-35	188	11	,	,	PUNCT
ffhd-35	188	12	hara	hara	PROPN
ffhd-35	188	13	k	k	PROPN
ffhd-35	188	14	,	,	PUNCT
ffhd-35	188	15	ueki	ueki	PROPN
ffhd-35	188	16	k	k	PROPN
ffhd-35	188	17	,	,	PUNCT
ffhd-35	188	18	tobe	tobe	PROPN
ffhd-35	188	19	k.	k.	PROPN
ffhd-35	188	20	adiponectin	adiponectin	NOUN
ffhd-35	188	21	and	and	CCONJ
ffhd-35	188	22	adiponectin	adiponectin	NOUN
ffhd-35	188	23	receptors	receptor	NOUN
ffhd-35	188	24	in	in	ADP
ffhd-35	188	25	insulin	insulin	NOUN
ffhd-35	188	26	resistance	resistance	NOUN
ffhd-35	188	27	,	,	PUNCT
ffhd-35	188	28	diabetes	diabetes	NOUN
ffhd-35	188	29	,	,	PUNCT
ffhd-35	188	30	and	and	CCONJ
ffhd-35	188	31	the	the	DET
ffhd-35	188	32	metabolic	metabolic	NOUN
ffhd-35	188	33	syndrome	syndrome	NOUN
ffhd-35	188	34	.	.	PUNCT
ffhd-35	189	1	j	j	PROPN
ffhd-35	189	2	clin	clin	PROPN
ffhd-35	189	3	invest	invest	VERB
ffhd-35	189	4	2006	2006	NUM
ffhd-35	189	5	;	;	PUNCT
ffhd-35	189	6	116:1784–92	116:1784–92	NUM
ffhd-35	189	7	.	.	NOUN
ffhd-35	190	1	5	5	NUM
ffhd-35	190	2	.	.	X
ffhd-35	190	3	galiste	galiste	PROPN
ffhd-35	190	4	m	m	PROPN
ffhd-35	190	5	,	,	PUNCT
ffhd-35	190	6	duarte	duarte	PROPN
ffhd-35	190	7	j	j	PROPN
ffhd-35	190	8	,	,	PUNCT
ffhd-35	190	9	zarzuel	zarzuel	PROPN
ffhd-35	190	10	a.	a.	NOUN
ffhd-35	190	11	effects	effect	NOUN
ffhd-35	190	12	of	of	ADP
ffhd-35	190	13	dietary	dietary	ADJ
ffhd-35	190	14	fibers	fiber	NOUN
ffhd-35	190	15	on	on	ADP
ffhd-35	190	16	disturbances	disturbance	NOUN
ffhd-35	190	17	clustered	cluster	VERB
ffhd-35	190	18	in	in	ADP
ffhd-35	190	19	the	the	DET
ffhd-35	190	20	metabolic	metabolic	NOUN
ffhd-35	190	21	syndrome	syndrome	NOUN
ffhd-35	190	22	.	.	PUNCT
ffhd-35	191	1	j	j	PROPN
ffhd-35	191	2	nutr	nutr	PROPN
ffhd-35	191	3	biochem	biochem	PROPN
ffhd-35	191	4	2008	2008	NUM
ffhd-35	191	5	;	;	PUNCT
ffhd-35	191	6	19:71–84	19:71–84	NOUN
ffhd-35	191	7	.	.	PUNCT
ffhd-35	192	1	6	6	NUM
ffhd-35	192	2	.	.	X
ffhd-35	192	3	valsamakis	valsamakis	PROPN
ffhd-35	192	4	g	g	NOUN
ffhd-35	192	5	,	,	PUNCT
ffhd-35	192	6	mcternan	mcternan	NOUN
ffhd-35	192	7	p	p	NOUN
ffhd-35	192	8	,	,	PUNCT
ffhd-35	192	9	chetty	chetty	ADJ
ffhd-35	192	10	r	r	NOUN
ffhd-35	192	11	,	,	PUNCT
ffhd-35	192	12	al	al	PROPN
ffhd-35	192	13	daghri	daghri	PROPN
ffhd-35	192	14	n	n	CCONJ
ffhd-35	192	15	,	,	PUNCT
ffhd-35	192	16	field	field	NOUN
ffhd-35	192	17	a	a	PRON
ffhd-35	192	18	,	,	PUNCT
ffhd-35	192	19	hanif	hanif	PROPN
ffhd-35	192	20	w	w	PROPN
ffhd-35	192	21	,	,	PUNCT
ffhd-35	192	22	barnett	barnett	PROPN
ffhd-35	192	23	a	a	X
ffhd-35	192	24	,	,	PUNCT
ffhd-35	192	25	and	and	CCONJ
ffhd-35	192	26	kumar	kumar	PROPN
ffhd-35	192	27	s.	s.	PROPN
ffhd-35	192	28	modest	modest	ADJ
ffhd-35	192	29	weight	weight	NOUN
ffhd-35	192	30	loss	loss	NOUN
ffhd-35	192	31	and	and	CCONJ
ffhd-35	192	32	reduction	reduction	NOUN
ffhd-35	192	33	in	in	ADP
ffhd-35	192	34	waist	waist	NOUN
ffhd-35	192	35	circumference	circumference	NOUN
ffhd-35	192	36	after	after	SCONJ
ffhd-35	192	37	medical	medical	ADJ
ffhd-35	192	38	treatment	treatment	NOUN
ffhd-35	192	39	are	be	AUX
ffhd-35	192	40	associated	associate	VERB
ffhd-35	192	41	with	with	ADP
ffhd-35	192	42	favorable	favorable	ADJ
ffhd-35	192	43	changes	change	NOUN
ffhd-35	192	44	in	in	ADP
ffhd-35	192	45	serum	serum	NOUN
ffhd-35	192	46	adipocytokines	adipocytokine	NOUN
ffhd-35	192	47	.	.	PUNCT
ffhd-35	193	1	metabolism	metabolism	NOUN
ffhd-35	193	2	2004	2004	NUM
ffhd-35	193	3	;	;	PUNCT
ffhd-35	193	4	53:430	53:430	NUM
ffhd-35	193	5	-	-	SYM
ffhd-35	193	6	34	34	NUM
ffhd-35	193	7	.	.	NOUN
ffhd-35	193	8	7	7	X
ffhd-35	193	9	.	.	X
ffhd-35	193	10	national	national	PROPN
ffhd-35	193	11	task	task	PROPN
ffhd-35	193	12	force	force	NOUN
ffhd-35	193	13	on	on	ADP
ffhd-35	193	14	the	the	DET
ffhd-35	193	15	prevention	prevention	NOUN
ffhd-35	193	16	and	and	CCONJ
ffhd-35	193	17	treatment	treatment	NOUN
ffhd-35	193	18	of	of	ADP
ffhd-35	193	19	obesity	obesity	NOUN
ffhd-35	193	20	.	.	PUNCT
ffhd-35	194	1	long	long	ADJ
ffhd-35	194	2	term	term	NOUN
ffhd-35	194	3	pharmacotherapy	pharmacotherapy	NOUN
ffhd-35	194	4	in	in	ADP
ffhd-35	194	5	the	the	DET
ffhd-35	194	6	management	management	NOUN
ffhd-35	194	7	of	of	ADP
ffhd-35	194	8	obesity	obesity	NOUN
ffhd-35	194	9	.	.	PUNCT
ffhd-35	195	1	jama	jama	PROPN
ffhd-35	195	2	1996	1996	NUM
ffhd-35	195	3	;	;	PUNCT
ffhd-35	195	4	276:1907–15	276:1907–15	NUM
ffhd-35	195	5	.	.	NOUN
ffhd-35	195	6	8	8	NUM
ffhd-35	195	7	.	.	X
ffhd-35	195	8	bray	bray	PROPN
ffhd-35	195	9	ga	ga	PROPN
ffhd-35	195	10	,	,	PUNCT
ffhd-35	195	11	blackburn	blackburn	PROPN
ffhd-35	195	12	gl	gl	PROPN
ffhd-35	195	13	,	,	PUNCT
ffhd-35	195	14	ferguson	ferguson	PROPN
ffhd-35	195	15	jm	jm	PROPN
ffhd-35	195	16	,	,	PUNCT
ffhd-35	195	17	greenway	greenway	PROPN
ffhd-35	195	18	fl	fl	PROPN
ffhd-35	195	19	,	,	PUNCT
ffhd-35	195	20	jain	jain	PROPN
ffhd-35	195	21	ak	ak	PROPN
ffhd-35	195	22	,	,	PUNCT
ffhd-35	195	23	mendel	mendel	PROPN
ffhd-35	195	24	cm	cm	PROPN
ffhd-35	195	25	,	,	PUNCT
ffhd-35	195	26	mendels	mendel	VERB
ffhd-35	195	27	j	j	PROPN
ffhd-35	195	28	,	,	PUNCT
ffhd-35	195	29	ryan	ryan	PROPN
ffhd-35	195	30	dh	dh	PROPN
ffhd-35	195	31	,	,	PUNCT
ffhd-35	195	32	schwartz	schwartz	PROPN
ffhd-35	195	33	sl	sl	PROPN
ffhd-35	195	34	,	,	PUNCT
ffhd-35	195	35	scheinbaum	scheinbaum	PROPN
ffhd-35	195	36	ml	ml	PROPN
ffhd-35	195	37	,	,	PUNCT
ffhd-35	196	1	seaton	seaton	PROPN
ffhd-35	196	2	tb	tb	PROPN
ffhd-35	196	3	.	.	PROPN
ffhd-35	196	4	sibutramine	sibutramine	NOUN
ffhd-35	196	5	produces	produce	VERB
ffhd-35	196	6	dose	dose	NOUN
ffhd-35	196	7	-	-	PUNCT
ffhd-35	196	8	related	relate	VERB
ffhd-35	196	9	weight	weight	NOUN
ffhd-35	196	10	loss	loss	NOUN
ffhd-35	196	11	.	.	PUNCT
ffhd-35	197	1	obes	obes	PROPN
ffhd-35	197	2	res	re	NOUN
ffhd-35	197	3	relat	relat	PROPN
ffhd-35	197	4	metab	metab	PROPN
ffhd-35	197	5	disord	disord	NOUN
ffhd-35	197	6	1999	1999	NUM
ffhd-35	197	7	;	;	PUNCT
ffhd-35	197	8	7	7	NUM
ffhd-35	197	9	:	:	SYM
ffhd-35	197	10	189–98	189–98	NUM
ffhd-35	197	11	.	.	PUNCT
ffhd-35	198	1	9	9	X
ffhd-35	198	2	.	.	X
ffhd-35	198	3	sjöström	sjöström	NOUN
ffhd-35	198	4	l	l	NOUN
ffhd-35	198	5	,	,	PUNCT
ffhd-35	198	6	rissanen	rissanen	NOUN
ffhd-35	198	7	a	a	X
ffhd-35	198	8	,	,	PUNCT
ffhd-35	198	9	andersen	andersen	PROPN
ffhd-35	198	10	t	t	PROPN
ffhd-35	198	11	,	,	PUNCT
ffhd-35	198	12	boldrin	boldrin	PROPN
ffhd-35	198	13	m	m	PROPN
ffhd-35	198	14	,	,	PUNCT
ffhd-35	198	15	golay	golay	VERB
ffhd-35	198	16	a	a	PRON
ffhd-35	198	17	,	,	PUNCT
ffhd-35	198	18	koppeschaar	koppeschaar	PROPN
ffhd-35	198	19	hp	hp	PROPN
ffhd-35	198	20	,	,	PUNCT
ffhd-35	198	21	krempf	krempf	NOUN
ffhd-35	198	22	m.	m.	NOUN
ffhd-35	198	23	for	for	ADP
ffhd-35	198	24	the	the	DET
ffhd-35	198	25	european	european	PROPN
ffhd-35	198	26	multicentre	multicentre	PROPN
ffhd-35	198	27	orlistat	orlistat	PROPN
ffhd-35	198	28	study	study	NOUN
ffhd-35	198	29	group	group	NOUN
ffhd-35	198	30	.	.	PUNCT
ffhd-35	199	1	randomised	randomise	VERB
ffhd-35	199	2	placebocontrolled	placebocontrolle	VERB
ffhd-35	199	3	trial	trial	NOUN
ffhd-35	199	4	of	of	ADP
ffhd-35	199	5	orlistat	orlistat	NOUN
ffhd-35	199	6	for	for	ADP
ffhd-35	199	7	weight	weight	NOUN
ffhd-35	199	8	loss	loss	NOUN
ffhd-35	199	9	and	and	CCONJ
ffhd-35	199	10	prevention	prevention	NOUN
ffhd-35	199	11	of	of	ADP
ffhd-35	199	12	weight	weight	NOUN
ffhd-35	199	13	regain	regain	NOUN
ffhd-35	199	14	in	in	ADP
ffhd-35	199	15	obese	obese	ADJ
ffhd-35	199	16	patients	patient	NOUN
ffhd-35	199	17	lancet	lancet	VERB
ffhd-35	199	18	1998	1998	NUM
ffhd-35	199	19	;	;	PUNCT
ffhd-35	199	20	352:167–72	352:167–72	NUM
ffhd-35	199	21	.	.	PUNCT
ffhd-35	200	1	10	10	NUM
ffhd-35	200	2	.	.	PUNCT
ffhd-35	201	1	pari	pari	PROPN
ffhd-35	201	2	l	l	PROPN
ffhd-35	201	3	,	,	PUNCT
ffhd-35	201	4	umamaheswari	umamaheswari	ADJ
ffhd-35	201	5	j.	j.	PROPN
ffhd-35	201	6	antihyperglycaemic	antihyperglycaemic	ADJ
ffhd-35	201	7	activity	activity	NOUN
ffhd-35	201	8	of	of	ADP
ffhd-35	201	9	musa	musa	ADJ
ffhd-35	201	10	sapientum	sapientum	PROPN
ffhd-35	201	11	flowers	flower	NOUN
ffhd-35	201	12	:	:	PUNCT
ffhd-35	201	13	effect	effect	NOUN
ffhd-35	201	14	on	on	ADP
ffhd-35	201	15	lipid	lipid	ADJ
ffhd-35	201	16	peroxidation	peroxidation	NOUN
ffhd-35	201	17	in	in	ADP
ffhd-35	201	18	alloxan	alloxan	NOUN
ffhd-35	201	19	diabetic	diabetic	ADJ
ffhd-35	201	20	rats	rat	NOUN
ffhd-35	201	21	.	.	PUNCT
ffhd-35	202	1	phytother	phytother	PROPN
ffhd-35	202	2	res	re	NOUN
ffhd-35	202	3	2000	2000	NUM
ffhd-35	202	4	;	;	PUNCT
ffhd-35	202	5	14:1	14:1	NUM
ffhd-35	202	6	-	-	SYM
ffhd-35	202	7	3	3	NUM
ffhd-35	202	8	.	.	PUNCT
ffhd-35	203	1	http://www.ncbi.nlm.nih.gov/pubmed?term=%22bray%20ga%22%5bauthor%5d	http://www.ncbi.nlm.nih.gov/pubmed?term=%22bray%20ga%22%5bauthor%5d	NOUN
ffhd-35	203	2	http://www.ncbi.nlm.nih.gov/pubmed?term=%22blackburn%20gl%22%5bauthor%5d	http://www.ncbi.nlm.nih.gov/pubmed?term=%22blackburn%20gl%22%5bauthor%5d	PRON
ffhd-35	203	3	functional	functional	ADJ
ffhd-35	203	4	foods	food	NOUN
ffhd-35	203	5	in	in	ADP
ffhd-35	203	6	health	health	NOUN
ffhd-35	203	7	and	and	CCONJ
ffhd-35	203	8	disease	disease	NOUN
ffhd-35	203	9	2013	2013	NUM
ffhd-35	203	10	;	;	PUNCT
ffhd-35	203	11	3(11):416	3(11):416	NUM
ffhd-35	203	12	-	-	SYM
ffhd-35	203	13	427	427	NUM
ffhd-35	203	14	page	page	NOUN
ffhd-35	203	15	426	426	NUM
ffhd-35	203	16	of	of	ADP
ffhd-35	203	17	427	427	NUM
ffhd-35	203	18	11	11	NUM
ffhd-35	203	19	.	.	PUNCT
ffhd-35	204	1	valiathan	valiathan	PROPN
ffhd-35	204	2	ms	ms	PROPN
ffhd-35	204	3	,	,	PUNCT
ffhd-35	204	4	healing	heal	VERB
ffhd-35	204	5	plants	plant	NOUN
ffhd-35	204	6	.	.	PUNCT
ffhd-35	205	1	current	current	ADJ
ffhd-35	205	2	science	science	NOUN
ffhd-35	205	3	1998	1998	NUM
ffhd-35	205	4	;	;	PUNCT
ffhd-35	205	5	75:1122–27	75:1122–27	X
ffhd-35	205	6	.	.	NOUN
ffhd-35	205	7	12	12	NUM
ffhd-35	205	8	.	.	PUNCT
ffhd-35	206	1	tchiégang	tchiégang	PROPN
ffhd-35	206	2	c	c	PROPN
ffhd-35	206	3	,	,	PUNCT
ffhd-35	206	4	mbougueng	mbougueng	PROPN
ffhd-35	206	5	pd	pd	PROPN
ffhd-35	206	6	.	.	PROPN
ffhd-35	206	7	chemical	chemical	PROPN
ffhd-35	206	8	composition	composition	NOUN
ffhd-35	206	9	of	of	ADP
ffhd-35	206	10	spices	spice	NOUN
ffhd-35	206	11	used	use	VERB
ffhd-35	206	12	in	in	ADP
ffhd-35	206	13	the	the	DET
ffhd-35	206	14	cooking	cooking	NOUN
ffhd-35	206	15	of	of	ADP
ffhd-35	206	16	nah	nah	INTJ
ffhd-35	206	17	poh	poh	PROPN
ffhd-35	206	18	and	and	CCONJ
ffhd-35	206	19	nkui	nkui	NOUN
ffhd-35	206	20	of	of	ADP
ffhd-35	206	21	western	western	ADJ
ffhd-35	206	22	cameroon	cameroon	PROPN
ffhd-35	206	23	.	.	PUNCT
ffhd-35	207	1	tropicultura	tropicultura	NOUN
ffhd-35	207	2	2005	2005	NUM
ffhd-35	207	3	;	;	PUNCT
ffhd-35	207	4	23:193–200	23:193–200	NUM
ffhd-35	207	5	.	.	PUNCT
ffhd-35	208	1	13	13	NUM
ffhd-35	208	2	.	.	PUNCT
ffhd-35	209	1	roth	roth	PROPN
ffhd-35	209	2	lw	lw	PROPN
ffhd-35	209	3	,	,	PUNCT
ffhd-35	209	4	keller	keller	PROPN
ffhd-35	209	5	f	f	PROPN
ffhd-35	209	6	,	,	PUNCT
ffhd-35	209	7	u.s	u.s	PROPN
ffhd-35	209	8	.	.	PROPN
ffhd-35	209	9	patent	patent	NOUN
ffhd-35	209	10	3,089,817	3,089,817	NUM
ffhd-35	209	11	,	,	PUNCT
ffhd-35	209	12	1963	1963	NUM
ffhd-35	209	13	.	.	PUNCT
ffhd-35	210	1	14	14	NUM
ffhd-35	210	2	.	.	PUNCT
ffhd-35	210	3	fankam	fankam	PROPN
ffhd-35	210	4	ag	ag	PROPN
ffhd-35	210	5	,	,	PUNCT
ffhd-35	210	6	kuete	kuete	ADJ
ffhd-35	210	7	v	v	NOUN
ffhd-35	210	8	,	,	PUNCT
ffhd-35	210	9	voukeng	voukeng	PROPN
ffhd-35	210	10	ik	ik	PROPN
ffhd-35	210	11	,	,	PUNCT
ffhd-35	210	12	kuiate	kuiate	PROPN
ffhd-35	210	13	jr	jr	PROPN
ffhd-35	210	14	,	,	PUNCT
ffhd-35	210	15	pages	page	NOUN
ffhd-35	210	16	jm	jm	PROPN
ffhd-35	210	17	.	.	PROPN
ffhd-35	210	18	antibacterial	antibacterial	ADJ
ffhd-35	210	19	activities	activity	NOUN
ffhd-35	210	20	of	of	ADP
ffhd-35	210	21	selected	select	VERB
ffhd-35	210	22	cameroonian	cameroonian	ADJ
ffhd-35	210	23	spices	spice	NOUN
ffhd-35	210	24	and	and	CCONJ
ffhd-35	210	25	their	their	PRON
ffhd-35	210	26	synergistic	synergistic	ADJ
ffhd-35	210	27	effects	effect	NOUN
ffhd-35	210	28	with	with	ADP
ffhd-35	210	29	antibiotics	antibiotic	NOUN
ffhd-35	210	30	against	against	ADP
ffhd-35	210	31	multidrug	multidrug	NOUN
ffhd-35	210	32	-	-	PUNCT
ffhd-35	210	33	resistant	resistant	ADJ
ffhd-35	210	34	phenotypes	phenotype	NOUN
ffhd-35	210	35	.	.	PUNCT
ffhd-35	211	1	bmc	bmc	ADJ
ffhd-35	211	2	complementary	complementary	ADJ
ffhd-35	211	3	and	and	CCONJ
ffhd-35	211	4	alternative	alternative	ADJ
ffhd-35	211	5	medicine	medicine	NOUN
ffhd-35	211	6	2011	2011	NUM
ffhd-35	211	7	;	;	PUNCT
ffhd-35	211	8	11:104	11:104	NUM
ffhd-35	211	9	.	.	PROPN
ffhd-35	211	10	doi:10.1186	doi:10.1186	VERB
ffhd-35	211	11	/1472	/1472	X
ffhd-35	211	12	-	-	SYM
ffhd-35	211	13	6882	6882	NUM
ffhd-35	211	14	-	-	SYM
ffhd-35	211	15	11104	11104	NUM
ffhd-35	211	16	.	.	PUNCT
ffhd-35	212	1	15	15	NUM
ffhd-35	212	2	.	.	PUNCT
ffhd-35	212	3	atsang	atsang	PROPN
ffhd-35	212	4	akg	akg	PROPN
ffhd-35	212	5	,	,	PUNCT
ffhd-35	212	6	dzeufiet	dzeufiet	ADJ
ffhd-35	212	7	dpd	dpd	PROPN
ffhd-35	212	8	,	,	PUNCT
ffhd-35	212	9	foyet	foyet	NOUN
ffhd-35	212	10	hs	hs	PROPN
ffhd-35	212	11	,	,	PUNCT
ffhd-35	212	12	nana	nana	PROPN
ffhd-35	212	13	p	p	PROPN
ffhd-35	212	14	,	,	PUNCT
ffhd-35	212	15	sokeng	sokeng	PROPN
ffhd-35	212	16	ds	ds	PROPN
ffhd-35	212	17	,	,	PUNCT
ffhd-35	212	18	dimo	dimo	PROPN
ffhd-35	212	19	t	t	PROPN
ffhd-35	212	20	,	,	PUNCT
ffhd-35	212	21	kamtchouing	kamtchoue	VERB
ffhd-35	212	22	p.	p.	NOUN
ffhd-35	212	23	analgesic	analgesic	ADJ
ffhd-35	212	24	and	and	CCONJ
ffhd-35	212	25	anti	anti	ADJ
ffhd-35	212	26	-	-	ADJ
ffhd-35	212	27	inflammatory	inflammatory	ADJ
ffhd-35	212	28	activities	activity	NOUN
ffhd-35	212	29	of	of	ADP
ffhd-35	212	30	dichrostachys	dichrostachy	NOUN
ffhd-35	212	31	glomerata	glomerata	NOUN
ffhd-35	212	32	(	(	PUNCT
ffhd-35	212	33	forssk	forssk	NOUN
ffhd-35	212	34	.	.	PUNCT
ffhd-35	212	35	)	)	PUNCT
ffhd-35	212	36	hutch	hutch	NOUN
ffhd-35	212	37	.	.	PUNCT
ffhd-35	213	1	fruits	fruit	NOUN
ffhd-35	213	2	methanolic	methanolic	NOUN
ffhd-35	213	3	extract	extract	VERB
ffhd-35	213	4	in	in	ADP
ffhd-35	213	5	rats	rat	NOUN
ffhd-35	213	6	.	.	PUNCT
ffhd-35	214	1	j	j	PROPN
ffhd-35	214	2	phys	phy	NOUN
ffhd-35	214	3	pharm	pharm	VERB
ffhd-35	214	4	adv	adv	PROPN
ffhd-35	214	5	2012	2012	NUM
ffhd-35	214	6	;	;	PUNCT
ffhd-35	214	7	2(8	2(8	NUM
ffhd-35	214	8	):	):	PUNCT
ffhd-35	214	9	269	269	NUM
ffhd-35	214	10	-	-	SYM
ffhd-35	214	11	276	276	NUM
ffhd-35	214	12	16	16	NUM
ffhd-35	214	13	.	.	PUNCT
ffhd-35	215	1	kudi	kudi	PROPN
ffhd-35	215	2	ac	ac	PROPN
ffhd-35	215	3	,	,	PUNCT
ffhd-35	215	4	umoh	umoh	PROPN
ffhd-35	215	5	ju	ju	PROPN
ffhd-35	215	6	,	,	PUNCT
ffhd-35	215	7	eduvie	eduvie	PROPN
ffhd-35	215	8	lo	lo	PROPN
ffhd-35	215	9	,	,	PUNCT
ffhd-35	215	10	gefu	gefu	PROPN
ffhd-35	215	11	j.	j.	PROPN
ffhd-35	215	12	screening	screening	NOUN
ffhd-35	215	13	of	of	ADP
ffhd-35	215	14	some	some	DET
ffhd-35	215	15	nigerian	nigerian	ADJ
ffhd-35	215	16	medicinal	medicinal	ADJ
ffhd-35	215	17	plants	plant	NOUN
ffhd-35	215	18	for	for	ADP
ffhd-35	215	19	antibacterial	antibacterial	ADJ
ffhd-35	215	20	activity	activity	NOUN
ffhd-35	215	21	.	.	PUNCT
ffhd-35	216	1	j	j	PROPN
ffhd-35	216	2	ethnopharm	ethnopharm	PROPN
ffhd-35	216	3	1999	1999	NUM
ffhd-35	216	4	;	;	PUNCT
ffhd-35	216	5	67(2	67(2	NUM
ffhd-35	216	6	):	):	PUNCT
ffhd-35	216	7	225	225	NUM
ffhd-35	216	8	-	-	SYM
ffhd-35	216	9	228	228	NUM
ffhd-35	216	10	.	.	PUNCT
ffhd-35	217	1	17	17	NUM
ffhd-35	217	2	.	.	PUNCT
ffhd-35	218	1	kuate	kuate	PROPN
ffhd-35	218	2	d	d	PROPN
ffhd-35	218	3	,	,	PUNCT
ffhd-35	218	4	etoundi	etoundi	ADJ
ffhd-35	218	5	bco	bco	NOUN
ffhd-35	218	6	,	,	PUNCT
ffhd-35	218	7	soukontoua	soukontoua	PROPN
ffhd-35	218	8	yb	yb	PROPN
ffhd-35	218	9	,	,	PUNCT
ffhd-35	218	10	ngondi	ngondi	ADJ
ffhd-35	218	11	jl	jl	PROPN
ffhd-35	218	12	,	,	PUNCT
ffhd-35	218	13	oben	oben	PROPN
ffhd-35	218	14	je	je	PROPN
ffhd-35	218	15	.	.	PUNCT
ffhd-35	218	16	antioxidant	antioxidant	PROPN
ffhd-35	218	17	characteristics	characteristic	NOUN
ffhd-35	218	18	of	of	ADP
ffhd-35	218	19	dichrostachys	dichrostachys	PROPN
ffhd-35	218	20	glomerata	glomerata	NOUN
ffhd-35	218	21	spice	spice	NOUN
ffhd-35	218	22	extracts	extract	NOUN
ffhd-35	218	23	.	.	PUNCT
ffhd-35	219	1	cyta	cyta	NOUN
ffhd-35	219	2	-	-	PUNCT
ffhd-35	219	3	journal	journal	NOUN
ffhd-35	219	4	of	of	ADP
ffhd-35	219	5	food	food	NOUN
ffhd-35	219	6	2010	2010	NUM
ffhd-35	219	7	;	;	PUNCT
ffhd-35	219	8	8:23–37	8:23–37	NOUN
ffhd-35	219	9	.	.	PUNCT
ffhd-35	220	1	18	18	NUM
ffhd-35	220	2	.	.	X
ffhd-35	220	3	kuate	kuate	PROPN
ffhd-35	220	4	,	,	PUNCT
ffhd-35	220	5	d.	d.	PROPN
ffhd-35	220	6	effects	effect	NOUN
ffhd-35	220	7	of	of	ADP
ffhd-35	220	8	some	some	DET
ffhd-35	220	9	spices	spice	NOUN
ffhd-35	220	10	on	on	ADP
ffhd-35	220	11	glucose	glucose	NOUN
ffhd-35	220	12	and	and	CCONJ
ffhd-35	220	13	lipid	lipid	NOUN
ffhd-35	220	14	metabolism	metabolism	NOUN
ffhd-35	220	15	and	and	CCONJ
ffhd-35	220	16	oxidative	oxidative	ADJ
ffhd-35	220	17	stress	stress	NOUN
ffhd-35	220	18	.	.	PUNCT
ffhd-35	221	1	ph.d	ph.d	PROPN
ffhd-35	221	2	.	.	PUNCT
ffhd-35	222	1	thesis	thesis	NOUN
ffhd-35	222	2	,	,	PUNCT
ffhd-35	222	3	university	university	PROPN
ffhd-35	222	4	of	of	ADP
ffhd-35	222	5	yaounde	yaounde	PROPN
ffhd-35	222	6	,	,	PUNCT
ffhd-35	222	7	yaounde	yaounde	PROPN
ffhd-35	222	8	,	,	PUNCT
ffhd-35	222	9	cameroon	cameroon	PROPN
ffhd-35	222	10	.	.	PUNCT
ffhd-35	223	1	2010	2010	NUM
ffhd-35	223	2	.	.	PUNCT
ffhd-35	224	1	19	19	NUM
ffhd-35	224	2	.	.	X
ffhd-35	224	3	kuate	kuate	PROPN
ffhd-35	224	4	d	d	PROPN
ffhd-35	224	5	,	,	PUNCT
ffhd-35	224	6	etoundi	etoundi	PROPN
ffhd-35	224	7	bc	bc	PROPN
ffhd-35	224	8	,	,	PUNCT
ffhd-35	224	9	ngondi	ngondi	ADJ
ffhd-35	224	10	jl	jl	PROPN
ffhd-35	224	11	,	,	PUNCT
ffhd-35	224	12	oben	oben	PROPN
ffhd-35	224	13	je	je	PROPN
ffhd-35	224	14	.	.	PUNCT
ffhd-35	225	1	effects	effect	NOUN
ffhd-35	225	2	of	of	ADP
ffhd-35	225	3	dichrostachys	dichrostachys	PROPN
ffhd-35	225	4	glomerata	glomerata	NOUN
ffhd-35	225	5	spice	spice	NOUN
ffhd-35	225	6	on	on	ADP
ffhd-35	225	7	cardiovascular	cardiovascular	ADJ
ffhd-35	225	8	diseases	disease	NOUN
ffhd-35	225	9	risk	risk	NOUN
ffhd-35	225	10	factors	factor	NOUN
ffhd-35	225	11	in	in	ADP
ffhd-35	225	12	normoglycemic	normoglycemic	NOUN
ffhd-35	225	13	and	and	CCONJ
ffhd-35	225	14	type	type	NOUN
ffhd-35	225	15	2	2	NUM
ffhd-35	225	16	diabetic	diabetic	ADJ
ffhd-35	225	17	obese	obese	NOUN
ffhd-35	225	18	volunteers	volunteer	NOUN
ffhd-35	225	19	.	.	PUNCT
ffhd-35	226	1	food	food	NOUN
ffhd-35	226	2	res	re	NOUN
ffhd-35	226	3	int	int	NOUN
ffhd-35	226	4	2011	2011	NUM
ffhd-35	226	5	;	;	PUNCT
ffhd-35	226	6	44:1197	44:1197	X
ffhd-35	226	7	-	-	SYM
ffhd-35	226	8	02	02	NUM
ffhd-35	226	9	.	.	NOUN
ffhd-35	226	10	20	20	NUM
ffhd-35	226	11	.	.	PUNCT
ffhd-35	227	1	executive	executive	ADJ
ffhd-35	227	2	summary	summary	NOUN
ffhd-35	227	3	of	of	ADP
ffhd-35	227	4	the	the	DET
ffhd-35	227	5	third	third	ADJ
ffhd-35	227	6	report	report	NOUN
ffhd-35	227	7	of	of	ADP
ffhd-35	227	8	the	the	DET
ffhd-35	227	9	national	national	ADJ
ffhd-35	227	10	cholesterol	cholesterol	PROPN
ffhd-35	227	11	education	education	NOUN
ffhd-35	227	12	program	program	NOUN
ffhd-35	227	13	(	(	PUNCT
ffhd-35	227	14	ncep	ncep	NOUN
ffhd-35	227	15	)	)	PUNCT
ffhd-35	227	16	.	.	PUNCT
ffhd-35	228	1	expert	expert	ADJ
ffhd-35	228	2	panel	panel	NOUN
ffhd-35	228	3	on	on	ADP
ffhd-35	228	4	detection	detection	NOUN
ffhd-35	228	5	,	,	PUNCT
ffhd-35	228	6	evaluation	evaluation	NOUN
ffhd-35	228	7	,	,	PUNCT
ffhd-35	228	8	and	and	CCONJ
ffhd-35	228	9	treatment	treatment	NOUN
ffhd-35	228	10	of	of	ADP
ffhd-35	228	11	high	high	ADJ
ffhd-35	228	12	blood	blood	NOUN
ffhd-35	228	13	cholesterol	cholesterol	NOUN
ffhd-35	228	14	in	in	ADP
ffhd-35	228	15	adults	adult	NOUN
ffhd-35	228	16	(	(	PUNCT
ffhd-35	228	17	adult	adult	NOUN
ffhd-35	228	18	treatment	treatment	NOUN
ffhd-35	228	19	panel	panel	NOUN
ffhd-35	228	20	iii	iii	PROPN
ffhd-35	228	21	)	)	PUNCT
ffhd-35	228	22	.	.	PUNCT
ffhd-35	229	1	jama	jama	PROPN
ffhd-35	229	2	.	.	PUNCT
ffhd-35	230	1	2001	2001	NUM
ffhd-35	230	2	;	;	PUNCT
ffhd-35	230	3	285:2486	285:2486	NUM
ffhd-35	230	4	-	-	SYM
ffhd-35	230	5	97	97	NUM
ffhd-35	230	6	.	.	PUNCT
ffhd-35	231	1	21	21	NUM
ffhd-35	231	2	.	.	PUNCT
ffhd-35	232	1	trinder	trinder	PROPN
ffhd-35	232	2	p.	p.	NOUN
ffhd-35	232	3	determination	determination	NOUN
ffhd-35	232	4	of	of	ADP
ffhd-35	232	5	blood	blood	NOUN
ffhd-35	232	6	glucose	glucose	NOUN
ffhd-35	232	7	using	use	VERB
ffhd-35	232	8	4	4	NUM
ffhd-35	232	9	-	-	PUNCT
ffhd-35	232	10	aminophenazone	aminophenazone	NOUN
ffhd-35	232	11	as	as	ADP
ffhd-35	232	12	oxygen	oxygen	NOUN
ffhd-35	232	13	acceptor	acceptor	NOUN
ffhd-35	232	14	.	.	PUNCT
ffhd-35	233	1	j	j	PROPN
ffhd-35	233	2	clin	clin	PROPN
ffhd-35	233	3	pathol	pathol	NOUN
ffhd-35	233	4	1969	1969	NUM
ffhd-35	233	5	;	;	PUNCT
ffhd-35	233	6	22	22	NUM
ffhd-35	233	7	:	:	SYM
ffhd-35	233	8	158	158	NUM
ffhd-35	233	9	-	-	SYM
ffhd-35	233	10	61	61	NUM
ffhd-35	233	11	.	.	PUNCT
ffhd-35	234	1	22	22	NUM
ffhd-35	234	2	.	.	PUNCT
ffhd-35	235	1	richmond	richmond	PROPN
ffhd-35	235	2	w.	w.	PROPN
ffhd-35	235	3	preparation	preparation	NOUN
ffhd-35	235	4	and	and	CCONJ
ffhd-35	235	5	properties	property	NOUN
ffhd-35	235	6	of	of	ADP
ffhd-35	235	7	a	a	DET
ffhd-35	235	8	cholesterol	cholesterol	NOUN
ffhd-35	235	9	oxidase	oxidase	NOUN
ffhd-35	235	10	from	from	ADP
ffhd-35	235	11	nocardia	nocardia	PROPN
ffhd-35	235	12	sp	sp	PROPN
ffhd-35	235	13	.	.	PROPN
ffhd-35	235	14	and	and	CCONJ
ffhd-35	235	15	its	its	PRON
ffhd-35	235	16	application	application	NOUN
ffhd-35	235	17	to	to	ADP
ffhd-35	235	18	the	the	DET
ffhd-35	235	19	enzymatic	enzymatic	ADJ
ffhd-35	235	20	assay	assay	NOUN
ffhd-35	235	21	of	of	ADP
ffhd-35	235	22	total	total	ADJ
ffhd-35	235	23	cholesterol	cholesterol	NOUN
ffhd-35	235	24	in	in	ADP
ffhd-35	235	25	serum	serum	PROPN
ffhd-35	235	26	clin	clin	PROPN
ffhd-35	235	27	chem	chem	NOUN
ffhd-35	235	28	1973	1973	NUM
ffhd-35	235	29	;	;	PUNCT
ffhd-35	235	30	19:1350–56	19:1350–56	NUM
ffhd-35	235	31	.	.	PUNCT
ffhd-35	236	1	23	23	NUM
ffhd-35	236	2	.	.	PUNCT
ffhd-35	237	1	bucolo	bucolo	PROPN
ffhd-35	237	2	g	g	PROPN
ffhd-35	237	3	,	,	PUNCT
ffhd-35	237	4	david	david	PROPN
ffhd-35	237	5	h.	h.	PROPN
ffhd-35	237	6	quantitative	quantitative	ADJ
ffhd-35	237	7	determination	determination	NOUN
ffhd-35	237	8	of	of	ADP
ffhd-35	237	9	serum	serum	NOUN
ffhd-35	237	10	triglycerides	triglyceride	NOUN
ffhd-35	237	11	by	by	ADP
ffhd-35	237	12	the	the	DET
ffhd-35	237	13	use	use	NOUN
ffhd-35	237	14	of	of	ADP
ffhd-35	237	15	enzymes	enzyme	NOUN
ffhd-35	237	16	.	.	PUNCT
ffhd-35	238	1	clin	clin	PROPN
ffhd-35	238	2	chem	chem	PROPN
ffhd-35	238	3	1973	1973	NUM
ffhd-35	238	4	;	;	PUNCT
ffhd-35	238	5	19:476–82	19:476–82	NUM
ffhd-35	238	6	.	.	PUNCT
ffhd-35	239	1	24	24	NUM
ffhd-35	239	2	.	.	PUNCT
ffhd-35	240	1	bachorik	bachorik	PROPN
ffhd-35	240	2	ps	ps	PROPN
ffhd-35	240	3	,	,	PUNCT
ffhd-35	240	4	wood	wood	PROPN
ffhd-35	240	5	pd	pd	PROPN
ffhd-35	240	6	,	,	PUNCT
ffhd-35	240	7	albers	albers	PROPN
ffhd-35	240	8	jj	jj	PROPN
ffhd-35	240	9	,	,	PUNCT
ffhd-35	240	10	steiner	steiner	PROPN
ffhd-35	240	11	p	p	PROPN
ffhd-35	240	12	,	,	PUNCT
ffhd-35	240	13	dempsey	dempsey	PROPN
ffhd-35	240	14	m	m	PROPN
ffhd-35	240	15	,	,	PUNCT
ffhd-35	240	16	kuba	kuba	PROPN
ffhd-35	240	17	k	k	PROPN
ffhd-35	240	18	,	,	PUNCT
ffhd-35	240	19	karlsson	karlsson	PROPN
ffhd-35	240	20	l.	l.	PROPN
ffhd-35	240	21	plasma	plasma	PROPN
ffhd-35	240	22	high	high	ADJ
ffhd-35	240	23	-	-	PUNCT
ffhd-35	240	24	density	density	NOUN
ffhd-35	240	25	lipoprotein	lipoprotein	ADJ
ffhd-35	240	26	cholesterol	cholesterol	NOUN
ffhd-35	240	27	concentrations	concentration	NOUN
ffhd-35	240	28	determined	determine	VERB
ffhd-35	240	29	after	after	ADP
ffhd-35	240	30	removal	removal	NOUN
ffhd-35	240	31	of	of	ADP
ffhd-35	240	32	other	other	ADJ
ffhd-35	240	33	lipoproteins	lipoprotein	NOUN
ffhd-35	240	34	by	by	ADP
ffhd-35	240	35	heparin	heparin	NOUN
ffhd-35	240	36	/	/	SYM
ffhd-35	240	37	manganese	manganese	NOUN
ffhd-35	240	38	precipitation	precipitation	NOUN
ffhd-35	240	39	or	or	CCONJ
ffhd-35	240	40	by	by	ADP
ffhd-35	240	41	ultracentrifugation	ultracentrifugation	NOUN
ffhd-35	240	42	.	.	PUNCT
ffhd-35	241	1	clin	clin	PROPN
ffhd-35	241	2	chem	chem	PROPN
ffhd-35	241	3	1976	1976	NUM
ffhd-35	241	4	;	;	PUNCT
ffhd-35	241	5	22	22	NUM
ffhd-35	241	6	:	:	SYM
ffhd-35	241	7	1928–34	1928–34	NUM
ffhd-35	241	8	.	.	PUNCT
ffhd-35	242	1	25	25	NUM
ffhd-35	242	2	.	.	PUNCT
ffhd-35	242	3	friedewald	friedewald	ADJ
ffhd-35	242	4	wt	wt	NOUN
ffhd-35	242	5	,	,	PUNCT
ffhd-35	242	6	levy	levy	NOUN
ffhd-35	242	7	ri	ri	PROPN
ffhd-35	242	8	,	,	PUNCT
ffhd-35	242	9	fredrickson	fredrickson	PROPN
ffhd-35	242	10	ds	ds	PROPN
ffhd-35	242	11	.	.	PROPN
ffhd-35	242	12	estimation	estimation	NOUN
ffhd-35	242	13	of	of	ADP
ffhd-35	242	14	the	the	DET
ffhd-35	242	15	concentration	concentration	NOUN
ffhd-35	242	16	of	of	ADP
ffhd-35	242	17	lowdensity	lowdensity	NOUN
ffhd-35	242	18	lipoprotein	lipoprotein	ADJ
ffhd-35	242	19	cholesterol	cholesterol	NOUN
ffhd-35	242	20	in	in	ADP
ffhd-35	242	21	plasma	plasma	NOUN
ffhd-35	242	22	,	,	PUNCT
ffhd-35	242	23	without	without	ADP
ffhd-35	242	24	use	use	NOUN
ffhd-35	242	25	of	of	ADP
ffhd-35	242	26	the	the	DET
ffhd-35	242	27	preparative	preparative	ADJ
ffhd-35	242	28	ultracentrifuge	ultracentrifuge	NOUN
ffhd-35	242	29	.	.	PUNCT
ffhd-35	243	1	clin	clin	PROPN
ffhd-35	243	2	chem	chem	NOUN
ffhd-35	243	3	1972	1972	NUM
ffhd-35	243	4	;	;	PUNCT
ffhd-35	243	5	18:499	18:499	NUM
ffhd-35	243	6	-	-	SYM
ffhd-35	243	7	02	02	NUM
ffhd-35	243	8	.	.	PROPN
ffhd-35	243	9	26	26	NUM
ffhd-35	243	10	.	.	PUNCT
ffhd-35	244	1	chandran	chandran	PROPN
ffhd-35	244	2	m	m	PROPN
ffhd-35	244	3	,	,	PUNCT
ffhd-35	244	4	phillips	phillips	PROPN
ffhd-35	244	5	sa	sa	PROPN
ffhd-35	244	6	,	,	PUNCT
ffhd-35	244	7	ciaraldi	ciaraldi	PROPN
ffhd-35	244	8	t	t	PROPN
ffhd-35	244	9	,	,	PUNCT
ffhd-35	244	10	henry	henry	PROPN
ffhd-35	244	11	rr	rr	PROPN
ffhd-35	244	12	.	.	PUNCT
ffhd-35	245	1	adiponectin	adiponectin	NOUN
ffhd-35	245	2	:	:	PUNCT
ffhd-35	245	3	more	more	ADJ
ffhd-35	245	4	than	than	ADP
ffhd-35	245	5	just	just	ADV
ffhd-35	245	6	another	another	DET
ffhd-35	245	7	fat	fat	ADJ
ffhd-35	245	8	cell	cell	NOUN
ffhd-35	245	9	hormone	hormone	NOUN
ffhd-35	245	10	?	?	PUNCT
ffhd-35	246	1	diabetes	diabete	NOUN
ffhd-35	246	2	care	care	VERB
ffhd-35	246	3	2003	2003	NUM
ffhd-35	246	4	;	;	PUNCT
ffhd-35	246	5	26:2442–50	26:2442–50	NUM
ffhd-35	246	6	.	.	PUNCT
ffhd-35	247	1	functional	functional	ADJ
ffhd-35	247	2	foods	food	NOUN
ffhd-35	247	3	in	in	ADP
ffhd-35	247	4	health	health	NOUN
ffhd-35	247	5	and	and	CCONJ
ffhd-35	247	6	disease	disease	NOUN
ffhd-35	247	7	2013	2013	NUM
ffhd-35	247	8	;	;	PUNCT
ffhd-35	247	9	3(11):416	3(11):416	NUM
ffhd-35	247	10	-	-	SYM
ffhd-35	247	11	427	427	NUM
ffhd-35	247	12	page	page	NOUN
ffhd-35	247	13	427	427	NUM
ffhd-35	247	14	of	of	ADP
ffhd-35	247	15	427	427	NUM
ffhd-35	247	16	27	27	NUM
ffhd-35	247	17	.	.	PUNCT
ffhd-35	247	18	ouchi	ouchi	PROPN
ffhd-35	247	19	n	n	CCONJ
ffhd-35	247	20	,	,	PUNCT
ffhd-35	247	21	kihara	kihara	PROPN
ffhd-35	247	22	s	s	PROPN
ffhd-35	247	23	,	,	PUNCT
ffhd-35	247	24	arita	arita	PROPN
ffhd-35	247	25	y	y	PROPN
ffhd-35	247	26	,	,	PUNCT
ffhd-35	247	27	nishida	nishida	PROPN
ffhd-35	247	28	m	m	PROPN
ffhd-35	247	29	,	,	PUNCT
ffhd-35	247	30	matsuyama	matsuyama	PROPN
ffhd-35	247	31	a.	a.	NOUN
ffhd-35	247	32	adipocyte	adipocyte	NOUN
ffhd-35	247	33	-	-	PUNCT
ffhd-35	247	34	derived	derive	VERB
ffhd-35	247	35	plasma	plasma	NOUN
ffhd-35	247	36	protein	protein	NOUN
ffhd-35	247	37	,	,	PUNCT
ffhd-35	247	38	adiponectin	adiponectin	NOUN
ffhd-35	247	39	,	,	PUNCT
ffhd-35	247	40	suppresses	suppress	VERB
ffhd-35	247	41	lipid	lipid	ADJ
ffhd-35	247	42	accumulation	accumulation	NOUN
ffhd-35	247	43	and	and	CCONJ
ffhd-35	247	44	class	class	NOUN
ffhd-35	247	45	a	a	DET
ffhd-35	247	46	scavenger	scavenger	NOUN
ffhd-35	247	47	receptor	receptor	NOUN
ffhd-35	247	48	expression	expression	NOUN
ffhd-35	247	49	in	in	ADP
ffhd-35	247	50	human	human	ADJ
ffhd-35	247	51	monocyte	monocyte	NOUN
ffhd-35	247	52	-	-	PUNCT
ffhd-35	247	53	derived	derive	VERB
ffhd-35	247	54	macrophages	macrophage	NOUN
ffhd-35	247	55	circulation	circulation	NOUN
ffhd-35	247	56	2001;103:1057	2001;103:1057	NUM
ffhd-35	247	57	-	-	SYM
ffhd-35	247	58	63	63	NUM
ffhd-35	247	59	.	.	PUNCT
ffhd-35	248	1	28	28	NUM
ffhd-35	248	2	.	.	PUNCT
ffhd-35	249	1	matsushita	matsushita	PROPN
ffhd-35	249	2	k	k	PROPN
ffhd-35	249	3	,	,	PUNCT
ffhd-35	249	4	ishikawa	ishikawa	PROPN
ffhd-35	249	5	t	t	PROPN
ffhd-35	249	6	,	,	PUNCT
ffhd-35	249	7	sumita	sumita	PROPN
ffhd-35	249	8	s	s	PROPN
ffhd-35	249	9	,	,	PUNCT
ffhd-35	249	10	kobayashi	kobayashi	PROPN
ffhd-35	249	11	t	t	PROPN
ffhd-35	249	12	,	,	PUNCT
ffhd-35	249	13	ogawa	ogawa	PROPN
ffhd-35	249	14	h	h	PROPN
ffhd-35	249	15	,	,	PUNCT
ffhd-35	249	16	inoue	inoue	PROPN
ffhd-35	249	17	n	n	PRON
ffhd-35	249	18	,	,	PUNCT
ffhd-35	249	19	katsumi	katsumi	PROPN
ffhd-35	249	20	matsumoto	matsumoto	PROPN
ffhd-35	249	21	k.	k.	PROPN
ffhd-35	249	22	comparison	comparison	NOUN
ffhd-35	249	23	of	of	ADP
ffhd-35	249	24	circulating	circulate	VERB
ffhd-35	249	25	adiponectin	adiponectin	NOUN
ffhd-35	249	26	and	and	CCONJ
ffhd-35	249	27	proinflammatory	proinflammatory	ADJ
ffhd-35	249	28	markers	marker	NOUN
ffhd-35	249	29	regarding	regard	VERB
ffhd-35	249	30	their	their	PRON
ffhd-35	249	31	association	association	NOUN
ffhd-35	249	32	with	with	ADP
ffhd-35	249	33	metabolic	metabolic	NOUN
ffhd-35	249	34	syndrome	syndrome	NOUN
ffhd-35	249	35	in	in	ADP
ffhd-35	249	36	japanese	japanese	ADJ
ffhd-35	249	37	men	man	NOUN
ffhd-35	249	38	.	.	PUNCT
ffhd-35	250	1	arterioscler	arterioscler	PROPN
ffhd-35	250	2	thromb	thromb	PROPN
ffhd-35	250	3	vasc	vasc	PROPN
ffhd-35	250	4	biol	biol	PROPN
ffhd-35	250	5	2006	2006	NUM
ffhd-35	250	6	;	;	PUNCT
ffhd-35	250	7	26:871–6	26:871–6	NUM
ffhd-35	250	8	.	.	X
ffhd-35	251	1	29	29	NUM
ffhd-35	251	2	.	.	PUNCT
ffhd-35	252	1	gazi	gazi	PROPN
ffhd-35	252	2	i	i	PROPN
ffhd-35	252	3	,	,	PUNCT
ffhd-35	252	4	liberopoulos	liberopoulos	PROPN
ffhd-35	252	5	en	en	PROPN
ffhd-35	252	6	,	,	PUNCT
ffhd-35	252	7	mikhailidis	mikhailidis	ADJ
ffhd-35	252	8	dp	dp	NOUN
ffhd-35	252	9	,	,	PUNCT
ffhd-35	252	10	elisaf	elisaf	ADP
ffhd-35	252	11	m.	m.	NOUN
ffhd-35	252	12	metabolic	metabolic	NOUN
ffhd-35	252	13	syndrome	syndrome	PROPN
ffhd-35	252	14	:	:	PUNCT
ffhd-35	252	15	clinical	clinical	ADJ
ffhd-35	252	16	features	feature	NOUN
ffhd-35	252	17	leading	lead	VERB
ffhd-35	252	18	to	to	ADP
ffhd-35	252	19	therapeutic	therapeutic	ADJ
ffhd-35	252	20	strategies	strategy	NOUN
ffhd-35	252	21	.	.	PUNCT
ffhd-35	253	1	vasc	vasc	PROPN
ffhd-35	253	2	dis	dis	PROPN
ffhd-35	253	3	prev	prev	PROPN
ffhd-35	253	4	2004	2004	NUM
ffhd-35	253	5	;	;	PUNCT
ffhd-35	253	6	1:243	1:243	NUM
ffhd-35	253	7	-	-	SYM
ffhd-35	253	8	53	53	NUM
ffhd-35	253	9	.	.	PUNCT
ffhd-35	253	10	30	30	NUM
ffhd-35	253	11	.	.	PUNCT
ffhd-35	254	1	brunzell	brunzell	PROPN
ffhd-35	254	2	jd	jd	PROPN
ffhd-35	254	3	,	,	PUNCT
ffhd-35	254	4	hokanson	hokanson	PROPN
ffhd-35	254	5	je	je	PROPN
ffhd-35	254	6	.	.	PROPN
ffhd-35	255	1	dyslipidemia	dyslipidemia	NOUN
ffhd-35	255	2	of	of	ADP
ffhd-35	255	3	central	central	ADJ
ffhd-35	255	4	obesity	obesity	NOUN
ffhd-35	255	5	and	and	CCONJ
ffhd-35	255	6	insulin	insulin	NOUN
ffhd-35	255	7	resistance	resistance	NOUN
ffhd-35	255	8	.	.	PUNCT
ffhd-35	256	1	diabetes	diabetes	NOUN
ffhd-35	256	2	care	care	VERB
ffhd-35	256	3	1999	1999	NUM
ffhd-35	256	4	;	;	PUNCT
ffhd-35	256	5	22	22	NUM
ffhd-35	256	6	:	:	PUNCT
ffhd-35	256	7	c10	c10	PROPN
ffhd-35	256	8	-	-	PUNCT
ffhd-35	256	9	c13	c13	PROPN
ffhd-35	256	10	.	.	PUNCT
ffhd-35	257	1	31	31	NUM
ffhd-35	257	2	.	.	PUNCT
ffhd-35	258	1	liberopoulos	liberopoulos	PROPN
ffhd-35	258	2	en	en	PROPN
ffhd-35	258	3	,	,	PUNCT
ffhd-35	258	4	daskalopoulou	daskalopoulou	PROPN
ffhd-35	258	5	ss	ss	PROPN
ffhd-35	258	6	,	,	PUNCT
ffhd-35	258	7	mikhailidis	mikhailidis	ADJ
ffhd-35	258	8	dp	dp	NOUN
ffhd-35	258	9	.	.	PUNCT
ffhd-35	258	10	management	management	NOUN
ffhd-35	258	11	of	of	ADP
ffhd-35	258	12	high	high	ADJ
ffhd-35	258	13	triglycerides	triglyceride	NOUN
ffhd-35	258	14	:	:	PUNCT
ffhd-35	258	15	what	what	PRON
ffhd-35	258	16	non	non	NOUN
ffhd-35	258	17	specialists	specialist	NOUN
ffhd-35	258	18	in	in	ADP
ffhd-35	258	19	lipids	lipid	NOUN
ffhd-35	258	20	need	need	NOUN
ffhd-35	258	21	to	to	PART
ffhd-35	258	22	know	know	VERB
ffhd-35	258	23	.	.	PUNCT
ffhd-35	259	1	hell	hell	NOUN
ffhd-35	259	2	j	j	PROPN
ffhd-35	259	3	cardiol	cardiol	NOUN
ffhd-35	259	4	2005	2005	NUM
ffhd-35	259	5	;	;	PUNCT
ffhd-35	259	6	46:268	46:268	NUM
ffhd-35	259	7	-	-	SYM
ffhd-35	259	8	72	72	NUM
ffhd-35	259	9	.	.	PUNCT
ffhd-35	259	10	32	32	NUM
ffhd-35	259	11	.	.	PUNCT
ffhd-35	260	1	bairaktari	bairaktari	PROPN
ffhd-35	260	2	et	et	PROPN
ffhd-35	260	3	,	,	PUNCT
ffhd-35	260	4	seferiadis	seferiadi	NOUN
ffhd-35	260	5	ki	ki	PROPN
ffhd-35	260	6	,	,	PUNCT
ffhd-35	260	7	elisaf	elisaf	ADP
ffhd-35	260	8	m.	m.	NOUN
ffhd-35	260	9	evaluation	evaluation	NOUN
ffhd-35	260	10	of	of	ADP
ffhd-35	260	11	methods	method	NOUN
ffhd-35	260	12	for	for	ADP
ffhd-35	260	13	the	the	DET
ffhd-35	260	14	measurement	measurement	NOUN
ffhd-35	260	15	of	of	ADP
ffhd-35	260	16	low	low	ADJ
ffhd-35	260	17	-	-	PUNCT
ffhd-35	260	18	density	density	NOUN
ffhd-35	260	19	lipoprotein	lipoprotein	ADJ
ffhd-35	260	20	cholesterol	cholesterol	NOUN
ffhd-35	260	21	.	.	PUNCT
ffhd-35	261	1	j	j	PROPN
ffhd-35	261	2	cardiovasc	cardiovasc	PROPN
ffhd-35	261	3	pharmacol	pharmacol	PROPN
ffhd-35	261	4	therapeut	therapeut	NOUN
ffhd-35	261	5	2005	2005	NUM
ffhd-35	261	6	;	;	PUNCT
ffhd-35	261	7	10:4554	10:4554	NUM
ffhd-35	261	8	.	.	PUNCT